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II 
Abstract 
 
Peroxisomes are subcellular organelles found virtually in all eukaryotic cells. They 
perform various functions depending on organism, cell type or environmental 
conditions. The importance of peroxisomes for human development and health is 
shown by the occurrence of inherited peroxisomal disorders. Peroxisome biogenesis 
involves a number of processes including peroxisomal membrane protein and matrix 
protein import, growth of the lipid bilayer and proliferation. Peroxisomal matrix 
proteins are directed to peroxisomes by the conserved targeting signals PTS1 and 
PTS2. However, a subset of matrix proteins neither contains a PTS1 nor PTS2. In 
this, study I describe how one of these latter enzymes, the nicotinamidase Pnc1 
enters peroxisomes. We found that Pnc1 is co-imported with the PTS2-containing 
enzyme Gpd1 by a piggy-back mechanism. This mechanism requires the PTS2 
receptor Pex7 and its coreceptor Pex21. In addition, we found that Pnc1 piggy-back 
import relies on homodimerisation of Gpd1. 
In the second part of this thesis, I describe the analysis of the AAA+ATPase Msp1 
and the attempts to uncover its role in peroxisome biogenesis. A genome wide 
screen revealed a genetic interaction with two proteins; Pex25 and the novel PMP 
Ygr168c indicating a role of Msp1 in the regulation of peroxisome abundance. A 
preliminary analysis of Ygr168c is also presented. 
Together these studies further our understanding of peroxisomal protein import and 
biogenesis and provide novel areas for future exploration. 
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Chapter 1  
 
 
1 Introduction 
 
1-1 Peroxisomes  
 
Peroxisomes are members of the microbody family of organelles, which are related 
to the glyoxysomes of plants and glycosomes of trypanosomes (Holroyd and 
Erdmann, 2001). Microbodies were first observed in mouse kidney cells by Rhodin 
(Rhodin, 1954). Moreover, peroxisomes were defined by de Duve as a compartment 
containing at least one hydrogen peroxide generating oxidase and catalase, which 
catalyses the conversion of the toxic hydrogen peroxide to oxygen and water (De 
Duve and Baudhuin, 1966). The term peroxisome relates to metabolism of hydrogen 
peroxide, not to peroxidases (Lazarow and Fujiki, 1985). 
 
Peroxisomes are present in all eukaryotic cells ranging from single to multicellular 
microorganisms to plants and animals (van den Bosch et al., 1992). However, some 
parasitic eukaryotic protozoa such as Giardia and Trichomonas lack peroxisomes  
(Hawkins et al., 2007). Furthermore, Tapeworms, flukes and parasitic roundworms of 
the order Trichocephalida have lost many genes associated with peroxisomes and 
are lacking these organelles (Tsai et al., 2013; Zarsky and Tachezy, 2015). 
 
 
 
The abundance of peroxisomes can vary from a few per cell like in yeast, to 
hundreds or thousands per cell in mammals (Gould and Valle, 2000). However, 
peroxisomes are abundant in liver cells and neurons (Hawkins et al., 2007). 
Peroxisomes are surrounded by a single membrane (Baker and Sparkes, 2005), 
have a spherical shape and range in diameter from 0.1 to 1µm (Holroyd and 
Erdmann, 2001). Unlike mitochondria, nuclei, and chloroplasts, peroxisomes lack 
DNA. Therefore, all peroxisomal proteins are nuclear encoded (Lazarow and 
Fujiki,1985). 
 
Peroxisomal matrix and membrane proteins are imported posttranslationally (Baker 
and Sparkes, 2005). The peroxisomes have the ability to import folded cofactor-
bound, and/or oligomeric polypeptides (Léon et al., 2006a). This translocation 
machinery differs from import of unfolded polypeptides to the endoplasmic reticulum 
(ER), mitochondria, and chloroplast (Schnell and Hebert, 2003). Although 
peroxisomes can import folded proteins, it is unclear whether this is the preferred 
mechanism of import (Dias et al., 2016). 
 
 
 
2 
Peroxisomes are responsible for different metabolic functions that vary according to 
species and cell type, and the environmental or developmental circumstances. Many 
peroxisomal processes produce hydrogen peroxide; consequently, decomposition of 
this harmful substance is an essential function, which happens in almost all 
peroxisomes by catalase (Heiland and Erdmann, 2005).  
 
In addition, beta-oxidation of fatty acids (FAs) is a function for virtually all types of 
peroxisomes. In humans, mitochondria metabolise short and medium-chain FAs and 
long-chain FAs via beta-oxidation; whereas, very long- chain FAs (VLCFAs) are 
oxidised exclusively in peroxisomes. Moreover, in mammals, peroxisomes have 
additional functions including ether phospholipid (plasmalogen) biosynthesis, FA 
alpha-oxidation, glyoxylate detoxification and bile acid formation (Wanders and 
Waterham, 2006a; Scott and Olpin, 2011).  
 
 
Although beta-oxidation is distributed between mitochondria and peroxisomes in 
mammals, it occurs only in peroxisomes in plants and yeast (Wanders and 
Waterham, 2006a). Moreover, peroxisomes were recently reported to function in 
antiviral signal transduction and a rapid response to viral infection (Dixit et al., 2010). 
Furthermore, a protective function has been described for peroxisomes in neuron 
response to ischemic injury by increasing peroxisome biogenesis, likely mediated by 
enhanced antioxidant capacity of neurons (Young et al., 2015). Another role for 
peroxisomes has been shown in deafness recently (Delmaghani et al., 2015). 
 
 
The glycosomes in the parasitic protozoa Trypanosoma and Leishmania contain the 
glycolytic enzymes. These enzymes are required for the survival of these organisms 
(Sibirny, 2012). Peroxisomes are required for specific functions in filamentous fungi 
including penicillin biosynthesis (Meijer et al., 2010). Filamentous fungi contain 
Woronin bodies, which are peroxisome derived organelles that have the ability to 
seal septal pores in the hyphae to prevent fatal cytosolic bleeding after injury (Jedd 
and Chua, 2000). In addition, peroxisomes have a role in pathogenicity of fungi. For 
example, peroxisomes in some pathogenic fungi are responsible for the toxin 
production that is essential for host invasion (Islinger et al., 2012). 
 
 
Plant peroxisomes are involved in, for instance, photorespiration and Vitamin K 
biosynthesis (Brown and Baker, 2003; Babujee et al., 2010; Widhalm et al., 2012). 
Recently, new functions of peroxisomes were described in the fruit fly, Drosophila 
melanogaster. The disruption of PEX genes in this fly leads to spermatogenesis 
defects (Chen et al., 2010) and affects muscle physiology (Faust et al., 2014). 
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Together, the above evidence illustrates the variability of peroxisomal functions in 
different organisms and undoubtedly new functions will be discovered in the future. 
 
 
1-2 Human peroxisomal disorders 
 
  
The important roles for peroxisomes in human life are revealed by the discovery of 
inherited disorders that are a consequence of peroxisomal dysfunction (Fidaleo, 
2010). The first connection between peroxisomes and Zellweger syndrome (Zs) was 
reported in 1973 when Goldfisher et al., reported that peroxisomes were absent in 
hepatocytes and kidney tubule cells from ZS patients (Goldfischer et al., 1973). In 
1984, a specific biomarker was identified to screen for peroxisomal disorder patients. 
The high level of VLCFAs provides an effective method for screening, diagnosis and 
prenatal detection of the Zellweger syndrome (Moser et al., 1984). Impairment in 
genes that encode peroxisomal proteins in humans can lead to various peroxisomal 
disorders (Ebberink et al., 2012). These disorders are divided into two groups: 
Peroxisomal Biogenesis Disorders (PBDs) and the Peroxisomal Enzyme Deficiencies 
(PEDs). 
 
 
1-2-1 Peroxisomal biogenesis disorders (PBDs) 
 
PBDs are autosomal recessive disorders caused by mutation of genes encoding 
peroxins. These are proteins required for peroxisome biogenesis (Gould and Valle, 
2000; Waterham and Ebberink, 2012; Waterham et al., 2016). Consequently, 
peroxisomes are either completely absent as a result of a defect in their biogenesis 
(Hettema et al., 2000) or form empty membrane compartments lacking enzymatic 
content (‘ghosts’) (Schliebs and Kunau, 2004). Therefore, these diseases are 
classified as protein targeting diseases (Hettema et al., 1999). Thirteen PEX genes 
have now been associated with PBDs (Steinberg et al., 2006; Waterham and 
Ebberink, 2012 ). More recently, a few patients have been identified with mutations 
that affect peroxisomal division (Ebberink et al., 2012; Huber et al., 2013). 
 
The PBDs can be divided into three subgroups: Zellweger syndrome spectrum 
(ZSS), rhizomelic chondrodysplasia punctata type 1 and 5 (RCDP1) and the 
peroxisomal fission defects. These disorders are listed in Table 1-1. 
 
The ZSS involves a group of overlapping clinical phenotypes including Zellweger 
syndrome (ZS), neonatal adrenoleukodystrophy (NALD) and infantile Refsum 
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disease (IRD). With Zellweger syndrome is being the most severe followed by NALD 
and IRD respectively (Wanders and Waterham, 2005; Braverman et al., 2013). 
Children with ZS normally die during their first year of life. However, children with 
NALD may live longer until their teens, while IRD patients may reach adulthood 
(Waterham and Ebberink, 2012). The common characteristics of PBD patients are 
neurological abnormalities and developmental defects, which appear early after birth 
(Wanders and Waterham, 2005). 
 
 
 
 
 
 
 
 
Table 1-1: Peroxisomal biogenesis disorders. Table is adapted from (Fujiki et al., 2012, 
Waterham et al., 2016). 
 
   
 
Human peroxisomal disorders 
 
Gene affected 
 
Role 
ZS, NALD PEX5 PTS1 receptor 
RCDP1 PEX7 PTS2 receptor 
ZS PEX14 Docking complex 
ZS, NALD PEX13  Docking complex 
ZS, NALD PEX10 RING finger complex 
ZS, NALD, IRD PEX12 RING finger complex 
ZS, IRD PEX2 RING finger complex 
ZS, NALD, IRD PEX6 AAA export complex 
ZS, NALD, IRD PEX26 AAA export complex 
ZS, NALD, IRD PEX1 AAA export complex 
ZS PEX3 Membrane biogenesis 
ZS PEX19 Membrane biogenesis 
ZS PEX16 Membrane biogenesis 
Peroxisomal fission defects DLP1, MFF 
GDAP1, PEX11β  
Peroxisome division  
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1-2-2 Single peroxisomal enzyme deficiencies (PEDs) 
 
 
PEDs are the consequence of a defect in a single peroxisomal matrix enzyme or 
membrane protein involved in metabolite transport (Waterham et al., 2016). In spite 
of more than 50 peroxisomal proteins having been identified; only few peroxisomal 
disorders related to loss of a single enzyme have been diagnosed. The majority of 
PEDs are a consequence of a deficiency in fatty acid β-oxidation. Other diseases 
include a deficiency in α-oxidation, glyoxylate detoxification, H2O2-metabolism and 
ether phospholipid synthesis. Recently, two new single enzyme deficiencies were 
reported that affect plasmalogens and bile acid synthesis, respectively (Table 1-2) 
(Clayton, 2011; Ferdinandusse et al., 2015).  
 
X-ALD is the most common peroxisomal disease and is a consequence of mutation 
in the ABCD1 gene. This gene encodes one of three known peroxisomal ABC half 
transporters. ABCD1 is involved in the transport of VLCFAs across the peroxisomal 
membrane (Scott and Olpin, 2011).  
More recently, a defect of Pejvakin in mice, and DFNB59 in humans, results in 
hypervulnerability to sound, as a result of a peroxisomal proliferation deficiency 
(Delmaghani et al., 2015). 
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Table 1-2: List of the single peroxisomal enzyme deficiencies. Adapted from (Wanders 
and  Waterham, 2006b; Waterham et al., 2016). 
 
 
 
 
Peroxisomal diseases 
 
Enzyme deficiency 
 
Peroxisomal metabolism   
affected 
Acyl-CoA oxidase deficiency ACOX1 Beta-oxidation  
Rhizomelic  
chondrodysplasia punctata 
Type 3 (alkyl-DHAP synthase) 
ADHAPS Beta-oxidation 
Hyperoxaluria Type 1 AGT Glyoxylate detoxification 
Refsum disease (phytanoyl-
CoA hydroxylase deficiency) 
PHYH/PAHX Alpha-oxidation 
X-linked 
adrenoleukodystrophy 
ALDP 
ABCD1 
Beta-oxidation  
Rhizomelic chondrodysplasia 
punctata Type 2 (DHAPAT 
deficiency) 
DHAPAT     Ether phospholipid synthesis 
 
D-bifunctional protein 
deficiency 
DBP Beta-oxidation  
2-MethylacylCoA racemase 
deficiency 
AMACR Beta-oxidation  
Sterol carrier protein X 
deficiency 
SCPx Beta-oxidation  
Acatalasaemia CAT   H2O2-metabolism 
FAR1   deficiency  –RCDP 
type 4 
acyl-CoA reductase 1 Plasmalogen synthesis  
ABCD3 (PMP70) deficiency   ABCD3 Bile acid synthesis 
BAAT deficiency 
 
CoA:amino acid 
N-acyltransferase 
Bile acid synthesis 
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1-3 Peroxins and peroxisome biogenesis  
 
 
 
 
 
The genetic analysis of peroxisome biogenesis impairment in yeast and mammalian 
cells has assisted in the identification of a number of protein factors. These factors 
are known as peroxins, which are fundamental for peroxisome biogenesis (Tabak et 
al., 1999; Fujiki et al., 2000; Fujiki, 2000; Fujiki and Okumoto, 2000). The first 
peroxisome biogenesis mutants were isolated in the yeast Saccharomyces 
cerevisiae based on an inability to grow on oleate medium and mislocalisation of 
matrix proteins to the cytosol. Subsequent complementation identified the first PEX 
gene (Erdmann et al., 1989; Erdmann et al., 1991). Similar approaches were used to 
identify pex mutants in other yeast species including Yarrowia lipolytica, Pichia 
pastoris   and the methylotrophic yeast Hansenula polymorpha (Cregg et al., 1990; 
Liu et al., 1992; Nuttley et al., 1993). Furthermore, Chinese hamster ovary (CHO) cell 
mutants showing a deficiency in plasmalogens were isolated, as peroxisomes 
constitute the sole site for plasmalogen synthesis (Tsukamoto et al., 1990). 
Moreover, genome wide screens in S. cerevisiae, combined with transcriptomics and 
proteomics, have now identified a large number of proteins that affect peroxisome 
assembly, multiplication and functions (Smith et al., 2002; Smith et al., 2006; 
Lockshon et al., 2007). Detailed analysis of growth characteristics and peroxisome 
number, size, and shape suggests that over 211 proteins affect the peroxisomal 
compartment (Saleem et al., 2010). 
 
Many complementation analyses were performed on mutant CHO cells and PBD 
patient fibroblasts to identify many peroxisomal genes. Reintroduction of the 
complementary functional gene into these cells led to the restoration of peroxisome 
formation (Shimozawa et al., 1992; Honsho et al., 1998; Matsumoto et al., 2003). 
 
 
 
To date, 34 PEX genes have been discovered in different organisms and are 
responsible for the targeting and import of peroxisomal proteins, peroxisome 
membrane biogenesis and the control of size and abundance of peroxisomes 
(Table1-3) (Tower et al., 2011). Detailed analysis of pex mutants has culminated in a 
model for peroxisome biogenesis in which the ER provides membranes and some 
PMPs. The remaining PMPs and matrix proteins are posttranslationally imported into 
the peroxisomal membrane. When peroxisomes reach a particular size, they are 
thought to divide. Whether peroxisomes mainly multiply by fission or de novo 
formation from the ER is a matter of debate and may vary between 
growth/experimental conditions and organisms (Kim and Hettema, 2015). 
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Peroxin Peroxisomal function Description References 
Pex1* Peroxisomal matrix protein import AAA ATPase involved in Pex5 recycling to the cytosol (Erdmann et al., 1991) 
Pex2* Peroxisomal matrix protein import a RING finger protein required for formation of the importomer with other PMPs 
(Pex10 and Pex12) and involved in polyubiquitination of Pex5. 
(Platta et al., 2009) 
Pex3* Peroxisomal matrix protein import an integral membrane protein is involved in PMPs targeting (Hettema et al., 2000) 
Pex4* Peroxisomal matrix protein import E2-like ubiquitin-conjugating enzyme required for ubiquitination of receptor Pex5. (Wiebel and Kunau, 1992)  
Pex5* Peroxisomal matrix protein import PTS1 receptor (Brocard et al., 1994) 
Pex6* Peroxisomal matrix protein import  AAA ATPase involved in Pex5 recycling to the cytosol  (Platta et al., 2004b) 
Pex7* Peroxisomal matrix protein import PTS2 receptor (Lazarow, 2006) 
Pex8* Peroxisomal matrix protein import  an intraperoxisomal protein that binds the PTS1-signal receptor Pex5 after cargo 
translocation 
(Agne et al., 2003; 
 Zhang et al., 2006) 
Pex10* Peroxisomal matrix protein import  a RING finger protein required for formation of the importomer with other PMPs 
(Pex2 and Pex12).  
(Warren et al., 1998) 
Pex11* Peroxisome size and number  a peroxisomal  membrane protein involved in peroxisome division  (Rottensteiner et al., 2003) 
Pex12* Peroxisomal matrix protein import a RING finger protein required for formation of the importomer with other PMPs 
(Pex2 and Pex10) and Pex5 ubiquitination 
(Platta et al., 2009) 
Pex13* Peroxisomal matrix protein import an integral peroxisomal membrane protein, it is one of the components of the 
docking complex . 
(Erdmann and Blobel, 1996) 
Pex14* Peroxisomal matrix protein import an integral peroxisomal membrane protein, it is one of the components of the 
docking complex 
(Brocard et al., 1997) 
Pex15* Peroxisomal matrix protein import an integral peroxisomal membrane protein that acts as a membrane anchor of Pex6. (Birschmann et al., 2003) 
Pex16 Peroxisomal membrane protein 
import 
required for targeting of PMPs during membrane biogenesis in mammals (Kim et al., 2006) 
Pex17* Peroxisomal matrix protein import a peripheral  peroxisomal membrane protein, it is one of the components of the 
docking complex 
(Huhse et al., 1998) 
Pex18* Peroxisomal matrix protein import a PTS2 co-receptor that interacts with Pex7 and the PTS2 (Stein et al., 2002) 
Table 1-3: shows peroxins and their peroxisomal function  
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Pex19* Peroxisomal membrane protein 
import 
a cytosolic protein that acts as a chaperone and import receptor for PMPs (Hettema et al., 2000) 
Pex20 Peroxisomal matrix protein import a homologue of Pex18 and Pex21 that is found in  Yarrowia lipolytica 
 
(Einwachter et al., 2001) 
Pex21* Peroxisomal matrix protein import a PTS2 co-receptor that interacts with Pex7 and the PTS2 (Stein et al., 2002) 
Pex22* Peroxisomal matrix protein import a PMP required to anchor Pex4 at the peroxisomal membrane (Koller et al., 1999) 
Pex23 Peroxisomal matrix protein import an integral membrane protein found  only in Yarrowia lipolytica . (Brown et al., 2000) 
Pex24 Peroxisomal matrix protein import an integral membrane protein found in Yarrowia lipolytica. It shows sequence 
similarity with Pex28 and Pex29 in S.cerevisiae. 
(Tam and Rachubinski, 
2002) 
Pex25 * Peroxisome abundance  PMP involved in regulating peroxisome number and size.  (Rottensteiner et al., 2003) 
Pex26 Peroxisomal matrix protein import a peroxisomal membrane protein in mammals, that offers a docking site for Pex6. (Léon et al., 2006a) 
Pex27* Peroxisome abundance   involved in regulating peroxisome number and size (Rottensteiner et al., 2003) 
Pex28* Peroxisome abundance  involved in regulating peroxisome size, number and distribution (Vizeacoumar et al., 2003) 
Pex29* Peroxisome abundance involved in regulating peroxisome size, number and distribution (Vizeacoumar et al., 2003) 
Pex30* Peroxisome abundance involved in regulation of peroxisome number (Vizeacoumar et al., 2004) 
Pex31* Peroxisome abundance involved in regulation of peroxisome number and size (Vizeacoumar et al., 2004) 
Pex32* Peroxisome abundance involved in regulation of peroxisome number and size (Vizeacoumar et al., 2004) 
Pex33 Peroxisomal matrix protein import part of the peroxisomal docking complex in Neurospora crassa. Its function is similar 
to Pex17 
(Managadze et al., 2010) 
Pex34* 
 
Peroxisome abundance regulates peroxisome division, morphology and numbers (Tower et al., 2011) 
 Table 1-3: shows the known peroxins and describes briefly their functions. 
* Peroxins present in S. cerevisiae 
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1-4 Import of peroxisomal matrix proteins  
 
 
Peroxisomal matrix proteins are synthesised on free ribosomes in the cytosol and are 
posttranslationally imported into peroxisomes (Figure1-1) (reviewed by Lazarow and 
Fujiki, 1985).  Most peroxisomal matrix proteins contain one of two distinct types of 
Peroxisomal Targeting Signals (PTS1 or PTS2). Most peroxisomal matrix proteins 
contain a PTS1 at the C-terminus, and few have a PTS2 near the N-terminus 
(Girzalsky et al., 2010). The PTS1 consists of a conserved tripeptide SKL sequence 
or variant thereof (Gould et al., 1989). The PTS2 is unrelated with the consensus 
sequence (R/K) (L/V/I) X5 (H/Q) (L/A) (Swinkels et al., 1991; Rachubinski and 
Subramani, 1995; Holroyd and Erdmann, 2001). 
 
In S. cerevisiae, only three proteins contain a PTS2 consensus sequence; thiolase 
(Pot1), glycerol-3-phosphate dehydrogenase1 (Gpd1) and peroxisomal coenzyme A 
diphosphatase (Pcd1) (Cartwright et al., 2000; Smith et al., 2006;  Grunau, 2009; 
Jung et al., 2010). Only for thiolase and Gpd1, the role of the putative PTS2 was 
confirmed to function as an independent targeting signal. However, the PTS2 
pathway is absent in some organisms such as Caenorhabditis elegans, Drosophila 
melanogaster and diatom Phaeodactylum tricornutum (Motley et al., 2000; Faust et 
al., 2012; Gonzalez et al., 2011). Therefore, the import of all peroxisomal matrix 
proteins in these organisms is exclusively performed by the PTS1 pathway (Hasan et 
al., 2013). However, about one-third of peroxisomal proteins in plants contain a PTS2 
targeting signal (Reumann, 2004).  
 
 
The PTS1 and PTS2 are recognised by soluble receptors (Pex5 and Pex7, 
respectively) that interact with the docking complex at the peroxisomal membrane to 
deliver cargo to the peroxisomal membrane (Islinger and Schrader, 2011). Pex5 
contains two domains: one domain at the C-terminus is composed of six 
tetratricopeptide repeats (TPRs) and shows high affinity binding sites for PTS1; and 
an N-terminal domain that is required for docking and recycling of the receptor 
(Stanley et al., 2006; Rucktaschel et al., 2011). Cargo proteins with a PTS2 are not 
only recognised by the soluble receptor Pex7 but also by coreceptors including 
Pex18 and Pex21 in S. cerevisiae (Schliebs and Kunau, 2006; Lazarow, 2006; Pan 
et al., 2013). Pex18 and Pex21 are paralogues that have partial overlapping 
substrate specificities (this thesis, Chapter 3) (Purdue et al., 1998). The orthologous 
Pex20 is the co-receptor for Pex7 in most other yeasts and fungi (reviewed by Hasan 
et al., 2013). However, a splice variant of Pex5, Pex5L, has been known to 
cooperate with Pex7 in mammalian and plant cells (Platta and Erdmann, 2007). 
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The import pathways for PTS1 and PTS2 proteins in yeast meet at the peroxisomal 
docking complex. In mammals, these two routes might meet in the cytosol at the 
point of the PTS1 receptor Pex5L (Holroyd and Erdmann, 2001).  
 
 
 
 
 
 Figure 1-1: Diagram of peroxisomal matrix protein import. 
1-Recognition of cargo by the receptors   2-Docking at peroxisomal membrane  3-Formation 
of protein conducting channel  4-Releasing the cargo  5-Recycling of the receptors. 
Peroxisomal matrix proteins carrying the PTS1 and PTS2 are recognised by soluble receptors 
Pex5 and Pex7, respectively. In contrast, Pex7 requires cooperation with other proteins such 
as Pex18 and Pex21. The receptor with its cargo docks at the peroxisomal membrane via the 
docking complex (Pex13, Pex14 and Pex17). The PTS1-proteins are transported through the 
membrane via a pore mainly consisting of Pex14 and Pex5. It has been suggested a specific 
pore for PTS2 proteins, the main PTS2 pore components are the co-receptor Pex18 and the 
Pex14/Pex17-docking complex. The RING finger proteins (Pex2, Pex10 and Pex12) 
associate with the docking complex via Pex8. Then, the receptor releases its cargo at the 
luminal side. Pex5 is ubiquitinated at the cytosolic side of the membrane and this is a 
prerequisite of subsequent recycling back to cytosol with help from Pex1 and Pex6. These 
AAA+ proteins are anchored to the peroxisomal membrane by Pex15 or Pex26. Picture is 
adapted from (Hettema et al., 2014). 
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In the second step, the cargo-loaded receptor binds the peroxisomal proteins Pex13 
and Pex14 that, together with Pex17, form the docking complex (Albertini et al., 
1997; Bottger et al., 2000). In addition, the protein import machinery is composed of 
a second complex that performs downstream of the docking event and is composed 
of three E3-like proteins; Pex2, Pex10, and Pex12. A common characteristic of these 
proteins is a RING finger domain at the C-terminus. The RING finger and the docking 
sub complex associate in a Pex8-dependent manner to constitute the importomer 
(Platta et al., 2009). Pex8 has been proposed to be the regulator of the importomer 
and is essential for import of peroxisomal matrix proteins through the PTS1 and 
PTS2 pathways (Agne et al., 2003; Zhang et al., 2006). 
Initially, it was believed that the receptors have the ability to recycle back into the 
cytosol after releasing their cargo at the docking site, termed the “‘simple shuttle’” 
model (Smith and Schnell, 2001; Lazarow, 2003). The extended shuttle hypothesis 
assumes that the receptor and its cargo enter the peroxisomal lumen rather than 
staying at the peroxisomal membrane. In this case, the cargo protein is released into 
the peroxisomal matrix and the receptor is recycled back to the cytosol (Dammai and 
Subramani, 2001; Heiland and Erdmann, 2005). 
A third model, the transit pore hypothesis, proposes a protein-conducting channel 
specific for import of peroxisomal matrix proteins. The pore assembles after docking 
of the receptor–cargo complex at the peroxisomal membrane and it is large and 
flexible to permit the translocation of completely folded proteins of different sizes. 
Experimental evidence of the existence of such pore has been reported (Meinecke et 
al., 2010). Pex5 together with Pex14 forms a gated ion-conducting channel that 
opens in the presence of cargo. The size of the opening of the channel varies 
between different cargoes, with larger cargoes opening the pore up to 9nm in 
diameter. Therefore, Pex5/Pex14 may be the minimal parts required for pore 
formation (Meinecke et al., 2010). Recently, it has been suggested that a PTS2-
specific pore exists that is distinct from the PTS1 pore. The major PTS2 pore 
components are the PTS2 co-receptor Pex18 and the Pex14/Pex17-docking 
complex. Unlike the PTS1 channel, the PTS2 pore is constitutively in an open state 
in vitro (Montilla-Martinez et al., 2015).  
 
Receptor-cargo dissociation and receptor recycling back to cytosol is performed by 
specific molecular machinery called the peroxisomal exportomer. This machinery is 
composed of sub-complexes that are required for generation of an export signal, 
which is the ubiquitination of receptors and mechano-enzymes that generate the 
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pulling-force to export the receptors from the peroxisomal membrane (Hasan et al., 
2013). This export complex consists of Pex4, Pex22, Pex1 and Pex6, and Pex26 or 
Pex15 (Miyata and Fujiki, 2005; Léon et al., 2006b). Pex4 is an E2-like ubiquitin-
conjugating enzyme. In S. cerevisiae, Pex5 is mono-ubiquitinated by the peroxisomal 
E2-enzyme Pex4 (Platta et al., 2007) and it is anchored to the peroxisomal 
membrane via Pex22 (Zolman et al., 2005; Koller et al., 1999). 
 
Pex4 and its membrane anchor Pex22 are absent in mammalian cells. After 
monoubiquitination, Pex5 is exported to the cytosol in an AAA ATPase dependent 
manner for another round of targeting (Hasan et al., 2013). Pex1 and Pex6 are two 
AAA ATPases that export Pex5 in an ATP-dependent manner (Platta et al., 2004b; 
Miyata and Fujiki, 2005). Pex15 in S. cerevisiae, or Pex26 in mammals, are 
peroxisomal membrane proteins that offer a docking site for Pex6 (Léon et al., 
2006a). The ATP consumption is hypothesised to introduce conformational changes 
within the AAA-peroxins that create the driving force to pull the receptor out of the 
membrane and release it into the cytosol.  Pex5 is polyubiquitinated and degraded by 
the proteasome if the recycling pathway is hampered (Platta et al., 2004a; Platta et 
al., 2007). This might be an essential step in a quality control system for removal of 
dysfunctional Pex5 and is also known as ‘Receptor Accumulation and Degradation in 
Absence of Recycling’ (RADAR) (Léon et al., 2006a). However, no evidence has 
been found for Pex7 ubiquitination or degradation, while it has been demonstrated 
that the ubiquitination of Pex18 in S. cerevisiae and Pex20 in P. pastoris has a role in 
their recycling (Léon et al., 2006b; Hensel et al., 2011). 
 
Interestingly, a subset of peroxisomal matrix proteins are targeted to peroxisomes 
independent of the two known classical targeting signals (Hasan et al., 2013). They 
can be imported into peroxisomes by using a PTS protein as a shuttle and this is 
called the piggy-back import (Figure 1-2). 
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Figure 1-2: Diagram illustrating piggy-back import of peroxisomal matrix proteins in 
yeast. Non-PTS proteins can be imported into peroxisomes by using a PTS protein as a 
shuttle factor. 
 
Initially, the piggy-back mechanism was observed when a subunit lacking a targeting 
signal was co-imported with another subunit carrying the targeting signal. In S. 
cerevisiae, thiolase lacking its targeting signal was shown to form a heterodimer 
with a full-length thiolase and imported into peroxisomes (Glover et al., 1994a). This 
type of mutimeric co-import is reported for different proteins (McNew and Goodman, 
1994; Elgersma et al., 1996; Lee et al., 1997; Jung et al., 2010; Thoms et al., 2008; 
Schueren et al., 2014). Therefore, oligomerisation of these proteins proceeds before 
their import into peroxisomes. 
 
Even though peroxisomes are known for their capacity to accommodate oligomeric 
proteins, there is evidence to support a monomeric import preference. The enzymes 
acyl-CoA oxidase 1 (ACOX1) and urate oxidase (UOX) were suggested to enter 
peroxisomes as a monomer and that Pex5 interferes with their oligomerisation 
(Freitas et al., 2015).  
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“Piggy-back import” has been described for many proteins in different organisms. 
However, only a few examples of natural piggy-back are known. First example is 
lactase dehydrogenase (LDH), which is a tetrameric protein composed of two 
subunits A and B. LDH is imported into peroxisomes by a PTS1 on B subunit. This 
PTS1 is encoded after the stop codon but occasional translational read-through 
results in a low percentage of LDH subunit B with a PTS1 (reviewed by Thoms, 
2015). A second example is the import of Cu/Zn superoxide dismutase 1 (SOD1) into 
peroxisomes, which hitchhikes with the PTS1-bearing copper chaperone of SOD1 
(CCS) (Islinger et al., 2009).  
During the course of our study, two groups in addition to our work reported a piggy-
back mechanism in S. cerevisiae for Pnc1, which is mediated by a cofactor Pex21 
and a PTS2 enzyme Gpd1 (Effelsberg et al., 2015; Kumar et al., 2015). Pnc1 
(nictionamidase) is an enzyme that converts nicotinamide to nicotinic acid as part of 
the NAD salvage pathway and is imported to peroxisomes by the PTS2 pathway. 
However, Pnc1 lacks a PTS2 targeting signal (Anderson et al., 2003). Gpd1 is the 
NAD+ dependent glycerol 3-phosphate dehydrogenase, which is involved in a cellular 
response to osmotic stress and redox balance. The expression of Pnc1 is strongly 
correlated with Gpd1 and is increased in cells subjected to high osmolarity (1M NaCl 
and 1M sorbitol). Both proteins share the same peroxisomal, nuclear and cytosolic 
localisations (Jung et al., 2010). It was shown that Pnc1 piggy-backing into 
peroxisomes is dependent on Pex21 as a co-receptor of Pex7 rather than Pex18 
(see chapter 3), as described for thiolase import (Effelsberg et al., 2015).  
 
It has been found that a small subset of matrix proteins (alcohol oxidase from H. 
polymorpha and acyl-CoA oxidase from S. cerevisiae) interact directly with the N-
terminus of Pex5 in a PTS1-independent manner by binding to the N-terminus of 
Pex5 (Klein et al., 2002; Gunkel et al., 2004).  This process is known as  “non-PTS 
import” (van der Klei and Veenhuis, 2006a) . 
 
 
 
 
 
 
 
 
  
 
16 
1-4 Peroxisome membrane biogenesis  
 
 
Genetic dissection of peroxisome biogenesis in yeast has only identified two genes 
that are required for peroxisome membrane formation, Pex3 and Pex19. In 
mammals, an additional factor, Pex16, is required for import of peroxisomal 
membrane proteins (PMPs) and peroxisomal membrane biogenesis (Honsho et al., 
1998; South and Gould, 1999). However, in Yarrowia lipolytica, Pex16 has a different 
function related to peroxisome fission (Eitzen et al., 1997). Interestingly, no 
homologue for Pex16 has been identified in S. cerevisiae (South and Gould, 1999; 
Hettema et al., 2000). This finding suggests that an unrelated protein can substitute 
for the function of Pex16 or it is not essential in all organisms (Theodoulou et al., 
2013).  
Pex3, Pex19 and Pex16 (in mammals) have essential roles in peroxisome 
membrane biogenesis and are likely to form the PMP import machinery (Figure1-3) 
(Holroyd and Erdmann, 2001). Pex3, Pex19 and Pex16 import PMPs from the 
cytosol to the peroxisomal membrane. Mutations in these genes lead to lack of any 
detectable peroxisomal structures and mislocalise their PMPs to the cytosol 
(Hettema et al., 2000; Sacksteder et al., 2000; Fang et al., 2004; Jones et al., 2004). 
Most PMPs are synthesised on free ribosomes in the cytosol and imported post-
translationally to the peroxisomal membrane. Many of  these PMPs are targeted to 
peroxsiomes by a  distinct targeting signal termed the mPTS (Dyer et al., 1996). In 
general, mPTSs are a cluster of basic amino acids and are sometimes mixed with 
hydrophobic residues flanked by one or two transmembrane segments (Dyer et al., 
1996; Baerends et al., 2000; Jones et al., 2004; Honsho and Fujiki, 2001; Honsho et 
al., 2002; Rottensteiner et al., 2004). Two models have been proposed for PMP 
import: direct import from the cytosol in a Pex19-dependent manner (Class 1 or 
mPTS1) or indirectly via the endoplasmic reticulum (ER) that is independent of 
Pex19 (Class 2 or mPTS2) (Kim and Hettema, 2015).  
 
Pex19 binds newly synthesised class 1 PMPs in the cytosol and docks at Pex3 on 
the peroxisomal membrane (Fang et al., 2004; Matsuzono et al., 2006). However, 
how PMPs are subsequently inserted into peroxisomal membranes is still unknown. 
Pex3, Pex16 and Pex22 are known class 2 PMPs (Schliebs and Kunau, 2004; Kim 
et al., 2006; Halbach et al., 2009). Hoepfiner et al., showed that Pex3 (an integral 
membrane protein) in S. cerevisiae migrates via the ER to peroxisomes, where it 
concentrates in foci in the ER, which bud off in a Pex19-dependent manner 
(Hoepfiner et al., 2005). This finding suggested a novel pathway of intracellular traffic 
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between the ER and peroxisomes. In addition, Pex16 acts as specific peroxisomal 
membrane receptor for newly synthesised Pex3 in complex with Pex19 (Matsuzaki 
and Fujiki, 2008).   However, a study suggests that mammalian Pex3 inserts directly 
from the cytosol into peroxisomal membranes in a Pex19 dependent manner 
(Matsuzaki and Fujiki, 2008).  
 
The transport mechanism of class 2 PMPs from the ER to peroxisomes is unknown. 
It is believed that PMPs are sorted from the ER to peroxisomes by an 
uncharacterised transport pathway (Tam et al., 2005; Hoepfner et al., 2005). It has 
been suggested that Pex3 and Pex15 are transported from the ER to peroxisomes in 
ER-derived vesicles. However, trafficking of PMPs was independent of COPII 
(coatomer protein II) vesicles. In addition, Pex19 is implicated in Pex3 and Pex15 
trafficking from the ER to peroxisomes. This ER-peroxisome transport mechanism 
might be dependent on a novel budding mechanism that relies on Pex19 and 
additional unknown factors (Lam et al., 2010). However, a recent study reported that 
Sec16B is required for Pex16 export from the ER in mammals (Yonekawa et al., 
2011). 
 
ATPases or other sources of energy required for this pathway have not been 
identified which may reflect their redundancy or their essential function in another 
cellular pathway (Dimitrov et al., 2013). Therefore, this pathway is still  an active area 
of research. 
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Figure 1-3: Model for peroxisomal membrane biogenesis. Some PMPs are targeted and 
directly inserted into the peroxisomal membrane, whereas others (Pex3, Pex16 and Pex22) 
are targeted to the ER from where they are sorted to peroxisomes via an unknown vesicular 
transport pathway. Factors involved in the ER to peroxisome pathway are still under 
investigation. 
 
 
 
 
 
Studies by van der Zand et al., using live cell imaging in S. cerevisiae, observed that 
16 PMPs (class 1 and class 2 PMPs) were firstly inserted into the ER from where 
they were transported to peroxisomes in wild type cells and mutant cells lacking 
peroxisomes (de novo formation). In addition, both the SEC61 translocon and GET 
complex were required for insertion of PMPs into the ER (van der Zand et al., 2010). 
In addition, the same authors reported in a following study that peroxisomes are 
assembled by heterotypic fusion of at least two distinct preperoxisomal vesicles. 
These vesicles arise from the ER, and carry half of the peroxisomal translocon 
complex, then fuse together to from the full peroxisomal translocon. Subsequently, 
matrix proteins were imported to form the fully mature peroxisome (van der Zand et 
al., 2012). Therefore, these studies support the idea that all PMPs in S. cerevisiae 
are first inserted into the ER before sorting to peroxisomes.  
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A recent microscopic study showed the appearance of membrane vesicles in H. 
polymorpha pex3Δ and pex19Δ cells and that these structures contain Pex13 and 
Pex14 (Knoops et al., 2014). This is opposed to the view that pex3Δ and pex19Δ 
lack any detectable peroxisomal structures. They may represent a third class of 
PMPs (Hettema et al., 2014). Peroxisomal membrane biogenesis and involvement of 
the ER is still hotly debated and many controversies remain. 
 
1-5 Peroxisomal size and abundance 
 
 
 
Some identified PEX genes are involved in controlling peroxisome size and 
abundance. Mutations of these genes show normal functional peroxisomes, because 
the import of PMPs and matrix proteins is not defective (reviewed by Yuan et al., 
2016).   
 
Pex28 and Pex29 are integral membrane proteins identified by sequence similarity to 
Pex24 in the yeast Yarrowia lipolytica, which is involved in peroxisome biogenesis. 
Deletion of these genes leads to more peroxisomes that are frequently found in 
clusters (Vizeacoumar et al., 2003). Furthermore, another three peroxins Pex30, 
Pex31 and Pex32 are involved in regulation of peroxisome size, shape and 
abundance, and act downstream of Pex28 and Pex29. Deletion of Pex31 and Pex32 
leads to enlarged peroxisomes but a deletion of Pex30 results in an increase in 
peroxisome number (Vizeacoumar et al., 2004). In addition, the regulation of 
peroxisome abundance has been studied in S. cerevisiae using oleate growth 
conditions, which enhances peroxisome proliferation. On oleate, peroxisome size 
and number are increased (Tower et al., 2011). Three peroxins have been shown to 
be involved in peroxisome proliferation, which are known as the Pex11 family. This 
family consists of Pex11, Pex25, and Pex27 (Erdmann and Blobel, 1995; Smith et al., 
2002; Rottensteiner et al., 2003; Tam et al., 2003). Deletion of Pex11, Pex25 or 
Pex27 affects peroxisome size and number, leading to enlarged peroxisomes and a 
reduction in peroxisome number (Rottensteiner et al., 2003; Tam et al., 2003). How 
these multiple proteins act to regulate peroxisome number remains unclear. 
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1-6 De novo peroxisomes formation versus growth and division  
 
The origin of peroxisomes has been controversial for a long time. Two models of 
peroxisome formation have been proposed: multiplication by growth and division and 
de novo formation from the ER. A third more detailed de novo formation model has 
been proposed recently (Figure 1-4). The earliest model of peroxisome formation 
hypothesised that peroxisomes were formed from the ER due to the close 
association of the ER with peroxisomes. Furthermore, peroxisomes were thought to 
be a dilated region of the ER (Novikoff and Novikoff, 1972). However, in the early 
1980s, the growth and division model was proposed. This model suggests that 
peroxisomes are autonomous organelles, like mitochondria and chloroplasts, and 
multiply by fission from pre-existing organelles (Lazarow and Fujiki, 1985). The 
evidence supporting this model came from studies indicating that peroxisomal 
proteins were imported post-translationally from the cytosol (Fujiki et al., 1984; 
Rachubinski et al., 1984). Moreover, the discovery of peroxisomal targeting signals 
(PTS1 and PTS2) of peroxisomal matrix proteins supported the growth and division 
model (Gould et al., 1987).  
 
The growth and division model could not explain the regeneration of peroxisomes in 
mutants that lack any peroxisomal remnants after reintroduction of the corresponding 
wild-type gene. A model was proposed suggesting that peroxisomes can form de 
novo. Many studies indicated a role of the ER in de novo peroxisome biogenesis 
(Geuze et al., 2003; Hoepfner et al., 2005; Kragt et al., 2005; Motley and Hettema, 
2007; van der Zand et al., 2010; van der Zand et al., 2012). 
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Figure 1-4: Models of peroxisome formation. A- Growth and division suggests that 
peroxisomes form by fission and the ER provides only some PMPs and membrane lipids.  
B- Maturation model suggests that a subset of PMPs is targeted to the ER and form 
precompartments that are fused together to form new peroxisomes.  C-Vesicular fusion 
model whereby distinct ER-derived vesicles fuse to generate a new peroxisome that starts 
importing matrix proteins. The picture is adapted from (Hettema and Motley, 2009; Hettema et 
al., 2014). 
 
 
 
Three PMPs, Pex3, Pex16 and Pex19, are essential for the early steps of synthesis 
and maintenance of the peroxisomal membrane. The absence any of these PMPs 
leads to complete loss of any detectable peroxisome structures (South and Gould, 
1999; Hettema et al., 2000; Heiland and Erdmann, 2005). The finding that 
peroxisomes are regenerated in mutants lacking peroxisomes, after addition of the 
wild copy of the mutated gene, gives strength for de novo formation of peroxisomes. 
This mechanism has not been described for autonomous organelles like chloroplasts 
and mitochondria (South and Gould, 1999; Muntau et al., 2000; Titorenko and 
Rachubinski, 2001; Geuze et al., 2003; Hoepfner et al., 2005; Haan et al., 2006; Kim 
et al., 2006; Dimitrov et al., 2013). Interestingly, some yeasts, including S. cerevisiae 
lack Pex16. The ER-maturation model suggests peroxisomes form de novo from the 
ER. This model proposes that vesicles arise from the ER carrying PMPs. These 
vesicles fuse together to form peroxisomal precompartments. Then, matrix proteins 
are imported to form mature peroxisomes (Tabak et al., 2006). The first support for 
the ER origin of peroxisomes came from Hoepfner et al., who showed that Pex3 
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travels via the ER to peroxisomes during de novo formation (Hoepfner et al., 2005). 
Moreover, additional studies confirmed that Pex3 travels via the ER to peroxisomes 
(Kragt et al., 2005; Tam et al., 2005). Furthermore, another factor, Pex25 was shown 
to be required for de novo formation of peroxisomes in S. cerevisiae (Gardzielewski, 
2011; Huber et al., 2012).  
 
An extension of this model was recently proposed. Peroxisome formation initiates 
from the ER by via fusion of at least two biochemically distinct preperoxisomal 
vesicles, which each carries half of the matrix protein translocation machinery (van 
der Zand et al., 2012). The AAA+ ATPases Pex1 and Pex6 are required for vesicle 
fusion. It is proposed that the ER provides PMPs and lipids for peroxisomes (van der 
Zand et al., 2012; Tabak et al., 2013; van der Zand and Tabak, 2013; Agrawal and 
Subramani, 2016; Agrawal et al., 2016). In a separate study in S. cerevisiae, 
peroxisomes are shown to multiply by growth and division in wild type cells that 
already contain peroxisomes, and that the ER provides membrane constituents. In 
addition, de novo peroxisome formation occurs only in cells temporarily lacking 
peroxisomes (Motley and Hettema, 2007; Motley et al., 2015; Knoops et al., 2015).  
In contrast, the two pathways of de novo formation or growth and division can occur 
simultaneously in mammals (Kim et al., 2006). However, the contribution of de novo 
and growth and division to the peroxisomal population is still debated (Nuttall et al., 
2011; Hettema et al., 2014; Kim and Hettema, 2015; Mukherji and O'Shea, 2015; 
Craven, 2016). 
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1-7 Synthetic Genetic Array (SGA) 
 
Genetic analysis is an essential tool for assessing the biological function of genes in 
vivo. In addition, it is a powerful method for identifying new components of specific 
pathways and arranging the products of genes within a pathway (Tong and Boone, 
2006). S. cerevisiae was used as an initial model organism to study a network of 
genes and genetic interactions (Giaever et al., 2002; Boone et al., 2007). Genetic 
interaction is defined as a mutation in a second gene that leads to a phenotype 
different from original single mutation (Baryshnikova et al., 2010). Synthetic genetic 
interactions are usually identified in cases of a second-site mutation, or increased 
dosage of gene leading to suppression or enhancement of the original mutant 
phenotype (Tong and Boone, 2007). 
The large-scale genetic interaction studies were developed initially in S. cerevisiae to 
identify a specific type of genetic interaction known as synthetic lethality, in which the 
second mutation leads to more severe phenotype (negative interaction) (Tong et al., 
2001; Tong et al., 2004). Furthermore, it has emerged that double mutants with less 
severe phenotypes than expected are valuable resources. This is known as a 
positive interaction and often occurs between two functionally related genes e.g. 
involved in same complex or pathway (Schuldiner et al., 2005; Collins et al., 2007). 
 
  
Approximately, 6000 deletion mutations have been constructed in S. cerevisiae. 
About 1000 essential genes are manipulated to produce conditional alleles or 
hypomorphic (partially functional) alleles (Ben-Aroya et al., 2008; Schuldiner et al., 
2005; Breslow et al., 2008). The essential genes seem to be more conserved from 
yeast to humans, compared with non-essential genes (Hughes, 2002). These genes 
perform various biological processes. The primary role of most essential yeast genes 
is known, but the full breadth of function associated with essential genes has not 
been characterised. Furthermore, about 5000 viable mutants were constructed by 
deletion and replacement of the target ORF with a kanamycin resistance marker ( 
Winzeler et al., 1999; Giaever et al., 2002 ). The fact that most deletion mutants are 
able to grow under normal conditions reflects the robustness of biological circuits and 
cellular buffering against genetic variation (Hartman et al., 2001; Hartwell, 2004). The 
non-essential mutants provide the valuable resources for systemic genetic analysis, 
and screen for 12.5 million combinations of double mutants for a synthetic lethal or 
sick phenotype (Tong et al., 2001). Synthetic genetic array (SGA) analysis has been 
developed as a method to isolate yeast double mutations to evaluate the function of 
these genes (Tong et al., 2001). 
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The typical SGA analysis includes a crossing of a query mutation to an array of 
viable mutations (and may include conditional essential genes) to form a double 
mutant array, which is examined for specific phenotypes (Tong et al., 2001, 
Baryshnikova et al., 2010). A starting strain with a query mutation is crossed to all 
non-essential mutations in yeast collections of the opposite mating type. The 
haploids are allowed to germinate after sporulation by a vigorous selection 
procedure. Finally, the haploids containing both mutations are selected dependent of 
the two selectable markers (Tong and Boone, 2007;  Baryshnikova et al., 2010).  
 
The SGA selection steps rely on the germination on only one meiotic progeny (MATa 
or MATα). Germination of both mating types would allow these haploids to mate with 
each other and generate diploids. These diploids would be heterozygous for one or 
both deletion alleles leading to a false negative (Tong and Bonne, 2007). To avoid 
this complication, an SGA reporter was developed in a query strain to ensure the 
germination of only a single mating type. This reporter was constructed by linking a 
selectable marker to a haploid and mating-type-specific promoter. For example, the 
MFA1 promoter was linked to the HIS3 open reading frame to generate MFA1pr-
HIS3. Subsequently, this reporter was integrated at the CAN1 locus, which allows 
MATa cells carrying this reporter to grow on synthetic media lacking histidine (His) 
(Tong and Bonne, 2007). However, MATα and MATa/α cells carrying MFA1pr-HIS3 
are unable to grow in media that lack histidine, as the MFA1 promoter is not switched 
on in these cells.  
 
 Many SGA reporters have been developed, including the HIS3 ORF under control of 
MATa specific promoter from the STE2 gene. In MATa/α diploid cells, mitotic 
crossover events can occur between homologous chromosomes. Of special concern 
are crossover events of the MAT locus (centromere on chromosome III). This can 
lead to a false negative and result in diploids MATa/a. The MATa/a cells behave as a 
haploid MATa on growth in medium lacking histidine. Therefore, two recessive drug 
markers were introduced at LYP1 and CAN1 gene loci (Tong and Boone, 2006; Tong 
and Boone, 2007). The LYP1 gene encodes the lysine permease (Sychrova and 
Chevallier, 1993), which permits a toxic analogue of lysine (thialysine) to be imported 
and kill the cells. In the same way, the arginine permease, encoded by the CAN1 
gene, allows the toxic analogue of arginine (canavanine) to kill the cells (Tong and 
Boone, 2007;  Baryshnikova et al., 2010). Therefore, introducing these mutations into 
the query strain allows the MATa/a diploids to be killed by thialysine and canavanine 
because they carry a wild type copy of these genes. 
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Figure 1-5: SGA methodology. The MATα strain with a specific mutation was used as a 
query strain, in which an ORF is deleted with a selectable marker such as the nourseothricin-
resistance marker cloNat (represented as a blue black circle). 1-This query strain is mated 
with an array of MATa deletion mutants (xxxΔ). In each of these mutants, a specific gene is 
replaced by a selectable marker, such as kanamycin-resistance (the disrupted gene is 
represented as a filled red circle).  2-Diploids are selected on medium containing cloNat and 
G418. 3-The resultant diploids are transferred onto sporulation medium. This medium 
contains less carbon and nitrogen to induce sporulation. 4-Spores are transferred and 
germinated on a synthetic medium lacking histidine to select MATa meiotic progeny. The 
MATa haploids can be selected because they express the SGA reporter STE2pr-SpHIS5 as 
the STE2 promoter is only active in MATa cells and allows only MATa cells to grow on 
histidine-deficient medium. In addition, canavanine and thialysine are added to medium to 
improve the selection because it selects can1Δ, lyp1∆ and kills CAN1, LYP1 cells. 5-The 
MATa haploids are transferred to a synthetic medium containing G418 to select for the gene 
deletion mutants. 6-The final step requires double mutants to be selected on synthetic 
medium containing both cloNat (nourseothricin) and G418. The figure is adapted from (Tong 
and Boone, 2007) 
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SGA has been developed to examine the morphology of various organelles like the 
ER and the mitochondria by GFP (or variant)-markers in diverse gene backgrounds 
(Tavassoli et al., 2009). 
 
The novel screening approach combines a synthetic genetic array (SGA) analysis, 
and a high-content screening (HCS). This automates image acquisition and the 
quantification of specific morphological phenotypes. The HCS-SGA method can be 
used to study specific cellular functions and applied to virtually any process that can 
be observed with a fluorescent reporter that can be detected quantitatively in the 
content of numerous genetic and environmental perturbations (Vizeacoumar et al., 
2010).  
 
1-8 Using yeast to study peroxisome biogenesis   
 
Yeast and filamentous fungi are used as a model to study fundamental eukaryotic 
processes. Yeast have many advantages over mammalian cells such as that they 
are easy to culture on defined media, have short generation time and are easily 
accessible towards molecular and classical genetics (van der Klei and Veenhuis, 
2006b). 
 
Yeast provides an excellent model to study peroxisome biogenesis because this 
process is well conserved from yeast to human. Therefore, many PEX genes in 
humans were discovered based on sequence similarity to yeast homologues (Dodt et 
al., 1996). Peroxisomes provide the sole site for β-oxidation in yeast. Any mutant 
affected in peroxisome biogenesis fails to grow on medium containing oleate as a 
sole carbon source. It was a failure to grow on oleic acid medium that was used as 
an initial screening procedure for selection of pex mutants in yeast (Erdmann et al., 
1989).  
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1-9 Aims of the research 
 
The initial aim of this study was to analyse Pnc1 import into peroxisomes. Two 
pathways are known for the import of peroxisomal matrix proteins, requiring two 
targeting signals: PTS1 and PTS2. Pnc1 import is dependent on the PTS2 pathway. 
However, Pnc1 neither contains a PTS1 nor a PTS2.  
In the second part of this thesis, I studied the genetic interactions of Msp1, a protein 
required for normal peroxisome abundance with the aim to understand its role in 
peroxisome biogenesis.  
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Chapter 2  
 
2 Materials and Methods 
 
2-1 Chemical and Enzymes  
 
Unless otherwise stated, chemicals, enzymes and materials used during this work 
were supplied by Sigma-Aldrich. Restriction enzymes and buffers were supplied by 
New England Biolabs. PCR buffers and DNA polymerases were supplied by Bioline. 
Miniprep kits were supplied from Sigma-Aldrich, Bioline and Qiagen. Gel Extraction 
kits were supplied by Qiagen. Unless otherwise stated, growth media components 
were supplied by Difco Laboratories.  
 
2-2 Strains and Plasmids 
2-2-1 Strains  
A-Saccharomyces cerevisiae strains  
 
Yeast strains used in this study are listed in Table 2-1. Any strains created in this 
study were modified from the BY4741 or BY4742 wild type strain. Gene deletions 
were performed by homologous recombination. 
 
 
S. cerevisiae strains 
 
Genotype description 
 
Yeast strains 
source 
 
BY4741 MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0 
 
Euroscarf 
BY4742 MATα  his3-Δ1, leu2-Δ0, lys2-Δ0, ura3-Δ0 Euroscarf  
gpd1 MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
 gpd1::kanMX 
 
Euroscarf  
 
gpd1  MATα  his3-Δ1, leu2-Δ0, lys2-Δ0, ura3-Δ0, 
gpd1::hphMX 
 
This study  
 
PNC1-GFP MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
PNC1-GFP::HIS3MX6 
 
This study  
 
fox3 MATa his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
  fox3::URA3 
 
This study 
 
pcd1 MATa his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
 pcd1::URA3 
 
This study 
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pex5Δ MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
pex5::kanMX 
 
Euroscarf 
pex7Δ MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
pex7::kanMX 
 
Euroscarf 
pex18Δ MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
pex18::kanMX, 
 
Euroscarf 
pex21Δ MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
pex21::kanMX 
 
Euroscarf 
gpd1 PNC1-GFP MATa   his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
gpd1::kanMX, PNC1-GFP::HIS3MX6 
This study 
  
 
pex7 PNC1-GFP MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
pex7::kanMX, PNC1-GFP::HIS3MX6 
 
This study  
 
fox3 PNC1-GFP MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
fox3::URA3, PNC1-GFP::HIS3MX6 
 
This study 
 
pcd1 PNC1-GFP MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
pcd1::URA3, PNC1-GFP::HIS3MX6 
 
This study 
 
pex5 PNC1-GFP MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
pex5::kanMX, PNC1-GFP::HIS3MX6 
 
This study 
 
gpd1/pex5 
PNC1-GFP 
MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
gpd1::hphMX, PNC1-GFP::HIS3MX6,   
pex5::kanMX 
 
This study  
 
gpd1/pex5  MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
gpd1::kanMX, pex5:: hphMX 
 
This study 
  
PNC1-TAP MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
PNC1-TAP-HIS3MX6 
 
Lab stock 
pex21 PNC1-GFP  MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
 pex21::kanMX, PNC1-GFP::HIS3MX6 
 
This study  
 
pex18 PNC1-GFP  MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
pex18:: KanMX, PNC1-GFP:: HIS3MX6 
 
This study  
 
PJ9-4 
(MATa and MAT 
strains used) 
trp1-901, leu2-3,112, ura3-52, his3-200, gal4, 
gal80, LYS2::GAL1-HIS3, GAL2-ADE2, 
met2::GAL7-lacZ 
 
Lab stock  
BJ1991 MATa  leu2, ura3-251, trp1, prb1-1122, pep4-
3, gal2 
 
Lab stock  
 
PJ9-4 gpd1 MATa   trp1-901, leu2-3,112, ura3-52, his3-
200, gal4, gal80, LYS2::GAL1-HIS3, GAL2-
ADE2, met2::GAL7-lacZ,  gpd1::hphMX 
 
This study  
 
PJ9-4 gpd1 MAT  trp1-901, leu2-3,112, ura3-52, his3-
200, gal4, gal80, LYS2::GAL1-HIS3, GAL2-
ADE2, met2::GAL7-lacZ,  gpd1::hphMX 
 
This study 
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PJ9-4 gpd1/pex7Δ MATa trp1-901, leu2-3,112, ura3-52, his3-200, 
gal4, gal80, LYS2::GAL1-HIS3, GAL2-
ADE2, met2::GAL7-lacZ,  gpd1::hphMX,  
pex7::kanMX 
 
This study  
 
PJ9-4 gpd1/pex7Δ MAT trp1-901, leu2-3,112, ura3-52, his3-200, 
gal4, gal80, LYS2::GAL1-HIS3, GAL2-
ADE2, met2::GAL7-lacZ, gpd1::hphMX,  
pex7::kanMX 
 
This study 
 
PJ9-4 gpd1/pex21Δ MATa trp1-901, leu2-3,112, ura3-52, his3-200, 
gal4, gal80, LYS2::GAL1-HIS3, GAL2-
ADE2, met2::GAL7-lacZ, gpd1::hphMX,  
pex21::kanMX 
 
This study  
 
PJ9-4 gpd1/pex21Δ MAT  trp1-901, leu2-3,112, ura3-52, his3-
200, gal4, gal80, LYS2::GAL1-HIS3, GAL2-
ADE2, met2::GAL7-lacZ, gpd1::hphMX,  
pex21::kanMX 
 
This study  
 
PJ9-4 gpd1/pex18Δ MATa  trp1-901, leu2-3,112, ura3-52, his3-
200, gal4, gal80, LYS2::GAL1-HIS3, GAL2-
ADE2, met2::GAL7-lacZ, gpd1::hphMX,  
pex18::kanMX 
 
This study  
 
PJ9-4 gpd1/pex18Δ MAT trp1-901, leu2-3,112, ura3-52, his3-200, 
gal4, gal80, LYS2::GAL1-HIS3, GAL2-
ADE2, met2::GAL7-lacZ,  gpd1::hphMX,  
pex18::kanMX 
 
This study  
 
DLY7325 
 
MATα  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2 
 
David Lydall 
DLY7325 msp1 
 
MATα  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- 
Δ0, LYS2, msp1::TPI-GFP-PTS1-natMX 
 
This study 
 
 
DLY7325 msp1/pex1 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2, pex1::kanMX, msp1::TPI-GFP-PTS1-
natMX 
 
This study  
 
DLY7325 msp1/pex2 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2, pex2::kanMX, msp1::TPI-GFP-PTS1-
natMX 
 
This study  
 
 
DLY7325 msp1/pex3 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2  pex3::kanMX, msp1::TPI-GFP-PTS1-
natMX 
 
This study  
 
DLY7325 msp1/pex5 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2,  pex5::kanMX, msp1::TPI-GFP-PTS1-
natMX 
 
This study 
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DLY7325 msp1/pex6 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2,  pex6::kanMX, msp1::TPI-GFP-PTS1-
natMX 
 
This study 
 
DLY7325 msp1/pex7 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2, pex7::kanMX, msp1::TPI-GFP-PTS1-
natMX 
 
This study 
 
DLY7325 msp1/pex8 
 
MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2, pex8::kanMX, msp1::TPI-GFP-PTS1-
natMX 
 
This study  
 
 
DLY7325 msp1/pex10 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2, pex10::kanMX, msp1::TPI -GFP-PTS1-
natMX 
 
This study 
 
DLY7325 msp1/pex12 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2, pex12::kanMX, msp1::TPI -GFP-PTS1-
natMX 
 
This study 
 
 
DLY7325 msp1/pex13 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2, pex13::kanMX, msp1::TPI -GFP-PTS1-
natMX 
 
This study 
 
 
DLY7325 msp1/pex14 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2, pex14::kanMX, msp1::TPI -GFP-PTS1-
natMX 
 
This study 
 
 
DLY7325 msp1/pex15 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2, pex15::kanMX, msp1::TPI -GFP-PTS1-
natMX 
This study 
 
DLY7325 msp1/pex17 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2,  pex17::kanMX, msp1::TPI -GFP-PTS1-
natMX 
 
This study  
 
        
DLY7325 msp1/pex19 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2,  pex19::kanMX, msp1::TPI -GFP-PTS1-
natMX 
 
This study  
 
 
DLY7325 msp1/pex22 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2  pex22::kanMX, msp1::TPI -GFP-PTS1-
natMX 
 
This study  
 
 
DLY7325 msp1/pex25 MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2,  pex25::kanMX, msp1::TPI -GFP-PTS1-
natMX 
 
This study 
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DLY7325 
msp1/dnm1 
MATa  can1::STE2pr-SpHIS5 lyp1::LEU2 :: 
hphMX, his3-Δ1, leu2-Δ0, met15-Δ0, ura3- Δ0, 
LYS2,  dnm1::kanMX, msp1::TPI -GFP-PTS1-
natMX 
This study  
 
atg36Δ 
 
MATa   his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
 atg36::kanMX4 
 
Euroscarf 
ygr168cΔ MATa    his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
ygr168c::HIS3 
 
Euroscarf 
 
YGR168C-GFP MATa   his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
YGR168C-GFP:: HIS3MX6 
 
This study 
msp1Δ/ygr168c MATα  his3-Δ1, leu2-Δ0, lys2-Δ0, ura3-Δ0, 
msp1::hphMX, ygr168c ::HIS3 
 
This study 
 
msp1Δ MATα his3-Δ1, leu2-Δ0, lys2-Δ0, ura3-Δ0, 
 msp1::hphMX 
 
Lab stock 
 
msp1Δ 
GAL1/10 PEX19 
MATa his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
PEX19::HIS3MX6-GAL1/10 PEX19, msp1:: 
hphMX 
This study 
 
 
pex25Δ  
GAL1/10 PEX19 
MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
PEX19::HIS3MX6-GAL1/10 PEX19, pex25:: 
kanMX 
 
Lab stock 
 
msp1Δ/pex25Δ  
GAL1/10 PEX19 
MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
PEX19::HIS3MX6-GAL1/10 PEX19, msp1:: 
hphMX, pex25::kanMX 
 
This study  
ygr168cΔ  
GAL1/10 PEX19 
MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
 PEX19::HIS3MX6-GAL1/10 PEX19, yg168c:: 
kanMX 
 
This study 
pex25Δ MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-Δ0, 
pex25::kanMX 
Lab stock  
ygr168cΔ/pex5Δ MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-
Δ0, ygr168c::hphMX,  pex5::kanMX 
 
This study  
ygr168cΔ/pex7Δ MATa  his3-Δ1, leu2-Δ0, met15-Δ0, ura3-
Δ0, ygr168c::hphMX,  pex7::kanMX 
This study  
ygr168cΔ/pex13Δ MATa his3-Δ1, leu2-Δ0, met15-Δ0, ura3-
Δ0, ygr168c::hphMX,  pex13::kanMX 
This study  
ygr168cΔ/vps1Δ MATa his3-Δ1, leu2-Δ0, met15-Δ0, ura3-
Δ0,  ygr168c::hphMX,  vps1::kanMX 
This study  
 
 
Table 2-1 Yeast strains used in this study. 
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B- Escherichia coli strains   
 
 
E. coli strains used in this study are listed in Table (2-2). 
 
 
 
E. coli strain 
 
 
Genotype 
 
 
Purpose 
 
Source 
DH5α supE44 lacU169 (80 lacZ M15) 
hsdR17 recA1 endA1 gyrA96 thi-1 relA1 
 
Plasmid transformation Lab stock 
 
  
Table 2-2: E. coli strains used in this study. 
 
 
2-2-2 Plasmids  
 
 
Plasmids used in this study are listed in Table 2-3. The majority of plasmids were 
constructed by homologous recombination in S. cerevisiae and a minority by cloning 
using T4 DNA ligase and transformation to E. coli. The parental plasmids Ycplac33 
and Ycplac111 (Gietz and Sugino, 1988) were used to insert promoters (between 
EcoR1 and Sac1 site, tags (N-terminal tags between Sac1 and BamHI sites, or C-
terminal tags between Pst1 and HindIII sites) and open reading frames using the 
remaining restriction sites in the multiple cloning site. 
 
 
 
 
Plasmid 
name 
 
Promoter 
 
ORF Description 
 
Parental 
plasmid 
 
Source 
 
 
Ycplac33  --- Empty plasmid 
URA3/Centromeric 
  
 Lab stock  
Ycplac111 --- Empty plasmid 
LEU2/Centromeric  
 
 Lab stock  
pEH001 HIS3 GFP-PTS1 
 
Ycplac33 Ewald Hettema  
pEH012 TPI GFP-PTS1 
 
Ycplac33 Ewald Hettema  
 
 
pAS63 HIS1 Hc-Red-PTS1 
 
Ycplac111 Alison Motley 
pGAD424 ADH1 GAL4 activation domain  Marc Fransen, 
Univ. of Leuven 
 
pGBT9 ADH1 GAL4 binding domain  Marc Fransen, 
Univ. of Leuven 
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pBDC ADH1 GAL4 binding domain  Stefan Milson, 
Univ. Lincoln 
pADC ADH1 GAL4 activation domain  Stefan Milson, 
Univ. Lincoln 
pNA032 GPD1 GPD1-mCherry Ycplac33 This study 
 
pNA033 GPD1 GPD1-GFP Ycplac33 This study 
 
pNA046 PNC1 PNC1-GFP   
 
Ycplac33 This study  
pNA052 ADH1 GAL4 activation domain-PNC1 
 
pGAD424 This study 
pNA055 ADH1 GAL4 binding domain-PEX7  
 
pGBT9 This study 
pNA058 ADH1 GAL4 binding domain-POT1 pGBT9 This study 
pNA079 ADH1 GPD1- GAL4 activation domain  pADc This study 
pNA082 ADH1 GAL4 binding domain-PEX21  pGBT9 This study 
pNA083 ADH1 PNC1-GAL4 binding domain pDBC This study 
pNA098 ADH1 GPD1 R270E-GAL4 activation 
domain  
pADc This study 
pNA096 GPD1 GPD1 R270E-GFP Ycplac111 This study 
pNA070 GPD1 GPD1 S24A, S27A-mCherry  
 
Ycplac33 This study 
pNA089 GPD1 GPD1 R270E-mCherry Ycplac33 This study 
pNA090 GPD1 GPD1 R310E-mCherry Ycplac33 This study 
pNA091 GPD1 GPD1 K254A-mCherry Ycplac33 This study 
pNA092 GPD1 GPD1 D301N-mCherry Ycplac33 This study 
pNA095 GPD1 GPD1 G43E-mCherry Ycplac33 This study 
pNA101 GPD1 GPD1 R270E-GFP Ycplac33 This study 
pNA115  GPD1 GPD1 R310E-GFP Ycplac33 This study 
pNA102 GPD1 GPD1 K254A-mCherry Ycplac33 This study 
pNA103 GPD1 GPD1 D301N-mCherry Ycplac33 This study 
pNA104 GPD1 GPD1 G43E-mCherry  Ycplac33 This study 
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pNA105 GPD1 ΔPTS2 GPD1-mCherry Ycplac33 This study 
pNA106 GPD1 ΔPTS2 GPD1 R270E-mCherry Ycplac33 This study 
pNA107 GPD1 GPD1 R270E, E195R-mCherry Ycplac33 This study 
pNA116 GPD1 GPD1 R270E, E195R-GFP Ycplac33 This study 
pNA110 GPD1 GPD1 R270E, E195R-GFP Ycplac111 This study 
pNA112 GPD1 ΔPTS2 GPD1 R270E, E195R-
GFP 
Ycplac111 This study 
pNA114 GPD1 ΔPTS2 GPD1 R270E, E195R-
mCherry 
Ycplac33 This study 
pNA121 GPD1 GPD1 R270E-HA Ycplac111 This study 
pNA122 GPD1 GPD1 R270E, E195R-HA Ycplac111 This study 
pNA123 GPD1 GPD1-HA Ycplac111 This study 
pNA125 GPD1 GPD1-mCherry-PTS1 Ycplac33 This study 
pNA126 GPD1 GPD1-GFP Ycplac111 This study 
pNA127 GPD1 ΔPTS2 GPD1-GFP Ycplac111 This study 
pNA128 GPD1 ΔPTS2 GPD1-mCherry-PTS1 Ycplac33 This study 
 
pNA019 PEX11  PEX11-mCherry  
 
Ycplac33  This study  
pNA013  TPI1 GFP-PTS1-natMX 
 
Ycplac33 This study  
pNA03 TPI1 MSP1-GFP Ycplac33 This study  
pNA04 HIS3 MSP1-GFP Ycplac33 This study  
pJL018 GAL1/10 MSP1-GFP Ycplac33 Joanne Lacey  
pAS153 GAL1/10 OM45-mRFP Ycplac111 Alison Motley 
pNA085 MSP1 MSP1-untagged  Ycplac33 This study  
pEH005 PEX11 PEX11-GFP Ycplac33 Ewald Hettema 
pNA086 MSP1 MSP1 Walker A  
K139T-untagged  
 
Ycplac33 This study  
pNA086 MSP1 MSP1 Walker B 
E193Q-untagged  
Ycplac33 This study  
 
 
pNA029 GAL1/10 YGR168C-GFP 
 
Ycplac33 This study 
pNA031 YGR168C YGR168C-GFP Ycplac33 This study 
pNA034 YGR168C 
Point 
mutation of  
uORF 
YGR168C-GFP Ycplac33 This study 
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pNA044 GAL1/10 YGR168C 1-74aa-GFP 
 
Ycplac33 This study  
pNA036 GAL1/10 YGR168C 1-219aa-GFP 
 
Ycplac33 This study  
pNA043 GAL1/10 YGR168C 1-141aa-GFP  
 
Ycplac33 This study  
pNA038 GAL1/10 YGR168C 74-376aa-GFP  
 
Ycplac33 This study  
pNA039 GAL1/10 YGR168C 141-376aa-GFP  
 
Ycplac33 This study  
pNA037 GAL1/10 YGR168C 219-376aa-GFP  
 
Ycplac33 This study 
  
pHUT34 HIS3 SEC66-HcRed Ycplac33 John Hutchinson 
 
 
Table 2-3: Plasmids were used in this study. 
 
 
2-3 Oligonucleotides design for homologous recombination 
 
 
 
 
Plasmids were constructed by homologous recombination in yeast. PCR was 
performed to amplify a region of interest (promoters, ORF and tags to construct 
plasmids) using primers designed to anneal to the start and the end of a region of 
interest, and have 18 nucleotides as flanking regions identical to each side of the 
intended insertion site. PCR fragment and linearised vector were transformed to 
yeast and upon homologous recombination the vector is circularised. Recombinants 
were identified by the growth on selective medium (Figure 2-1). 
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Figure 2-1: Plasmid construction by homologous recombination in S. cerevisiae. 
Primers (presented by arrows) were designed to contain an extension of 18 nucleotides. This 
nucleotide extension is homologous between the PCR product and a linearised plasmid 
(presented in green). These primers were used to amplify the gene of interest (presented as 
red block). Homologous recombination between the linearised plasmid and the PCR product 
results in the cloned plasmid with gene of interest.   
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2-4 Culture media  
 
Culture media used in this study are listed in Table 2-4: 
 
 
Media 
 
Media ingredients 
 
2TY  (Bacterial medium) 1.6% Bacto Tryptone,1% yeast extract, 0.5% NaCl (+ antibiotics as 
required).  
YPD  
(yeast rich medium)  
2% peptone, 1% yeast extract, 2% glucose 
 
Yeast minimal media 1, 
YM1 
0.5% Ammonium sulphate, 0.17% yeast nitrogen base, 2% glucose. 
Amino acids were added from 100x stocks (0.2% histidine, 0.2% uracil, 
0.3% leucine, 0.3% lysine, 0.2% tryptophan, 0.2% methionine). 
Yeast minimal media 2, 
YM2 
0.5% Ammonium sulphate, 0.17% yeast nitrogen base, 1% casamino 
acids, 2% glucose or 2% galactose, amino acids were added as 
required  (uracil, tryptophan, leucine). 
Yeast minimal media 
YM2 for SGA 
0.1% MSG (L-glutamic acid sodium salt hydrate), 0.17% yeast nitrogen 
base, 1% casamino acids, 2% glucose, amino acids were added 100x 
stock (uracil, leucine, tryptophan). CloNat (final concentration 100mg/L) 
and G418 (final concentration 200mg/L) were added as required. 
 YM2 oleate  Stock (12 ml oleate +20 ml Tween40) 
320µl from stock above was added to 100ml Ym2. 0.1% from 10% 
yeast extract was added. 
Enriched sporulation 
agar (SGA) 
1% potassium acetate, 0.1% yeast extract, 0.05% glucose, 0.01% 
amino-acids supplement powder mixture for sporulation (contains 2g 
histidine, 10g leucine, 2g lysine, 2g uracil),2% bacto agar. 
SD-His-/Arg-/Lys-  
+ canavanine/thialysine 
0.5% Ammonium sulphate, 0.67% yeast nitrogen base w/o amino acids 
and 0.2% amino acids supplement powder mixture (DO- His- /Arg-/ 
Lys-) were added to 100ml water in a 250ml flask. 2% glucose, 2% 
bacto ager were dissolved in 900ml using a 2L flask. The solutions 
were autoclaved separately, combined together and the medium 
cooled to 65°C. 0.5ml canavanine (50mg /L) and 0.5ml thialysine 
(50mg/L) were then added, mixed thoroughly and plates were poured. 
(SD/MSG) His-/Arg-/Lys- 
+ canavanine/Thialysine 
0.17% yeast nitrogen base w/o amino acids or ammonium sulphate, 
0.1% MSG (L-glutamic acid sodium salt hydrate), 0.2% amino-acids 
supplement powder mixture (DO- His- /Arg-/ Lys-) were dissolved in 
100ml water in a 250ml flask. 2% glucose, 2% bacto agar were added 
to 900ml water in a 2L flask. Solutions were autoclaved separately, 
combined together and the medium cooled to 65°C. 0.5ml canavanine  
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(50mg/L), 0.5ml thialysine (50mg/L) were added, with extra antibiotics 
added as required.  
YEPD (SGA ) 0.0120% adenine, 1% yeast extract, 2% peptone, 2% glucose, 2% 
bacto agar. Antibiotics, Hygromycin B (final concentration 500mg/L) 
and G418 (final concentration 200mg/L) were added as necessary. 
Low Fluorescent media  
 
0.09% KH2PO4, 0.023% K2HPO4, 0.109% MgSO4, 0.352% (NH4)2SO4 
and complete drop out.  
Starvation medium  0.17% yeast nitrogen base, 2% glucose. Amino acids were added from 
100x stocks (0.2% histidine, 0.2% uracil, 0.3% leucine, 0.3% lysine, 
0.2% tryptophan, 0.2% methionine) 
YM2 NaCl  5% Ammonium sulphate, 0.17% yeast nitrogen base, 1% casamino 
acids, 2% glucose or 2% galactose, amino acids were added as 
required  (uracil, tryptophan, leucine). NaCl was added at 0.8M or 1M. 
 
 
Table 2-4: growth media, all percentage concentrations are stated as w/v. 
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2-5 Primers  
 
Table 2-5 presents oligonucleotides used in this study. 
 
 
 
Name 
 
 
Primer sequence 5’ 3’ 
 
 
Description or application 
 
VIP2388 ATAAGGTTAAGGAAGAGTTGAAGGCCCAC
AACATCAATGTCGTGGATAAACGGATCCC
CGGGTTAATTAA   
Forward primer for amplification of GFP 
to tag Pnc1 in the genome.  
VIP2389 CATTTGCAAGCCACCCTAGTTCATCAGGT
TGAAGAAGTATTATTCAGCTCGCATAGGC
CACTAGTGGATC 
Reverse primer for amplification of GFP 
to tag Pnc1 in the genome 
VIP2390 CACAGGATTGTGGTCACCAG 
 
Forward primer 500bp upstream of stop 
codon of Pnc1. 
VIP2973 TATATTGTACACCCCCCCCCTCCACAAAC
ACAAATATTGATAATATAAAGCAGCTGAAG
CTTCGTACGC 
Forward primer for Gpd1 deletion  
VIP2974 CCTCGAAAAAAGTGGGGGAAAGTATGATA
TGTTATCTTTCTCCAATAAATGCATAGGCC
ACTAGTGGATCTG 
Reverse primer for Gpd1 deletion 
   
VIP2481 
 
TATTTCTTGTGGCTCTGAGTACAGAGTGA
ATATAACACTACATAAAAGCACAGCTGAA
GCTTGTACGC 
Forward primer for Pot1 deletion  
VIP2482 
 
ATATGAGCATAATAAAAAGGGAGAATATTA
ACTATTATCAAGTATTAAAAGCATAGGCCA
CTAGTGGATCTG 
Reverse primer for Pot1 deletion  
VIP2483 
 
AATAATATTGTAGATTTGAAGAGAATCACA
CATGTAACAGAAAAGCTGTACAGCTGAAG
CTTGTACGC 
Forward primer for Pcd1 deletion 
VIP2484 
 
GATTATCTCTTGAGAGTATTGTTAGGCAA
CGCATTATACCACAGTTTTTTGCATAGGC
CACTAGTGGATCTG 
Reverse primer for Pcd1 deletion  
VIP2460  ACGTTGTAAAACGACGGCCAGTGAATTCC
AAGACAGGGTCAATGAGAC 
Forward primer for amplification of 
GPD1 promoter and this recombines 
with M13F sequence  
VIP3106 ATCTATCAGCAGCAGCAGACATGAGCTCC
TTTATATTATCAATATTTGTGTTTG       
Forward primer for amplification of 
GPD1 promoter and this recombines 
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with Gpd1 ORF 
VIP3107 AAAGAAACAGAAGAGGAACTCATGAGC 
TCCTTTATATTATCA ATA TTTGTG TTTG     
Forward primer for amplification of 
GPD1 promoter and this recombines 
with ΔPTS2 Gpd1 ORF 
VIP2675 GGATCCTCTAGAGTCGACCTGCAGATGGT
GAGCAAGGGCGAG 
Forward primer for cloning mCherry-
PTS1 behind Gpd1, recombines with a 
multiple cloning site (MCS).  
VIP2676 GATAACACAGGCGGGATCAAGCTTCTACA
GTTTACTGTGCAGTGGCTTGTACAGCTCG
TCCATG 
Reverse primer for amplification of   
mCherry-PTS1 to clone behind Gpd1, 
recombines with MFA2 terminator.  
VIP2427 GGAGAAAAAACTATAGAGCTCATGTCTGC
TGCTGCTGATAG  
Forward primer for cloning Gpd1 behind 
GAL1/10 promoter, recombines with 
GAL1/10 promoter.  
VIP2428 GCAGGTCGACTCTAGAGGATCCATCTTCA
TGTAGATCTAATTCTTC  
 
Reverse primer for cloning Gpd1 behind 
GAL1/10 promoter, recombines with the 
multiple cloning site. 
VIP2661  CGTCAAGGAGAAAAAACTATAGAGCTCAT
GAGTTCCTCTTCTGTTTCTTTG 
Forward primer for cloning Gpd1-without 
N-terminus (PTS2), recombines with 
GAL1/10 promoter  
VIP2680    TGCTGGTAGAAAGAGAAGTTCCGCTTCTG 
TTGCTTTG AAG GCTGCCGAA AAG CCT 
 
Forward primer to mutate 
phosphorylation sites S24A, S27A of 
Gpd1. 
VIP2681 AGGCTTTTCGGCAGCCTTCAAAGCAACAG
AAGCGGAACTTCTCTTTCTACCAGCA 
 
Reserve primer to mutate 
phosphorylation sites S24A, S27A of 
Gpd1. 
VIP2821 TGCTGGTAGAAAGAGAAGTTCCGATTCTG
TTGATTTGAAGGCTGCCGAAAAGCCT  
 
Forward primer to mutate 
phosphorylation sites S24D, S27D of 
Gpd1.  
VIP2822 AGGCTTTTCGGCAGCCTTCAAATCAACAG
AATC GGA ACTTCTCT TTCTACCAGCA 
 
Reverse primer to mutate 
phosphorylation sites S24D, S27D of 
Gpd1.  
VIP2562  GTAAAACGACGGCCAGTGAATTCGTCAAG
GATCAAGGTGGCAC 
Forward primer for amplification of 
PNC1 promoter, recombines with M13F 
sequence. 
VIP2397 CTGCAGGTCGACTCTAGAGGATCCCCGG
GTACCTTTATCCACGACATTGATGTTGTG 
Revere primer to amplify Pnc1 ORF, 
recombines with MCS. 
VIP3003 AACGCTTCTGCTGCCATCCAAGAAGTCGG
TTTGGGTGAGATCATC 
Forward primer to mutate R270E of 
Gpd1.  
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VIP3004 GATGATCTCACCCAAACCGACTTCTTGGA
TGGCAGCAGAAGCGTT 
 Reverse primer to mutate R270E of 
Gpd1.  
VIP3005 ATCTCCATCTGTGGTGCTTTGGCCAACGT
TGTTGCCTTAGGTTGTG 
Forward primer to mutate K245A of 
Gpd1.  
VIP3006 CACAACCTAAGGCAACAACGTTGGCCAAA
GCACCACAGATGGAGAT 
 Reverse primer to mutate K245A of 
Gpd1.  
VIP3007 CAAGAGTCTGCTGGTGTTGCTAACTTGAT
CACCACCTGCGCTGG 
Forward primer to mutate D301N of 
Gpd1.  
VIP3008 CCAGCGCAGGTGGTGATCAAGTTAGCAA
CACCAGCAGACTCTT 
Reverse primer to mutate D301N of 
Gpd1. 
VIP3086 ACCACCTGCGCTGGTGGTGAAAACGTCA
AGGTTGCTAGGCTA 
Forward primer to mutate R310E of 
Gpd1 
VIP3087 TAGCCTAGCAACCTTGACGTTTTCACCAC
CAGCGCAGGTGGT 
Reverse primer to mutate R310E of 
Gpd1 
VIP3044 TTCAAGGTTACTGTGATTGGATCTGAAAA
CTGGGGTACTACTATTGCCA 
Forward primer to mutate G43E of Gpd1 
VIP3045 TGGCAATAGTAGTACCCCAGTTTTCAGAT
CCAATCACAGTAACCTTGAA 
Reverse primer to mutate G43E of Gpd1  
VIP3094 AGTCGCTCAAGAACACTGGTCTAGAACAA
CAGTTGCTTACCACATTC 
Forward primer to mutate E195R of 
Gpd1  
VIP3095 GAATGTGGTAAGCAACTGTTGTTCTAGAC
CAGTGTTCTTGAGCGAC 
Reverse primer to mutate E195R of 
Gpd1  
VIP2919 AGCTTGAAGCAAGCCTCGATGAAGACTTT
AATTGTTGTTG 
Forward primer for amplification of Pnc1 
and recombination into pBDC.   
VIP2920 CAGTAGCTTCATCTTTCGTTATTTATCCAC
GACATTGATG 
Reverse primer for amplification of Pnc1 
and recombination into pBDC.   
VIP2923 CCAAGCATACAATCCAAGATGTCTGCTGC
TGCTGATAG 
Forward primer for amplification of Gpd1 
and recombination into pADC.   
VIP2924 TATCCATCTTTGCAAAGGCCTAATCTTCAT
GTAGATCTAATTC 
Reverse primer for amplification of Gpd1 
and recombination into pADC.   
VIP2730 GACAGTTGACTGTATCGCCGGAATTCATG
CTCAGATATCATATGCAAG 
Forward primer for amplification of Pex7 
and recombination into pGBT9  
 VIP2731 GGCTGCAGGTCGACGGATCCTCAACCTA
AGCCGTTCCATA 
Reverse primer for amplification of Pex7 
and recombination into pGBT9 
VIP2736 GACAGTTGACTGTATCGCCGGAATTCATG
TCTCAAAGACTACAAAGT 
Forward primer for amplification of Pot1 
and recombination into pGBT9 
VIP2737 GGCTGCAGGTCGACGGATCCCTATTCTTT
AATAAAGATGGCG 
Reverse primer for amplification of   
Pot1 and recombination into pGBT9 
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VIP2909 
 
CAAACCCAAAAAAAGAGATCGAATTCATG
CTCAGATATCATATGCAAG 
Forward primer for amplification of Pex7 
and recombination into pGAD424 
VIP2910 
 
CTCTGCAGGTCGACGGATCCTCAACCTAA
GCCGTTCCATA 
Reverse primer for amplification of Pex7 
and recombination into pGAD424 
VIP2915 GACAGTTGACTGTATCGCCGGAATTCATG
CCCAGTGTCTGCCATAC 
Forward primer for amplification of 
Pex21 and recombination into pGBT9 
VIP2916 GGCTGCAGGTCGACGGATCCTCAATCAA
GTATGTCTTTGTG 
Reverse primer for amplification of 
Pex21 and recombination into pGBT9 
VIP3046 CAAGATGTCTGCTGCTGCTGATGCTTTAA
ACTTAACTTCCGGCCACT 
Forward primer to mutate PTS2 R7A of 
Gpd1 in pADC 
VIP3047 AGTGGCCGGAAGTTAAGTTTAAAGCATCA
GCAGCAGCAGACATCTTG 
Reverse primer to mutate PTS2 R7A of 
Gpd1 in pADC 
VIP1225 AGAAGCAAGAACGAAAAGAGATAAGGATT
CAAAAGAAAGGAAGCCCAATGCAGCTGAA
GCTTCGTACGC 
Forward primer for Msp1 deletion  
VIP1226 GATGCGTGAATAAAAAGCTTTCTTCTTTTT
TTTCTAATTTTCCTTCCTTAGCATAGGCCA
CTAGTGGATCTG 
Reverse primer for Msp1 deletion  
VIP1989 GTCGACCTGCAGGCATGCAGCTGAAGCT
TCGTACGC 
Forward primer for cloning natMX 
behind GFP-PTS1, recombines with 
MCS 
VIP1990 AAAAAATTGATCTATCGATAGCATAGGCC
ACTAGTG 
Reverse primer for cloning natMX 
behind GFP-PTS1, recombines with 
PGK1 terminator.  
VIP2091  GGAAGAAGCAAGAACGAAAAGAGATAAG
GATTCAAAAGAAAGGAAGCCCAGAATTCC
ATCAGGTTGGTGGAAG 
Forward primer for Msp1 deletion in 
SGA strain  
VIP226 AACGCGGTTTCTGAGAGATATAAAGTGAA
GAAAGAATTACAAATTGTGGGGAATTCGA
GCTCGTTTAAAC 
Forward primer to amplify GAL1/10   
promoter and integrates before Pex19 
ORF  
VIP228 TCTAAAAGGTCATCCAAATCATCAAAATTA
TCGTACTCGTTTTCATTCATTTTTGAGATC
CGGGTTTT 
Reverse primer to amplify GAL1/10   
promoter and integrates before Pex19 
ORF 
VIP2948 TGTAAAACGACGGCCAGTGAATTCCATTC
TCAATCTTCATGGTATC 
Forward primer to amplify MSP1 
promoter, recombines with M13F 
sequence 
VIP2949 AGAGGATCCCCGGGTACCGAGCTCTGGG
CTTCCTTTCTTTTGAATC 
Reverse primer to amplify MSP1 
promoter, recombines with Msp1 ORF 
sequence 
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VIP2055 CCAGTCACGACGTTGTAAAACGACGGCC
AGTGAATTCCATCAGGTTGGTGGAAGATT
AC 
Forward primer to amplify TPI1 
promoter, recombines with M13F 
sequence 
VIP2056 TCGTTTTTAAATCAAATTTGCGAGACATGA
GCTCGTTTATGTATGTGTTTTTGT 
Reverse primer to amplify TPI1 
promoter, recombines with Msp1 ORF 
sequence 
VIP1998 GGTTTTCCCAGTCACGACGTTGTAAACGA
CGGCCAGTGAATTCTATTACTCTTGGCCT
CCTCTAGTAC 
Forward primer to amplify HIS3 
promoter, recombines with M13F 
sequence 
VIP2049 TCGTTTTTAAATCAAATTTGCGAGACATGA
GCTCTTTGCCTTCGTTTATCTTGC 
Reverse primer to amplify HIS3 
promoter, recombines with Msp1 ORF 
sequence 
VIP2517 GTAAAACGACGGCCAGTGAATTCCCCATC
GTCAACGATAGTGT 
Forward primer to amplify YGR168C 
promoter, recombines with M13F 
sequence 
VIP2107 
 
GTATGCAAGACATGTGGAAAGCTACATCT
AGAGTCGACCTGCAGGGAGC 
Forward primer to amplify mCherry and 
clone behind Pex11, recombines with 
MCS 
VIP2108 GAAAAAAATTGATCTATCGATAAGCTTCTA
CTTGTACAGCCTCGTCCATG 
Reverse primer to amplify mCherry and 
clone behind Pex11, recombines PGK1 
terminator 
VIP2429 
 
GGAGAAAAAACTATAGAGCTC 
ATGAAACACAATCGTCCAAATG 
Forward primer to amplify Ygr168c 
ORF, recombines with GAL1/10 
promoter 
VIP2430 GCAGGTCGACTCTAGAGGATCCCATAATA
CTAAGCTGAAACAA 
Reverse primer to amplify Ygr168c 
ORF, recombines with MCS 
VIP2517 GTAAAACGACGGCCAGTGAATTCCCCATC
GTCAACGATAGTGT 
Forward primer to amplify YGR168C 
promoter, recombines with M13F 
sequence 
VIP2518 TTTGGACGATTGTGTTTCATGAGCTCATA
GTTAGCAAGTGTATACTCTC 
Reverse to amplify YGR168C promoter, 
recombines with MCS 
VIP2540 TACACATCGCGAACAGAGCTAAAGAGAGT
ATACACTTGCTAACTA 
Forward primer to mutate of ATG of 
uORF of YGR168C promoter 
VIP 2541 TAGTTAGCAAGTGTATACTCTCTTTAGCTC
TGTTCGCGATGTGTA 
Reverse primer to mutate of ATG of 
uORF of YGR168C promoter 
VIP2573 CGTCAAGGAGAAAAAACTATAGAGCTCAT
GAAACACAATCGTCCAAATG 
Forward primer to amplify Ygr168c 
ORF, recombines with GAL1/10 
promoter 
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Table 2-5:Oligonucleotides used in this study. All primers were supplied by Sigma Aldrich. 
 
 
 
 
 
 
 
 
VIP2575 GCAGGTCGACTCTAGAGGATCCCCGGGT
ACCTGGCATGATATCATTTATTTG 
Reverse primer to amplify Ygr168c from 
1-74aa 
VIP2576 GCAGGTCGACTCTAGAGGATCCCCGGGT
ACCTTTTGCGATCTTTAATTTGGAGG 
Reverse primer to amplify Ygr168c  
1-141aa 
VIP2577 GCAGGTCGACTCTAGAGGATCCCCGGGT
ACCCCCTGAAGTAAAAAAGAATTTTA 
Reverse primer to amplify Ygr168c   
1-219aa 
VIP2578 CGTCAAGGAGAAAAAACTATAGAGCTCAT
GCCATGGCTAAGAGAGTCTA 
Forward primer to amplify Ygr168c from 
74-376aa  
VIP2579 CGTCAAGGAGAAAAAACTATAGAGCTCAT
GAAATTAACACAATGGTTGAAAAA 
Forward primer to amplify Ygr168c from 
141-376aa to end 
VIP2580 CGTCAAGGAGAAAAAACTATAGAGCTCAT
GGGGACGAAATCAAATAAGAATG 
Forward primer to amplify Ygr168c from 
219-376aa  
VIP2581 GCAGGTCGACTCTAGAGGATCCCCGGGT
ACCCATAATACTAAGCTGAAACAAAA 
Reverse primer to amplify Ygr168c  
ORF 
VIP2571 GAAATACACATCGCGAACAGAGCTAATGA
GAGTATACACTTGCTAACTATCAGCTGAA
GCTTCGTACGC 
Forward primer for Ygr168c deletion 
VIP2572 AATATAGATTATTTACAAACTTGTAAACTC
TTCTCTTCTAAAAAAACACAGCATAGGCC
ACTAGTGGATCTG 
Reverse primer for Ygr168c deletion 
VIP2955 GGATTCAAAAGAAAGGAAGCCCAGAGCC
TCATGTCTCGCAAATTTGATTTAAAA 
Forward primer to amplify Msp1 ORF 
VIP2956 CAGGTCGACTCTAGAGGATCCTTAATCAA
GAGGTTGAGATGAC 
Reverse primer to amplify Msp1 ORF 
VIP2426 CCAAACTGGACAGGAGTTCG Forward primer 500bp upstream of stop 
codon of Ygr168c ORF 
  
 
46 
2-6 Yeast protocols  
 
2-6-1 Yeast growth and maintenance 
 
All yeast strains were grown on liquid media YPD or YM1 and YM2 containing 2% 
glucose or 2% raffinose and incubated at 30°C. Amino acids, adenine and uracil 
were added to strains with auxotrophies as required. Antibiotics were used to select 
for resistance conferring selection cassettes. Glycerol stocks were prepared in 15% 
(v/v) glycerol and stored at -80°C. For yeast strains with a reporter gene under 
control of the GAL1/10 promoter, cells were grown overnight on 2% raffinose 
selective medium. Then, cells were transferred to YM2 2% galactose medium to 
induce expression for the times indicated. 
 
2-6-2 High efficiency transformation  
 
High efficiency yeast transformations were performed according to the lithium 
acetate procedure (Daniel Gietz and Woods, 2002). Sterile 1M LiAc pH 7.5 and 
10xTE (0.1M Tris-HCl, 0.01M EDTA, pH 7.4) stock solutions and 50% PEG 3350 
(w/v) were prepared. The yeast strains were grown overnight in the appropriate liquid 
media. 5ml of yeast culture was started at ODλ600 = 0.1 and allowed to grow to mid-
log phase (ODλ600=0.5-0.6). Cells were harvested at 2,500rpm for 5min by 
centrifugation and the supernatant was removed. The pellet was washed with 1ml of 
sterile water and transferred to an Eppendorf tube and centrifuged again at 2,500rpm 
for 5min. The supernatant was discarded and cells were washed by 1ml of freshly 
prepared 1xTE/100mM LiAc, pH 7.5. Then, the cells were resuspended in 50µl of 
1xTE/100mM LiAc, pH 7.5 and 2-10µl (0.5µg -1µg) of DNA (PCR product and/or 
plasmid) was added per single transformation. Next, 300µl sterile 40% PEG 3350 
(w/v), 10mM Tris-HCl pH 7.5, 0.1mM EDTA pH 8.0, 100mM LiAc pH 7.5) and 5µl 
(50µg) of single stranded DNA were added and vortexed. The tubes were left at 
room temperature for 30min. Subsequently the tubes were transferred to a water 
bath at 42°C for 15min (heat shock) and cells were spun down for 30s. Finally, cells 
were resuspended in 50µl 1xTE (10mM Tris-HCl pH 7.5, 0.1mM EDTA), and plated 
on selective media and incubated at 30°C for two days. Those instances where the 
resistance markers were used (cloNat, G418, Hygromycin B), cells were first 
recovered for 4 hours in liquid YPD medium before being spread onto YPD plates 
containing the antibiotic. 
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2-6-3 One step transformation  
 
Yeast strains were grown overnight in appropriate liquid media. 200µl from overnight 
culture was centrifuged for 1min at 13,000rpm in an Eppendorf microfuge. 1µl of 
plasmid DNA (100-300ng) was added and vortexed. Subsequently, 50µl of one step 
buffer (0.2M LiAc pH 5.0, 40% (w/v) PEG 3350, 0.1M DTT) and 5µl (50µg) of single 
stranded DNA were added. The tube was incubated at room temperature for several 
hours with occasional vortexing. Next, the tubes were heat shocked at 42°C for 
30min and the cell suspension was plated on appropriate selective media. The plates 
were incubated at 30°C for two days. 
 
 
2-6-4 Yeast genomic DNA isolation  
 
Yeast strains were grown overnight in 3ml liquid media and harvested at 13000rpm 
for 1min in an Eppendorf microfuge and resuspended in 1ml of sterilised water. In 
some cases, the cells were scraped from agar plates and resuspended in 1ml 
sterilised water. The cells were centrifuged at 13,000rpm for 1min, the supernatant 
was discarded and the cells were resuspended in the remaining volume. 200µl of 
TENTS (20mM Tris-HCl pH 8.0, 1mM EDTA, 100mM NaCl, 2%(v/v) Triton X-100, 
1%(w/v) SDS), 200µl of 425-600µm glass beads and 200µl phenol: 
chloroform:isoamyl alcohol (25:24:1) were added. Then, the cells were lysed using a 
mini bead beater (Biospec Products) at full speed for 30s; the mixture was 
centrifuged at 12,000rpm for 30s. 200µl of TENTS was added and suspension was 
vortexed. The samples were centrifuged at 12,000rpm for 5min and ~350µl of 
supernatant was kept. 200µl of phenol:chloroform:isoamyl alcohol was added and 
the samples were vortexed and centrifuged as above. 300µl of the supernatant was 
transferred to a clean tube, and DNA was precipitated by adding 1/10 volume of 3M 
NaAc pH 5.2 and 2.5x volume 100% ethanol and incubated on ice for 15min. The 
samples were centrifuged at 12,000rpm for 15min and washed with 70% ethanol. 
The samples were centrifuged at 12,000rpm for 15min and the supernatant was 
removed. The pellet was resuspended in 200µl 1xTE + 2µl RNase (100μl RNase/TE 
(10μg/ml)). The tubes were left at room temperature for 10min. The DNA 
precipitation step was performed as described. The pellet was washed with 70% 
ethanol. Finally, the pellet was dried at 56°C and resuspended in 50-100µl of 1xTE.  
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2-6-5 Pulse-chase experiments 
 
Pulse-chase experiments were used to follow the localisation of fluorescently tagged 
proteins under control of the GAL1/10 promoter. For rapid induction of expression, 
cells were grown for overnight in 2% raffinose selective medium at 30°C with shaking. 
The cells were diluted 1:10 and induced on 2% galactose selective medium for 1 
hour. The cells were spun down and resuspended in 2% glucose selective medium 
to shut down the GAL1/10 promoter. Live-cell imaging was done at regular intervals 
after shut down of expression. 
 
2-7 Synthetic Genetic Array (SGA) technology  
 
2-7-1 SGA query strain construction  
 
The Msp1 open reading frame (ORF) in a query strain (DLY7325 MATα) was 
replaced with the deletion cassette also containing an expression cassette to 
visualise peroxisomes (TPI1-GFP-PTS1-natMX). First, a plasmid was constructed 
containing both the well-established peroxisomal marker cassette TPI1-GFP-PTS1 
and a drug resistance marker cassette natMX (pNA013), which was used as a 
template to amplify a genome-editing cassette as described in section 2-3. 
Replacement of Msp1 ORF by TPI1-GFP-PTS1-natMX in the genome in DLY7325 
was accomplished by homologous recombination (Figure 2-2). Recombinants were 
selected on YPD-cloNat medium and checked for integration at the right locus by 
PCR.  
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Figure 2-2: Construction of msp1Δ in query strain (DLY7235) by homologous 
recombination. PCR was used to amplify TPI-GFP-PTS1-natMX by using a forward primer, 
which contains 45 nucleotides of identity in the region upstream of the start codon of Msp1. 
The 5’ end of the reverse primer contains 45 nucleotides identical to the sequence 
downstream of the stop codon of Msp1. Insertion of TPI-GFP-PTS1-natMX occurs by 
homologous recombination. 
 
 
 
2-7-2 SGA methodology  
 
The SGA procedure was performed according to (Tong and Boone, 2006). In short a 
query strain containing a gene modification (GFP tag or deletion or point mutation etc 
flanked by natMX cassette) is mated with an array of gene deletion mutants. 
Subsequently, the diploids are sporulated and spores are selected that contain the 
gene deletion and the gene modification of the query strain. The methodology 
described below allows for large numbers of strains being constructed in a relative 
short period of time.  
First, the query strain was grown in 200µl of liquid media (YPD or selective medium 
for a strain expressing a plasmid with selectable marker). Furthermore, the MATa 
gene deletion mutants were grown on 150µl YPD using 96 well plates at 30°C. The 
next day, 25µl of query strain culture was mated with 25µl of each MATa mutant 
culture in 150µl YPD, using a 96 well plate, and left at 30°C for 1 day. Diploids were 
selected on YEPD medium containing cloNat and G418 at 30°C for 2 days. 
Subsequently, the diploids were pinned onto an enriched sporulation medium and 
  
 
50 
the plates were incubated at 25°C for 5 days. Next, spores were pinned onto SD His-
/Arg-/Lys- + canavanine/ thialysine plates for meiotic progeny selection. Haploid-
selection plates were incubated at 30°C for 2-3 days. MATa meiotic progeny was 
pinned onto SD His-/Arg-/Lys- + canavanine/ thialysine plates for a second round of 
haploid selection and the plates were left at 30°C for 1 day. The MATa meiotic 
progenys were pinned onto SD/MSG His-/Arg-/Lys- + canavanine /thialysine/G418 
plates and incubated at 30°C for 2 days to select for the gene deletion spores. Finally, 
the MATa meiotic progeny were pinned onto SD/MSG His-/Arg-/Lys-+ canavanine/ 
thialysine/G418/ cloNat plates for MATa kanR-cloNatR meiotic progeny selection and 
left at 30°C for 2 days, resulting in spores that contain both the gene deletion and the 
gene modification of the initial query strain. In addition, SGA can be performed to 
cross a plasmid (carrying a specific gene or marker) to an array of gene deletion 
mutants. 
 
 
2-7-3 Sterilisation procedures for the pin tools 
 
For sterilisation of pin tools between pinning steps, three wash reservoirs were 
prepared as follows:  
A) Three trays of sterile water of increasing volume 30ml, 50ml, and 70ml 
B) One tray of 40ml of 20% bleach  
C) One tray of 90ml of 99% ethanol 
The replicator was placed in the 30ml water reservoir for ~1min to remove the cells. 
Next, the replicator was placed in 20% bleach for ~20s. The pinner was transferred 
to the 50ml water reservoir and then to the 70ml water reservoir to rinse the bleach 
off the pins. Finally, the replicator was transferred to 99% ethanol and left in the flow 
cabinet to dry. 
 
 
2-7-4 Making amino-acids supplement powder mixture for synthetic 
media (complete): 
 
This mixture is made from the combination of ingredients below minus the 
appropriate supplement: 
3g adenine (hemi-sulphate), 2g uracil, 2g myo-inositol, 0.2g para-aminobenzoic acid , 
2g alanine, 2g arginine, 2g asparagine, 2g aspartic acid, 2g cysteine, 2g glutamic 
acid, 2g glutamine, 2g glycine, 2g histidine, 2g isoleucine, 10g leucine, 2g lysine HCl, 
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2g methionine, 2g phenylalanine, 2g proline, 2g serine, 2g threonine, 2g tryptophan, 
2g tyrosine and  2g valine. 
 
The solid ingredients were combined and mixed thoroughly by turning end-over-end 
for at least 15min. The resultant mixture was stored in tinted glass bottles at room 
temperature. 
 
 
 
2-7-5 Preparation of antibiotic stocks for SGA 
 
 
1-G418 (Geneticin):  
2g of G418 was dissolved in 10ml water at 200mg/ml final concentration, filter 
sterilised, aliquoted and stored at -20°C.  
2- CloNat (nourseothricin):  
1g of cloNat was dissolved in 10ml water at 100mg/ml final concentration, filter 
sterilised, aliquoted and stored at -20°C. 
3- Canavanine (L-canavanine sulfate salt): 
1g of Canavanine was dissolved in 10ml water at a final concentration of 100mg/ml, 
filter sterilised, aliquoted and stored at -20°C. 
4-Thialysine (S-(2-aminoethyl)-L-cysteine hydrochloride): 
1g of Thialysine was dissolved in 10ml water at a final concentration of 100mg/ml, 
filter sterilised, aliquoted and stored at -20°C. 
 
                               
2-7-6 Imaging of mini SGA screen 
 
The cells were grown overnight on selective media supplemented with 2% glucose 
and appropriate amino acids. Next morning, cells were diluted to ODλ600=0.1 and 
grown to logarithmic phase. Cells were imaged using a 63x lens objective. See 
section 2-9.  
 
 
2-7-7 The Genome wide screen SGA  
 
The construction of a genome wide screen was performed in cooperation with Dr 
David Lydall (Institute for Cell and Molecular Biosciences, Newcastle University). The 
query gene mutation (msp1::GFP-PTS1-natMX) was combined with all non-essential 
mutations in the yeast genome to produce ~5000 different double mutant yeast 
strains, essential genes  and DAmP  (decreased abundance by mRNA perturbation). 
  
 
52 
The later collection was constructed for generating hypomorphic alleles of essential 
genes. The DAmP mutations were used to screen the phenotype of a desired mutant 
under disruption of essential genes (Schuldiner et al., 2005). 
 
2-7-8 Preparing SGA library for imaging  
 
The genome wide screen library (SGA) of msp1∆ combined with all non-essential 
genes mutants and DAmp, was screened and imaged after optimising the growth 
conditions. The mutants array is distributed on 24 columns and 16 rows in 384 well 
format plates (column 1, 24 and row 1 and 16 are the controls carrying a single 
mutant (msp1∆), which is crossed to an array of the MATa collection). These mutants 
were pinned in 4 different positions to screen the library in a 96 well plate format. 
These positions were presented as below: 
 
 
 
 
 
                            *C represents columns e.g., C8 is column number 8 in 384 plates 
*R represents rows, e.g., R2 is row number 2 in 384 plates. 
Figure 2-3: Distribution of 384-well plate format of SGA mutants to 96- well plate format 
for imaging. 
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The cells were pinned on fresh YM2 plates containing G418/cloNat in 4 positions, as 
represented in Figure 2-3 using the 96 well pin replicator. The following day, cells 
were pinned into 150µl of fresh YM2 liquid media using the 96 well pin replicator and 
left at 30°C overnight. 3µl from an overnight culture was added to 47µl of fresh media 
in 96 well plates with a glass bottom for microscopy. The plates were left for 3 hours 
at 30°C. Later, the media was removed and the cells were resuspended in a low 
fluorescent medium. The cells were left for 10-20min to settle down before imaging 
using a 40x non-oil objective. 
 
 
 
2-8 Yeast two-hybrid screen growth assay  
 
The basis of yeast two-hybrid (Y2H) relies on fusing a protein of the interest (called 
the “bait”) to the DNA binding domain (BD) of the transcriptional activator GAL4. A 
second protein known as “prey” is fused to the activation (AD) part of GAL4. 
Therefore, the interaction between these two proteins brings BD and AD domains in 
close proximity. This leads to expression of a functional GAL4 transcription factor 
and activates the reporter gene (e.g HIS3 gene). If two proteins do not interact, the 
binding domain cannot activate the GAL4 gene without the activation domain (Fields 
and Song, 1989; Brückner et al., 2009) (Figure 2-4).  In some cases, the bait protein 
fused to the BD can auto-activate the transcription of the reporter gene in absence of 
an interacting partner (AD protein). This leads to false positive results, which can be 
eliminated by adding 3AT (3-amino-1,2 ,4-triazole) into the selective growth medium. 
Addition of 3AT competitively inhibits the product of the HIS3 gene, Imidazole-
glycerol-phosphate dehydratase (Walhout and Vidal, 1999) 
The two-hybrid screen was performed by expressing the bait protein as a Gal4 DNA-
binding-domain-fusion in PJ69-4α and this was mated with an array of Gal4 
activation-domain-protein fusions, expressed in the PJ69-4a strain (Uetz et al., 2000). 
The cells were grown in selective media in 96 well plates overnight. For mating, 25µl 
from each mating type was mixed in 150ul YPD and plates were incubated at 30°C 
for two days. After mating, cells were spotted by pinning onto SD minimal media 
lacking tryptophan and leucine for diploids selection, and plates were incubated at 
30°C for two days. The diploids were pinned onto synthetic minimal media lacking 
tryptophan, leucine, histidine and adenine, and supplemented with an appropriate 
concentration of 3-amino-1, 2, 4-triazole (determined experimentally). The plate were 
scored for protein-protein interaction after incubation at 30°C after 2, 10, and 14 days. 
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Figure 2-4: Schematic diagram of the Yeast Two-Hybrid system to study protein-
protein interaction in vivo. The protein of interest fused to the BD (X) is expressed in 
haploid cells and mated with the opposite mating partner expressing the AD fusion protein (Y). 
Diploids cells expressing both BD and AD results in: A- No activation of the reporter gene. If 
the fusion proteins do not interact, then the binding domain is not able to enhance the 
transcription without the activation domain. B- Activation of the reporter gene. During protein-
protein interaction, the fused proteins enhance the GAL4 transpiration factor and express the 
reporter gene. UAS: upstream activator sequence. Picture is adapted from (Brückner et al., 
2009). 
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2-9 Fluorescence microscopy 
[F 
Live cell imaging was performed by an Axiovert 200M (Zeiss) microscope equipped 
with Exfo X-cite 120 excitation light source, band-pass filters (Zeiss and Chroma), 
and alpha plan-Fluar 100x/1.45, A plan-pochromat 63x /1.40, or A plan 40x /0.65 
ph2 objective lens (Zeiss) and Hamamatsu Orca ER digital camera.  
Volocity software (Improvision) was used to perform image acquisition and images 
were collected as 0.5μm z-stacks. Subsequently, the images were processed in 
Openlab and Photoshop. The bright field images were processed in the blue channel 
of Photoshop and they were blurred and sharpened to make yeast cell boundaries 
visible. 
 
 
2-10 Pexophagy assay  
 
Cells expressing Pex11-GFP or Pex11-mCherry were grown in 2ml of 2% glucose 
overnight. The following day, cells were switched to oleate medium and incubated 
overnight at 30°C. Next, cells were washed using YM1 and resuspended in 3ml of 
nitrogen starvation medium. 1ml of the 3ml sample was harvested and indicated as 
T=0, and 4ml of nitrogen starvation medium was added to the remaining volume. 
After 6 hours and 22 hours growth on starvation medium, 3ml was harvested and 
indicated as T=6 and T=22, respectively. 
 
 
2-11 Escherichia coli  protocols  
 
2-11-1 Preparation of chemical competent E. coli DH5α cells  
 
DH5α competent cells were prepared by the rubidium chloride method (Hanahan, 
1985). Overnight cultures were prepared from a single colony of DH5α from a 2TY 
plate, and incubated at 37°C. 200ml of 2TY medium was inoculated to start a 
secondary culture from ODλ600=0.05 and grown at 30°C with shaking until 
(ODλ600=0.5-0.6) mid log phase. The culture was left on ice to chill for 15min. The 
culture was divided over 50ml Falcon tubes and centrifuged at 3000rpm for 10min at 
4°C in a Sigma 4.16k centrifuge (11150 rotor). The supernatants were discarded and 
the bacterial cells were resuspended in 75ml of ice-cold RF1 solution (100mM 
rubidium chloride, 50mM manganese chloride, 30mM potassium acetate, 10mM 
calcium chloride, 15% w/v glycerol, pH 5.8) and chilled on ice for 20min. The tubes 
were centrifuged again as above. The pellet was resuspended in 16ml ice cold RF2 
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(10mM MOPS, 10mM rubidium chloride, 75mM calcium chloride15% w/v glycerol, pH 
6.8) and aliquoted in Eppendorf tubes. The cells were flash-frozen in liquid nitrogen 
and stored at -80°C.  
 
2-11-2 E. coli transformation 
 
The competent E. coli cells (DH5α) were thawed on ice. 1µl of plasmid or 10µl of 
ligation mixture was added to 100µl of cells. Cells were left on ice for 30min. The 
cells were subsequently heat shocked at 42°C for 90s and incubated for 2min on ice. 
For each transformation, 900µl of 2TY media was added and incubated at 37°C for 
60min. The cells were centrifuged at 12,000rpm for 1min and 900µl of supernatant 
was discarded. The cells were resuspended in the remaining volume and plated onto 
agar media with the desired antibiotic.  
 
2-11-3 Preparation of electroporation-competent DH5 cells 
 
1L of 2TY medium was inoculated from an overnight culture to start a secondary 
culture from ODλ600 =0.05 and grown at 30°C with shaking until (ODλ600 =0.5-0.6) mid 
log phase. The culture was left on ice to chill for 15min. The cells were harvested by 
centrifugation at 3,000rpm for 15min using a pre-cooled Sigma 4-K15 centrifuge 
(12166-H rotor). After harvesting, the supernatant was discarded and the pellet 
resuspended in 500ml ice-cold 10%(v/v) glycerol. The cells were harvested again 
and resuspended in 250ml 10%(v/v) glycerol. The harvesting was done for a third 
time and the cells were resuspended in 50ml 10%(v/v) glycerol. Finally, the last 
harvesting step was performed by centrifugation using a pre-cooled Sigma 4-16K 
centrifuge (11150 rotor) at 3000rpm for 15min. After discarding the supernatant, the 
pellet was resuspended in 750μl 10%(v/v) glycerol. 40μl aliquots (in 1.5ml Eppendorf 
tubes) were flash-frozen in liquid nitrogen and stored at -80C. 
 
 2-11-4 Electroporation transformation 
 
10μl of 10x diluted yeast genomic DNA was added to 40µl of E. coli DH5 
electrocompetent cells, which were thawed on ice. Cells were mixed and transferred 
to a chilled electroporation 0.2cm cuvette (Geneflow). The cuvette was placed in the 
electroporation chamber and pulsed using setting EC2 (v=2.5kV) on the 
electroporator BIORAD MicroPulser. After the pulse, 600µl of 2TY media was added 
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immediately and the cells were transferred to a 1.5ml eppendorf tube. The tube was 
left at 37°C for 30min and the cells were centrifuged at 5000rpm for 5min and 
supernatant was discarded. The cells were resuspended in the remaining 
supernatant and plated onto agar media with the desired antibiotic. The plates were 
incubated overnight at 37C. 
 
2-12 DNA procedures  
 
2-12-1 Polymerase chain reaction 
 
The polymerase chain reaction (PCR) was performed to amplify specific regions of 
DNA. PCR reactions consisted of:  
 
 
 ““““ 
Table 2-6: The PCR reaction components. 
 
 
 
 
 
 
 
 
Component 
 
Accuzyme polymerase 
 
Taq polymerase 
Reaction buffer 5µl 10x Accuzyme buffer  5µl 10x Taq buffer 
Forward primer 5µl of 5µM  5µl of 5µM 
Reverse primer 5µl of 5µM  5µl of 5µM  
dNTPs 6µl of 2.5mM  3µl of 2.5mM 
MgCl2 1.5µl of 50mM 1.5µl of 50mM 
DNA polymerase 1µl of 2.5U/µl  0.2µl of 5U/µl  
d.dH2O 25.5µl 29µl 
Total per reaction 50µl 50µl 
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PCR conditions used: 
1- 5min at 95°C for the initial denaturation of DNA 
2-30s at 95°C for the denaturation step of DNA 
3-30s at 56°C for the annealing step of the primers 
4---min at 72°C for the elongation step. 30 cycles of step 2-4 were performed 
followed by a  
5- 10min at 72°C for the final extension step 
The annealing temperature was occasionally changed depending on the base 
composition of the primers and an approximation of the Tm was calculated using the 
formula:   
Tm= 4(G+C) +2(A+T) 
The temperature used for annealing was typically 5°C below the Tm. 
For Taq DNA polymerase, 1min/kb of DNA product was used in the elongation step, 
and 2min/kb for the proofreading DNA polymerase Accuzyme. The Taq DNA 
polymerase enzyme was used to amplify gene disruption cassettes and for 
diagnostic PCRs. Accuzyme was used to amplify DNA fragments used for 
expression studies.  
In order to amplify the natMX cassette  (to perform a knockout in the SGA query 
strain), PCR conditions and a reaction were used as below according to (Goldstein 
and McCusker, 1999): 
1- 1min at 94°C for initial denaturation of DNA 
2-1min at 94°C for the denaturation step of DNA 
3- 1min at 55°C for the annealing step of the primers 
4- 3min at 72°C for elongation step. 30 cycles of step 2-4 were performed followed 
by   
5- 20min at 72°C for the final extension step 
In addition, the PCR reactions for natMX contained:  5µl of 5µM forward primer, 5µl 
of 5µM reverse primer, 3µl of 2.5mM dNTPs, 1µl of 1/50 diluted mini prep of plasmid 
P4339, 1.5µl of 50mM MgCl2, 5µl of 10x Taq buffer, 0.5µl of 5U/µl Taq DNA 
polymerase, 2.5µl of DMSO (5% final concentration, dimethyl sulfoxide), in a total 
reaction volume of 50µl. 
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2-12-2 Site directed mutagenesis 
 
Site directed mutagenesis was performed using Phusion high fidelity DNA 
polymerase (Promega). Each reaction consisted of: 2.5μl of 10x Phusion buffer, 4µl 
of 2.5mM dNTPs, 1μl of 5x diluted plasmid (30-50ng), 1µl of each 5µM primer, 15μl 
of sterilised water and 0.25μl of Phusion DNA polymerase. The PCR conditions that 
were used are shown below: 
1- 1min at 95°C for initial denaturation of DNA 
2- 30s at 95°C for the denaturation step of DNA 
3-1min at 55°C for the annealing step of the primers 
4- --min at 68°C for the elongation step. 25 cycles of step 2-4 were performed 
followed by   
5-20min at 68°C for the final extension step 
The elongation time was calculated as 2min /1kb, dependent on the plasmid size. 
 
2-12-3 DNA gel extraction  
 
The QIAquick Gel Extraction Kit (Qiagen) was used to perform a gel extraction 
according to manufacturer’s instructions. 
 
 
2-12-4 Agarose gel electrophoresis 
 
PCR product, plasmid digestion and gel-extracted DNA samples were examined by 
agarose gel electrophoresis. 1% agarose gels were prepared by melting 0.5g of 
agarose in 50ml of 1xTBE (90mM Tris-Borate, 1mM EDTA, pH 8.0) and adding 
ethidium bromide to a final concentration of 0.5µg/ml. Samples were loaded after 
mixing with DNA Loading Buffer at 1x final concentration (6x loading buffer: 0.25% 
bromophenol blue (w/v), 0.25% xylene cyanol FF (w/v), 30% glycerol (v/v)). A DNA 
marker (Bioline Hyper ladder I) was run alongside the DNA samples to determine the 
correct size of DNA fragments. Gels were run in 1xTBE buffer at a constant voltage 
of 100V. DNA bands were examined using an ultraviolet transilluminator imaging 
system (Gene Genius). 
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2-12-5 DNA sequence analysis  
 
The generated constructs used in this study were sequenced by Beckman Coulter 
Genomics and Source Bioscience. Data was analysed using the SNAP GENE viewer 
programme. 
 
 
 
 
2-12-6 Ligation  
 
 
Each DNA ligation reaction consisted of: 4µl of 5x ligase buffer, - µL of digested PCR 
product or purified insert in molar ratio 3:1 (insert DNA/vector), 2µl of linearised 
vector (25ng) and 1µl of T4 DNA ligase (Promega) in a final volume of 20µl. The 
reaction tubes were left in water at room temperature overnight before E. coli 
transformation. 
 
2-12-7 Plasmid miniprep preparation  
 
 
 
E. coli DH5α cells with plasmid were grown overnight in 5ml of 2TY (containing the 
appropriate antibiotic). Plasmid DNA was isolated from the culture using the Sigma 
Aldrich mini prep kit, following manufacturer’s instructions. 
 
 
2-12-8 Restriction enzyme digestion  
 
 
 
 
A restriction digestion reaction typically contained 4µl of 10x NEB buffer, 3-5µl of 
plasmid DNA (300-500ng/µl), 1xBSA (20mg/ml) if required and 2µl of enzyme in a 
total reaction volume of 40µl. The reactions were incubated for 4 hours at 37°C.  
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2-13 Protein procedures  
 
 
2-13-1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) 
 
 
SDS-PAGE was performed according to the procedure of (Sambrook and Russell, 
2006). The gel was prepared as shown in Table 2-7. 
 
[[[[ [  
 
 
 
 
 
 
 
 
 
Table 2-7: Components of SDS-PAGE gels.10% APS and TEMED were added last to start 
gel polymerisation. 
 
 
The protein-loading buffer (250mM Tris-Cl pH 6.8, 9.2% (w/v) SDS, 40% (v/v) 
glycerol, 0.2% (w/v) Bromophenol blue, 0.1M DTT) was added to the samples. 
Samples were heated at 95°C for 5min and 5-15µl of each sample was loaded on the 
gel. The gels were run in 1x protein running buffer (25mM Tris-HCl, 192mM Glycine, 
0.1% (w/v) SDS, pH 8.3) at constant voltage of 80V, until the marker dye reached the 
end of the stacking gel. Subsequently, the gels were run at 160V until the dye front 
reached the bottom of the separating gel. A Pre-stained marker was run alongside 
the samples to determine protein size.  
 
 
SDS gel components 
 
12% Resolving gel    5% Stacking gel   
 
2.6ml of resolving buffer 2.5ml of stacking buffer 
 
4ml of protogel (30%(w/v) acrylamide) 1.3ml of protogel 
 
3.4ml of water  6.1ml of water  
 
100µl of 10% APS (Ammonium persulfate) 100μl of 10% APS 
 
10μl of TEMED  
N,N,N',N' Tetramethylethylenediamine 
10μl of TEMED 
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2-13-2 Co-immunoprecipitation (Co-IP) 
 
Cells were grown on selective glucose medium overnight. The following morning, 
cultures were transferred to fresh selective medium for a few hours, shifted to 0.8M 
or 1M NaCl selective medium and grown overnight. Cells were harvested at 
2,500rpm for 5min and resuspended in pre cooled 1000μl 1xHEPES lysis buffer 
(20mM HEPES, 100mM KOAc and 5mM MgOAc pH 7.5 with protease inhibitor 
cocktail (Roche)). 400μl of 425-600µm glass beads and 1.5μl of (100mM) 
phenylmethanesulfonyl fluoride (PMSF) were added to each tube. The tubes were 
pulsed in a mini bead beater (Biospec Products) at full speed for 30s for 4 times with 
30s on ice between the pulses. The samples were centrifuged at 2500rpm 4°C for 
1min. The supernatant was centrifuged at 13,000rpm for 10min at 4°C. About 900μl 
of supernatant was transferred into a clean tube and 100μl was kept as total lysate 
(TL). The beads were washed with 1xHEPES lysis buffer for 3 times. An equal 
amount of beads were added to each sample and rotated at 4°C for an hour. The 
beads were washed four times before elution with 75μl 1xHEPES buffer. 25μl of 4x 
loading dye was added to each IP sample and 33.3μl for each TL sample, and 
samples were heated at 95°C for 5min. The samples were centrifuged at 13,000rpm 
for 1min before loading the SDS-PAGE gel. 
 
2-13-3 Western blot 
 
Following separation of protein samples by SDS-PAGE, samples were blotted onto a 
nitrocellulose membrane using a Biorad Mini Trans-Blot Electrophoretic transfer cell. 
The transferring was performed at a constant 200mA current for 2 hours using pre-
cooled transfer buffer (25mM Tris, 150mM glycine and 40% (v/v) methanol). 
Ponceau S solution (0.1% (w/v) Ponceau S in 5% (v/v) acetic acid) was used to 
detect the efficiency of transferring. 25ml of blocking buffer (2% (w/v) fat free Marvel 
milk, 0.1% (v/v) Tween20, 1xTris buffered saline (TBS) (20mM Tris, 150mM NaCl pH 
7.6)) was added to the blotted membrane and incubated for one hour with mixing. 
Subsequently, the membrane was incubated with 10ml of fresh blocking buffer 
containing the primary antibody with desired dilution and incubated for another hour 
with constant mixing. Next, the membrane was washed three times (5 min for each 
wash) with 0.1% (v/v) Tween20 /TBS to remove unbound primary antibody. The 
membrane was incubated with 10ml of blocking buffer containing the appropriate 
dilution of secondary antibody for one hour with mixing. Three washes with 0.1%(v/v) 
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Tween20/TBS were done before detection of protein using enhanced 
chemiluminesscence (ECL) reagents. 
 
 
2-13-4 Sources of antibodies 
 
The antibodies used in this study are listed in Table (2-8). 
 
Antibody Usages  Source 
Anti-GFP Used as primary antibody for detection of GFP 
tagged proteins 
Sigma 
Anti-HA Used as primary antibody for detection of HA 
tagged proteins 
Sigma 
 
Anti-PAP Used as primary antibody for detection of 
protein A tagged proteins 
Sigma 
Anti-PGK1 Used as primary antibody for detection of 3-
phosphoglycerate kinase 
Invitrogen 
Goat-anti-Mouse 
(GαM) 
Used as secondary antibody for detection of 
GFP, HA and PGK1 primary antibodies  
Bio-Rad 
 
Table 2-8: List of antibodies used in this study. 
 
2-14 Bioinformatics analysis  
 
Saccharomyces Genome Database (SGD) (http://www.yeastgenome.org/) was 
researched for gene function, regulation, localisation, expression and interaction. 
Multiple sequence alignment was performed using online Clustalw Omega tool 
(Sievers et al., 2011). Homologous protein sequences were identified using BLAST 
search tool (Altschul et al., 1990). 
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Chapter 3 
  
 
 3   Characterisation of Gpd1 and Pnc1 co-import into peroxisomes 
 
 
 
 
3-1 introduction 
                                          
 
Peroxisomes are organelles that participate in a large number of cellular functions 
that vary between organisms and cell types. Conserved activities include fatty acid 
oxidation and other hydrogen peroxide producing oxidation reactions. 
Enzymes destined for peroxisomes are synthesised in the cytosol and are 
posttranslationally targeted to peroxisomes. Most enzymes contain a Peroxisomal 
Targeting Signal type1 (PTS1) that comprises a C-terminal tripeptide with the 
sequence SKL or a derivative thereof (Gould et al., 1989). The PTS1 is recognised in 
the cytosol by a shuttling receptor, Pex5. The PTS2 is nonapeptide found near the 
amino terminus of a small number of peroxisomal proteins (Osumi et al., 1991; 
Swinkels et al., 1991). The PTS2 is cooperatively recognised by the shuttling PTS2 
receptor Pex7 and a coreceptor (Pex18 or Pex21 in Saccharomyces cerevisiae) in 
the cytosol (Glover et al., 1994a;  Marzioch et al., 1994; Pan et al., 2013). 
Pnc1 (pyrazinamidase/nictonamidase1) functions in the NAD+ salvage pathway by 
converting nicotinamide to nicotinic acid. Nicotinamide is generated by NAD+-
consuming enzymes including the NAD+-dependent protein lysine deacetylases or 
sirtuins. The best-characterised function of the sirtuins is the deacetylation of 
histones and the effect on chromatin structure and transcriptional regulation. Both 
Sir2 and Pnc1 are yeast longevity factors as their expression is both necessary and 
sufficient for an increase in replicative life span by calorie restriction. Since 
nicotinamide inhibits sirtuins, nuclear Pnc1 levels are important for Sir2 activity. Pnc1 
is localised to the cytosol, nucleus and peroxisomes and the relative distribution 
between these compartments varies with growth (Anderson et al., 2003; Jung et al., 
2010).  
Pnc1 is targeted via the PTS2 pathway to peroxisomes but lacks a PTS2 (Anderson 
et al., 2003). In addition, Pnc1 and another enzyme Gpd1 (glycerol-3-phosphate 
dehydrogenase) seem to be co-ordinately regulated and share the same localisation 
in the cytosol, nucleus and peroxisomes (Jung et al., 2010). Gpd1 is required for the 
production of glycerol from dihydroxyacetone phosphate during hyperosmotic stress. 
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Glycerol acts as an osmolyte and allows cells to grow under high salt conditions 
(Albertyn et al., 1994). The role of Gpd1 and Pnc1 in peroxisomes is unclear. The 
aim of this chapter is to characterise the co-import of Pnc1 with Gpd1 into 
peroxisomes. 
 
 
3-2 Pnc1 import is dependent on the PTS2 pathway  
 
Pnc1 is partially localised to peroxisomes, which is dependent on the PTS2 receptor 
Pex7 (Anderson et al., 2003). However, we were unable to detect a consensus PTS2 
sequence (Petriv et al., 2004) or an amino acid sequence closely related to it (Table 
3-1). We tested whether other factors specifically required for PTS2 import are also 
required for Pnc1 import. We tagged Pnc1 with GFP at the C-terminus under control 
of its own promoter and grew cells on glucose medium. Peroxisomal thiolase (Pot1) 
and peroxisomal glycerol-3-phosphate dehydrogenase (Gpd1) were used as control 
PTS2-proteins. As expected, the three GFP fusion proteins are mislocalised in pex7Δ 
cells. Both Pnc1 and Gpd1 require the coreceptor Pex21 for their peroxisomal 
localisation but not the coreceptor Pex18 (Figure 3-1). Pot1-GFP is imported into 
pex18Δ and pex21Δ cells, although, some cytosolic mislocalisation was observed in 
the latter mutant. This is in agreement with the previously reported redundancy 
between Pex18 and Pex21 for thiolase import (Purdue et al., 1998). As reported 
previously, PTS2 import was unaffected in pex5Δ cells as was Pnc1 import (Figure 3-
1). These observations confirm and extend previous reports on Pnc1‘s dependence 
on the PTS2 import pathway for its peroxisomal localisation. 
 
 
Enzyme N-termini of peroxisomal enzymes  
 PTS2 = (R/K) (L/V/ I) X5 (H/Q) (L/A) 
Gpd1 MSAAADRLNLTSGHLNAGRKRSSSSVSL- 
Pot1 ---MSQRLQSIKDHLVESAMGKGESKRK- 
Pcd1 -MILSQRRMLSSKQLIENLIRYKFHKTP- 
Pnc1 MKTLIVVDMQNDFISPLGSLTVPKGEEL- 
 
Table 3-1:The PTS2 targeting signal of Gpd1, Pot1 and the putative PTS2 of Pcd1, 
whereas Pnc1 lacks a PTS2 sequence. 
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Figure 3-1:Localisation of Pnc1-GFP, thiolase-GFP (Pot1) and Gpd1-GFP in different mutants backgrounds. GFP fusion proteins were expressed in 
the indicated strains also expressing the peroxisomal matrix marker HcRed-PTS1. Cells were grown on selective media before epifluorescence imaging. Bar 
=5μm.
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Since Pnc1 is lacking a PTS2, we hypothesised that Pnc1 may be co-imported with 
another PTS2 protein (Figure 3-2). Only two S. cerevisiae enzymes have been 
shown to target to peroxisomes depending on a PTS2, Pot1 and Gpd1 (Glover et al., 
1994b; Marzioch et al., 1994; Jung et al., 2010). A third protein, the nudix hydrolase 
Pcd1, was proposed to follow this pathway (Cartwright et al., 2000). Therefore, we 
tagged Pnc1 in the genome with GFP in pot1Δ, gpd1Δ and pcd1Δ cells. Pnc1-GFP 
colocalised with the peroxisomal marker HcRed-PTS1 in pot1Δ and pcd1Δ cells. 
However, deletion of Gpd1 prevented the punctate peroxisomal distribution of Pnc1-
GFP (Figure 3-3A). We conclude that peroxisomal localisation of Pnc1 requires the 
PTS2-containing enzyme Gpd1, in addition to the PTS2 receptor Pex7 and its 
coreceptor Pex21. Similar conclusions were recently reported recently during the 
course of our study (Effelsberg et al., 2015; Kumar et al., 2015). Pnc1-GFP import 
was restored upon expression of Gpd1-mCherry under its endogenous promoter in 
gpd1Δ cells (Figure 3-3B).  
 
 
 
Figure 3-2: Schematic diagram illustrating our model for Pnc1 import into peroxisomes. 
 Pnc1 does not harbour any targeting signal. We hypothesise that it is imported into 
peroxisomes by hitchhiking on a PTS2 protein.  
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 Figure 3-3: Gpd1 is required for Pnc1 localisation into peroxisomes. Various strains 
expressing Pnc1-GFP from its endogenous locus (A) and co-expressing Gpd1-mCherry (B) 
were grown on selective glucose medium prior to epifluorescence imaging. Bar=5μm. Pnc1 is 
mislocalised to the cytosol in gpd1Δ cells, whereas it is imported into peroxisomes in pot1Δ 
and pcd1Δ cells. Expression of Gpd1-mCherry rescues Pnc1-GFP import in gpd1Δ cells.  
 
 
 
 
  
 
69 
3-3 Pnc1 co-import requires Gpd1 to follow the PTS2 pathway 
[ 
Pnc1 is co-imported into peroxisomes by piggy-backing onto Gpd1. In gpd1Δ, pex7Δ 
and pex21Δ cells Pnc1-GFP is mislocalised to the cytosol, whereas in a mutant 
selectively disrupted in the PTS1 pathway, such as pex5Δ cells, Pnc1 is imported 
(Figure 3-1). Expression of Gpd1-mCherry restores import in gpd1Δ cells. Since 
Gpd1 is not imported into peroxisomes in pex7Δ and pex21Δ cells, we tested 
whether Pnc1 can be co-imported when Gpd1 is artificially directed to peroxisomes 
via the PTS1 pathway. Therefore, a fusion protein of Gpd1-mcherry-PTS1 under 
control of its endogenous promoter was constructed. Expression of Gpd1-mCherry-
PTS1 does not support co-import of Pnc1-GFP into peroxisomes in pex7Δ and 
pex21Δ cells (Figure 3-4). 
 
 
 
Figure 3-4: Analysis of Pnc1-GFP localisation in pex7Δ and pex21Δ cells expressing 
Gpd1-mCherry-PTS1. pex7Δ and pex21Δ cells constitutively expressing Gpd1-mCherry-
PTS1 and Pnc1-GFP were grown on glucose medium before epifluorescence imaging. 
Bar=5μm.  
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[Furthermore, deletion of the PTS2 in Gpd1-mCherry-PTS1 abolished co-import of 
Pnc1-GFP in gpd1Δ cells (Figure 3-5). Addition of a PTS1 to Gpd1-mCherry or 
ΔPTS2-Gpd1-mCherry results in a more pronounced peroxisomal localisation and a 
decrease in cytosolic labelling (Jung et al., 2010) (Figure 3-4 and Figure 3-10). This 
suggests that import of these constructs is more efficient than of Gpd1. 
 
 
 
 
 
 
Figure 3-5: Analysis of Pnc1-GFP co-import via PTS1 pathway. Cells co-expressing 
Pnc1-GFP from its endogenous locus and Gpd1-mCherry (top pan el) or ΔPTS2-Gpd1-
mCherry-PTS1 (bottom panel) and empty plasmid (middle panel) were grown on glucose 
medium prior the epifluorescence imaging. Bar = 5μm. 
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It is possible the failure of Gpd1-PTS1 to support Pnc1 co-import is a consequence of 
its efficient import and results in a cytosolic Gpd1 concentration being too low for the 
Pnc1-Gpd1 complex to form. This was tested below in two separate experiments:  
First, we performed a mating experiment where we co-expressed Pnc1-GFP with 
ΔPTS2-Gpd1-mCherry-PTS1 in gpd1Δ/pex5Δ cells. Both Pnc1-GFP and ΔPTS2-
Gpd1-mCherry-PTS1 accumulate in the cytosol. Subsequently, these cells were 
mated with gpd1Δ cells and imaged after 2 hours. Although upon mating ΔPTS2-
Gpd1-mCherry-PTS1 was imported efficiently and no co-import of Pnc1-GFP was 
observed. As expected Pnc1-GFP colocalised with ΔPTS2-Gpd1-mCherry-PTS1 to 
peroxisomes upon mating with cells expressing endogenous Gpd1 (WT cells) (Figure 
3-6).  
 
 
 
 
 
 
Figure 3-6: Mating assay to analyse Pnc1-GFP import. gpd1Δ/pex5Δ cells expressing 
Pnc1-GFP from its endogenous locus and ΔPTS2-Gpd1-mCherry-PTS1 on plasmid were 
mated with gpd1Δ  or WT cells. Equal ODs of each mating partner were mixed on a pre-
warmed YPD plate and incubated on 30°C for 2 hours before imaging. Bar=5μm.  
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Secondly, in gpd1Δ cells expressing Gpd1-mCherry-PTS1, Pnc1-GFP is co-imported 
(Figure 3-7). In this experiment, Pnc1-GFP is imported via the PTS2 pathway. On the 
other hand, ΔPTS2-Gpd1-PTS1 did not support co-import. Together, these 
observations support a model whereby Pnc1 co-import requires Gpd1 to contain a 
PTS2 and follow the PTS2 pathway.  
 
 
 
 
Figure 3-7:Pnc1-GFP import was restored in gpd1Δ cells expressing Gpd1-mCherry-
PTS1. gpd1Δ cells expressing Pnc1-GFP from endogenous locus were transformed with  
Gpd1-mCherry-PTS1 on plasmid. Cells were grown to logarithmic phase on glucose medium 
before epifluroscent imaging. Bar=5um. 
 
 
 
 
3-4 Gpd1 can be imported as a monomer or dimer 
 
Our study and previous studies have shown that the PTS2-containing enzyme Gpd1 
requires the cytosolic PTS2 receptor Pex7 and its coreceptor Pex21 for import into 
peroxisomes (Jung et al., 2010; Effelsberg et al., 2015). Deletion of the PTS2 
(ΔPTS2-Gpd1) prevented import into peroxisomes in gpd1Δ cells but import is 
unaffected in WT cells. This suggested that Gpd1 dimerises before import and that 
ΔPTS2-Gpd1 can be imported by a piggy-back mechanism in WT cells (Jung et al., 
2010). In line with this, the crystal structure of both human Gpd1 and S. cerevisiae 
Gpd1 revealed a dimeric organisation (Ou et al., 2006; Alarcon et al., 2012). Co-
immunoprecipitation experiments confirm that Gpd1 can form homo-oligomers. 
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Gpd1-HA is co-immunoprecipitated with Gpd1-GFP in gpd1Δ cells (Figure 3-8). A 
conserved Glutamate residue (E195 in ScGpd1, E163 in HsGpd1) is at the dimer 
interface and forms hydrogen bonds with the R270 residue of ScGpd1 (R229 in 
HsGpd1) in the other monomer (Ou et al., 2006; Alarcon et al., 2012). Gpd1 mutated 
at residue R270E was used in a co-immunoprecipitation experiment to analyse the 
dimerisation of Gpd1. Gpd1 R270E-HA does not form a stable interaction with WT 
Gpd1-GFP as it fails to co-immunoprecipitate with the latter (Figure 3-8). 
 
 
 
 
 
Figure 3-8: Immuno blot analysis of Gpd1 homo-dimerisation in gpd1Δ cells. Cells 
expressing Gpd1-GFP alongside Gpd1-HA or Gpd1 R270E-HA were grown on glucose 
medium before being transferred into 1M NaCl 2% glucose selective medium overnight. Cells 
were harvested and lysed subsequent to immunoprecipitation analysis by western blot. 
Immuno blots were probed with Anti-GFP and Anti-HA. 
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Gpd1 R270E localisation was analysed by fluorescence microscopy. The Gpd1 
(R270E) dimerisation mutant is targeted to peroxisomes in gpd1Δ cells, which is 
dependent on its own PTS2. However, deletion of the PTS2 (ΔPTS2-Gpd1 R270E) 
blocks its co-import in WT cells. In line with this, ΔPTS2-Gpd1 is co-imported in cells 
expressing WT Gpd1 but not in cells expressing Gpd1 R270E (Figure 3-9). This 
confirmed that the R270E affects the dimerisation of Gpd1. In addition it revealed that 
Gpd1 can be imported as a monomer and dimer.  
 
 
 
Figure 3-9: Analysis of the piggy-back mechanism of ΔPTS2-Gpd1 R270E in gpd1Δ and 
WT cells. Following overnight culture, cells expressing the fusion fluorescent proteins were 
grown on glucose selective medium before microscopy analysis. Bar=5μm. 
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3-5 Gpd1 piggy-back import can only be mediated via the PTS2 pathway 
 
 
We tested whether piggy-back import of Gpd1 can be redirected via the PTS1 
pathway. A ΔPTS2-Gpd1-mCherry-PTS1 construct was used to analyse the Gpd1 
piggy-back mechanism. This fusion protein is imported in gpd1Δ cells and in mutants 
blocked in the PTS2 pathway (gpd1Δ/pex7Δ and gpd1Δ/pex21Δ) but not in 
gpd1Δ/pex5Δ cells where PTS1 import is blocked (Figure 3-10A). Import of ΔPTS2-
Gpd1-mCherry-PTS1 in gpd1Δ/pex5Δ cells is restored upon co-expression of Gpd1-
GFP (Figure 3-10B). This indicates that Gpd1-GFP can support co-import of ΔPTS2-
Gpd1-mCherry-PTS1 via the PTS2 import pathway in these cells, i.e. that neither 
removal of the PTS2 nor addition of mCherry-PTS1 blocks dimer formation with 
Gpd1-GFP in gpd1Δ/pex5Δ cells. Surprisingly, although ΔPTS2-Gpd1-mCherry-
PTS1 is efficiently imported in gpd1Δ/pex7Δ and gpd1Δ/pex21Δ cells, it does not 
support co-import of Gpd1-GFP in gpd1Δ/pex7Δ and gpd1Δ/pex21Δ cells (Figure 3-
10B).  
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Figure 3-10: Gpd1 co-import requires the PTS2 pathway. Cells expressing ΔPTS2-Gpd1-
mCherry-PTS1 (A) or both Gpd1-GFP and ΔPTS2-Gpd1-mCherry-PTS1 (B) were grown on 
selective medium prior the imaging. Bar=5um. 
 
 
 
We conclude that Gpd1 co-import requires a functional PTS2 pathway. This is a 
surprising observation as import of oligomeric proteins into peroxisomes has been 
reported for both PTS1- and PTS2-containing proteins. A possible explanation for 
this observation is that Pex5 binding to the PTS1 prevents Gpd1 dimerisation or that 
import of ΔPTS2-Gpd1-mCherry-PTS1 is so fast that the cytosolic pool of it is too low 
for efficient dimer formation to occur.  
First, we performed a mating experiment where we co-expressed ΔPTS2-Gpd1-GFP 
with ΔPTS2-Gpd1-mCherry-PTS1 in gpd1Δ/pex5Δ cells. Both ΔPTS2-Gpd1-GFP 
and ΔPTS2-Gpd1-mCherry-PTS1 accumulate in the cytosol. Subsequently, these 
cells were mated with gpd1Δ cells and imaged after 2 hours. Although upon mating 
ΔPTS2-Gpd1-mCherry-PTS1 was imported efficiently and no co-import of ΔPTS2-
Gpd1-GFP was observed. As expected ΔPTS2-Gpd1-GFP colocalised with ΔPTS2-
Gpd1-mCherry-PTS1 to peroxisomes upon mating with cells expressing endogenous 
Gpd1 (WT cells) (Figure 3-11). 
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Figure 3-11: Mating assay to analyse Gpd1 dimerisation via the PTS1 pathway. gpd1Δ/ 
pex5Δ cells were transformed with ΔPTS2-Gpd1-mCherry-PTS1 and ΔPTS2-Gpd1-GFP 
expressing plasmids under their native promoters. These cells were mated with gpd1Δ or WT 
cells. Equal ODs of each mating partner were mixed on a pre-warmed YPD plate and 
incubated on 30°C for 2 hours before imaging. Bar=5μm.  
 
 
 
Secondly, in gpd1Δ cells expressing Gpd1-mCherry-PTS1, ΔPTS2-Gpd1-GFP was 
co-imported (Figure 3-12). This observation showed that the PTS2 pathway is 
required for Gpd1 co-import. 
 
 
Figure 3-12: Gpd1-mCherry-PTS1 co-imports ΔPTS2 Gpd1-GFP in gpd1Δ cells. Cells 
were expressing both Gpd1-mCherry-PTS1 and ΔPTS2 Gpd1-GFP grown on glucose 
medium then imaged using epifluorescence microscopy. Bar=5μm. 
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3-6 Pnc1 co-import requires Gpd1 to be imported as a dimer 
 
 
The requirements for Pnc1 co-import resemble those of Gpd1 dimer import. This 
raises the possibility that Pnc1 import requires Gpd1 to form a dimer before it can be 
co-imported. First, we tested whether Pnc1 and Gpd1 interact using Yeast two- 
hybrid. We made many BD and AD fusion proteins of Pnc1, Gpd1, Pex7, Pex21, 
Pex18, and Pot1. The fusion proteins were expressed in opposite mating type yeast 
strains. After mating, the diploids were selected on medium lacking histidine or 
adenine supplemented with 5mM 3AT. Our results showed that Pnc1 interacts with 
itself and with Gpd1. In addition, Gpd1 was found to interact with Pex7 and Pex21. 
No interaction was observed between Pnc1 and either Pex7 or Pex21. The 
interaction between Pot1 and Pex7 or Pex21 and Pex7 were used as positive 
controls, whereas the DB and AD were used as negative controls (Figure 3-13A). We 
exclude the Pex18 interaction because it was auto activated (data not shown). 
Deletion of Pex7 abolishes the interaction between Gpd1 and Pex21. Furthermore, 
deletion of Pex21 abolishes the interaction between Gpd1 and Pex7 (Figure 3-13B). 
Moreover, we tested the Gpd1 R270E interaction with Pnc1 and Pex21. The Pnc1-
Gpd1 interaction is abolished in the Gpd1 R270E dimerisation mutant whereas the 
interaction with Pex21 was not abolished (Figure 3-13C). 
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Figure 3-13: Yeast Two-hybrid growth assay to study Pnc1-Gpd1 interaction. Left 
panel= diploids selected on SD/Leu-/Trp-, Right panel= protein interactions selected on 
SD/His-/Leu-/Trp- or Ade-/His-/Leu-/Trp- plates supplemented with 5mM 3AT. Pnc1 interacted 
with Gpd1 (A) Gpd1-Pex21 interaction abolished in gpd1Δ/pex7Δ, while Gpd1-Pex7 
interaction abolished in gpd1Δ/pex21Δ (B) Gpd1 carrying a dimer mutant R270E did not 
interact with Pnc1 (C). The BD fusion proteins were expressed in MATα and the AD fusion 
proteins in MATa cells. The cells were grown overnight in selective medium in 96 well plates. 
25μl of each mating partner was mixed with 150μl YEPD and left to mate for 2 days. The 
diploids were pinned in selection medium for fusion protein plasmids. For interaction analysis, 
diploids were selected on His- or Ade-/His-/Leu-/Trp- plates supplemented with 5mM 3AT. 
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In addition, we performed co-immunoprecipitation experiments of WT cells 
expressing Pnc1-TAP and either Gpd1-GFP or Gpd1 R270E-GFP under control of 
their endogenous promoters. Pnc1-TAP co-precipitated with WT Gpd1-GFP but not 
with Gpd1 R270E-GFP (Figure 3-14). 
 
 
 
 
 
Figure 3-14: Immuno blot analysis of Gpd1-Pnc1 interaction. Cells expressing Gpd1-GFP 
or Gpd1 R270E-GFP and genomically tagged Pnc1-TAP were grown in glucose media before 
being transferred into 0.8M NaCl 2% glucose selective medium for overnight growth. Cells 
were harvested and lysed subsequent to immunoprecipitation analysis by western blot. 
Immuno blots were probed with anti-TAP and anti-GFP. 
 
 
The lack of interaction between Pnc1 and the dimerisation mutant of Gpd1-GFP are 
relevant to Pnc1 localisation as Pnc1-GFP was not co-imported with the Gpd1-
mCherry dimerisation mutant (Figure 3-15A). There are two interpretations for these 
results. Firstly, Pnc1 binds the Gpd1 dimer before or during its targeting to 
peroxisomes or secondly, the R270E mutation disrupts binding of Pnc1 to monomeric 
Gpd1. To test this we made a double mutant in Gpd1 in the anticipation that it would 
artificially restore Gpd1 homo-dimerisation. By combining the R270E mutation with 
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E195R we were indeed able to restore dimer formation as revealed by our co-import 
assay for Gpd1 lacking a PTS2 (Figure 3-15B) and confirmed this by co-
immunoprecipitation experiment (Figure 3-15C). The double mutant also restored 
Pnc1 co-import into peroxisomes (Figure 3-15A). We conclude that Gpd1 
dimerisation is required for Pnc1 piggy-back import.  
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Figure 3-15: Gpd1 R270E, E195R-mCherry restores dimer formation and Pnc1-GFP 
import. Cells expressing GFP or mCherry fusion were grown to logarithmic phase before 
analysis with fluorescent microscopy (A) and (B). Bar=5μm. C- Cells expressing Gpd1 R270E, 
E195E-HA alongside Gpd1-GFP or Gpd1 R270E, E195R-GFP were grown on glucose media 
before being transferred into 1M NaCl 2% glucose selective medium overnight. Cells were 
harvested and lysed subsequent to immunoprecipitation analysis by western blot (This co-IP 
experiment was done by John Hutchinson). 
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3-7 Analysis of enzyme activity for Gpd1 mutants  
 
 
Gpd1 is required for the production of glycerol from dihydroxyacetone phosphate 
during hyperosmotic stress. Glycerol acts as an osmolyte and allows cells to grow 
under high salt conditions (Albertyn et al., 1994). Firstly, we tested whether the 
dimerisation mutant affected growth on high salt medium. gpd1Δ cells are unable to 
grow on high salt medium, whereas gpd1Δ cells transformed with a plasmid encoding 
the GPD1 gene or  the mutant GPD1 (R270E) grew comparably. These results imply 
that formation of a stable Gpd1 dimer is not a prerequisite for function. On the other 
hand, mutations that are predicted to interfere with NAD+ binding (G43E and R310E) 
or substrate binding (D301N and K245A) (Ou et al., 2005) do not complement growth 
on high salt (Figure 3-16A). The subcellular distribution of these mutants varies. Of 
particular notice was the accumulation of the potential NAD-binding mutants in the 
nucleus. Nonetheless, all mutants targeted to peroxisomes, although, to a varying 
extent (Figure 3-16B). In addition, these mutants showed a comparable level of 
expression in glucose selective medium (Figure 3-16C).  
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Figure 3-16: Analysis of Gpd1 point mutants. A- Growth assay of Gpd1 mutants on high 
salt (1M NaCl) medium. Cells were grown to exponential phase before spotting serial dilutions 
on 2% glucose and 2% glucose/1M NaCl medium. The plates were imaged after 2 days on 
30°C B-Subcellular localisation of Gpd1-mCherry mutants analysed by fluorescence 
microscopy. Cells were grown on selective medium before epifluorescence imaging. Bar=5um 
C-Western blot analysis of the expression level of Gpd1-GFP point mutants. Cells expressing 
different Gpd1-GFP point mutations were TCA extracted and 0.1 or 0.01 OD was loaded to 
SDS-PAGE gel. Anti-Pgk1 blot was used as loading controls 
 
 
  
 
86 
3-8 Phosphorylation of Gpd1 
 
It has been reported that Gpd1 import into peroxisomes is regulated by 
phosphorylation of S24 and S27 residues adjacent to the PTS2 (Figure 3-17). 
Furthermore, the dephosphorylated mutants of Gpd1 (S24A, S27A) failed to 
efficiently import into peroxisomes in comparison to the WT Gpd1 or phosphomimic 
mutants (S24D, S27D). However, the S24A, S27A mutants still showed small 
punctate structures (Jung et al., 2010).  
 
 
 
 
 
Figure 3-17: The S24 and S27 phosphorylation site of Gpd1 are located in close 
proximity to its PTS2. The phosphorylation sites are represented by the blue underlined. 
 
 
 
We tested if the phosphorylation of Gpd1 is required for regulation of Pnc1 co-import 
into peroxisomes. Double point mutations were introduced by site directed 
mutagenesis as follows S24A/S27A and S24D/S27D in Gpd1-mCherry under control 
of its endogenous promoter. These mutants were expressed in gpd1Δ cells 
expressing Pnc1-GFP. All versions of Gpd1 were imported, although, slight 
differences of efficiency were observed. Likewise, Pnc1 co-import was not severely 
influenced by Gpd1 mutations (Figure 3-18). However, it is unclear if the 
phosphorylation of Gpd1 really regulated Gpd1 and the co-import of Pnc1. 
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Figure 3-18: Microscopic analysis of the phosphorylation mutants of Gpd1. Cells 
expressing genomically tagged Pnc1 with GFP were transformed with either Gpd1 S24A/ 
S27A-mCherry (Top panel) or non-phosphorylatable mutants S24D/S27D (middle panel) and 
empty plasmid (bottom panel) were growing on glucose medium and analysed by 
fluorescence microscopy. Bar=5μm. 
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3-9 Discussion  
 
In this chapter, we analysed the mechanism and factors required for Pnc1 import into 
peroxisomes. From our data we conclude that import of Pnc1 relies on the PTS2-
containing enzyme Gpd1 (Effelsberg et al., 2015; Kumar et al., 2016). Gpd1 and 
Pnc1 are enzymes that share the localisation to the cytosol, nucleus and 
peroxisomes. However, their peroxisomal function remains unclear. Gpd1 import into 
peroxisomes depends on Pex7 and Pex21, which it interacts in vivo. This is in 
contract to another PTS2 enzyme, thiolase. Thiolase import showed a redundant 
function for Pex18 and Pex21 (Purdue et al., 1998). The coreceptors may each be 
regulating the import of different enzymes under specific growth conditions. 
An interaction between Pnc1 and Gpd1 was confirmed by co-immunoprecipitation 
and yeast two-hybrid. The direction of Gpd1-PTS1 via the PTS1 pathway results in 
efficient import of Gpd1 and it is mainly peroxisomal as reported previously (Jung et 
al., 2010). Despite efficient import of Gpd1-PTS1, it cannot co-import Pnc1. This 
raises the question as to whether import via the PTS1 pathway is too fast (due 
depletion of cytosolic pool of Gpd1 with Gpd1-PTS1) for formation of the Pnc1-Gpd1 
complex or that co-import requires the PTS2 pathway. However, oligomeric import 
has been demonstrated for PTS1 and PTS2 pathways. Recently, it has been 
reported that Pex5 affects oligomerisation and that monomeric subunit import is 
preferable (Freitas et al., 2015). 
We analysed these possibilities by two experiments: a mating experiment, which 
excludes that the import is too fast to affect the oligomerisation between Gpd1 and 
Pnc1. In this experiment, ΔPTS2Gpd1-mCherry-PTS1 and Pnc1-GFP accumulated 
in the cytosol before mating with gpd1Δ cells. Secondly, Gpd1-PTS1 restored Pnc1 
import. This supports our hypothesis that a functional PTS2 pathway is required.  
Thus, we analysed Gpd1 import in more detail to understand both the Gpd1 and 
Pnc1 import mechanism. Human and yeast Gpd1 form a homo-dimer as we 
confirmed for ScGpd1 by our co-immunoprecipitation experiment. In addition, 
fluorescence microscopy analysis showed that ΔPTS2-Gpd1 can be co-imported by 
piggy-backing onto WT Gpd1, i.e. it forms a dimer with endogenous Gpd1, in WT 
cells. However, this piggy-back import cannot occur via the PTS1 import pathway.  
We found that this is not because Gpd1 monomers are imported too fast via the 
PTS1 pathway to allow piggy-backing to take place. Two experiments showed that 
dimerisation of Gpd1 is required for the PTS2 pathway. Gpd1 needs to be a dimer to 
  
 
89 
import Pnc1. From analysing the crystal structure of Gpd1, HsE195 and ScE195 
residues are at the dimer interface and form hydrogen bonds with R229 in HsGpd1 or 
R270 in ScGpd1. Indeed, a point mutation in Gpd1 R270E affects the dimer 
formation (Figure 3-19) as shown by co-immunoprecipitation and piggy-back import. 
 
 
 
 
Figure 3-19: Gpd1 dimer is disrupted by mutation of R270E. The residue R270 and E195 
of Gpd1 are dimer interface; mutation of R270E disrupts Gpd1 homo-dimer.   
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The R270E mutant lacking the PTS2 cannot form a dimer with another PTS2 subunit. 
However, Gpd1 R270E is imported as a monomer. This observation indicates that 
Gpd1 can be imported as a monomer or a dimer. Although, Gpd1 R270E is imported 
as a monomer, Pnc1 import is blocked in gpd1Δ cells expressing this mutant. In a co-
IP experiment, Pnc1 failed to interact with Gpd1 R270E, implying that Gpd1 homo-
dimer formation is essential for Pnc1 piggy-back import. Double mutations E195R 
alongside R270E in Gpd1 restore dimer formation (Figure 3-20) and Pnc1 co-import. 
 
 
 
 
Figure 3-20: Gpd1 R270E, E195R restores Gpd1 dimer formation. Point mutations of 
R270E, E195R residues of Gpd1 are able to restore homo-dimerisation. 
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In summary, Pnc1 is imported into peroxisomes by a natural piggy-back mechanism 
by using Gpd1 as shuttle, which requires Pex7 and the coreceptor Pex21 rather than 
Pex18. A dimerisation of Gpd1 is required to recruit Pnc1 and for peroxisomal import 
(Figure 3-21). 
 
 
 
 
 
Figure 3-21: Our model for Pnc1 and Gpd1 import mechanism. Gpd1 dimers in the 
cytosol and subsequently interacts with Pex7, Pex21 and Pnc1 to form import complex. 
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Chapter 4  
                           
 
 4    Functional and Genetic analysis of Msp1 
 
4-1 Introduction 
 
In 1991, a new family of ATPases and known as AAA ATPases (ATPases associated 
with diverse cellular activities), was described after the discovery of Pex1 as the first 
protein required for peroxisomes biogenesis (Erdmann et al., 1991). The initial known 
functions of AAA ATPases were in the biogenesis of peroxisomes (Pex1), regulation 
of the cell cycle (p97/cdc48), vesicle-mediated protein transport (NSF/Sec18) and 
expression of genes (proteasomal ATPases). AAA ATPases generally contain an N 
terminal domain (non ATPase) and one or two AAA ATPase domains (Lupas and 
Martin, 2002). The AAA domain consists of 200-250 amino acids and contains a 
Walker A and B motif that are required for ATP binding and hydrolysis. Additional 
elements in these domains include an N-terminal linker sequence, a pore sequence, 
sensor 1 and 2 and a SRH (second region of homology) (Figure 4-1A) (Hanson and 
Whiteheart, 2005). The combination of these motifs in a single domain specifies the 
ATPases as AAA+ proteins (Snider et al., 2008). AAA+ ATPase proteins form either 
homohexameric rings or heterohexameric rings. Many AAA+ proteins consist of two 
AAA+ domains and their hexameric assembly results in 12 AAA+ domains arranged 
in two rings on top of each other (Figure 4-1B). Some AAA+ proteins contain a single 
AAA+ domain that can assemble into a single hexameric ring (White and Lauring, 
2007). 
These ATPases perform different functions by extracting energy from ATP hydrolysis 
such as unfolding and degradation of proteins, peroxisome biogenesis, 
bacteriochlorophy biosynthesis, and DNA recombination, replication and repair 
processes (Snider et al., 2008).  Msp1 (intra mitochondrial sorting protein) is a highly 
conserved AAA+ ATPase. It is anchored with its N-terminus into the mitochondrial 
outer membrane (MOM). The AAA+ domain is localised to the C-terminal part of the 
protein that is exposed to the cytosol (Nakai et al., 1993) (Figure 4-1C). It is 
suggested that Msp1 oligomerises into a single homohexameric ring (Okreglak and 
Walter, 2014). Both the human and fly homologues have a similar organisation 
(Figure 4-2). 
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Msp1 and its human homologue ATAD1 were proposed to extract and degrade 
mislocalised tail-anchored proteins from the MOM to maintain mitochondrial integrity 
(Chen et al., 2014). Interestingly, the localisation of Msp1 and ATAD1 is not restricted 
to the MOM but both proteins are also found on peroxisomes (Wiese et al., 2007). 
The role of Msp1/ATAD1 on peroxisomes is still unknown.  
The Msp1 homologue in Drosophila melanogaster, called No mitochondrial derivative 
(NMD) also localised to both the MOM and peroxisomes. NMD interacts with Pex16, 
a factor required for peroxisomal membrane biogenesis. In line with this, NMD 
depletion results in a total absence of peroxisomes in Drosophila melanogaster 
(Joanne Lacey, Ewald Hettema unpublished observations) indicating a crucial role for 
this protein in peroxisomal membrane biogenesis. Surprisingly, disruption of the 
MSP1 gene in yeast or ATAD1 in Hela cells does not result in the absence of 
peroxisomes. Our working hypothesis is that in these organisms another protein or 
process can substitute for the loss of this AAA+ protein.  
The aim of this chapter is to analyse the peroxisomal function of Msp1 and to 
identify the back up mechanism that allows peroxisome biogenesis to take 
place in cells deficient of Msp1. 
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Figure 4-1: Schematic representation of the general domain organisation and 
oligomeric structure of AAA+ ATPases. A-Linear representation of domains and motifs in 
AAA+ ATPases.  B-Hexameric structure of AAA+ ATPases containing a single AAA+ domain 
(left hand panel) or two AAA+ domains (right hand panel). C-An N-terminal hydrophobic 
segment has been proposed to anchor Msp1 into the membrane, with the AAA+ domain 
exposed to the cytosol.  
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Figure 4-2: Protein sequence alignment of Homo sapiens (Hs) ATAD1, Drosophila 
melanogaster (Dm) NMD and Saccharomyces cerevisiae (Sc) Msp1. 
Walker A motif, red; Walker B motif, green; pore, blue; linker, orange; arginine finger, purple. 
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4-2 Msp1 localisation at different levels of expression in WT cells 
 
Msp1 localises to mitochondria and peroxisomes (Wiese et al., 2007). We decided to 
analyse Msp1 localisation under different levels of expression (using different 
promoters). Msp1 tagged with GFP was placed under control of the GAL1/10, HIS3 
and TPI1 promoters in yeast centromeric plasmids. The GAL1/10 promoter is 
activated on galactose medium and repressed on glucose medium, while the TPI1 
and HIS3 promoters are constitutively active. TPI1 is a strong constitutive promoter in 
comparison to the HIS3 promoter. Msp1-GFP expression under control of the 
GAL1/10 promoter was induced in WT cells expressing HcRed-PTS1 (a peroxisomal 
marker) or Om45-mRFP  (mitochondrial marker). The fluorescence pattern of Msp1-
GFP reveals a dual localisation as it partially overlaps with the mitochondrial marker 
(Figure 4-3A) and with the peroxisomal marker (Figure 4-3B). This is in agreement 
with previous studies (Chen et al., 2014; Okreglak and Walter, 2014). 
 
 
Figure 4-3: Dual localisation of Msp1-GFP in WT cells after induction from the GAL1/10 
promoter. WT cells were transformed with Msp1-GFP under control of the GAL1/10 promoter 
alongside either a GAL1/10 regulatable Om45-mRFP plasmid (A) or HIS3 regulated HcRed-
PTS1 plasmid (B). Cells were grown overnight in raffinose medium and transferred to 
galactose medium to induce GAL1/10 mediated expression (pulse) for 1 hour. After the pulse, 
cells were transferred to glucose medium to shut down GAL1/10 expression for 2 hours 
before epifluorescence imaging. Bar =5µm. 
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Constitutive expression of Msp1-GFP from either the HIS3 promoter or the TPI1 
promoter showed dual localisation to mitochondria and peroxisomes (Figure 4-4 and 
Figure 4-5). We conclude that the dual localisation of Msp1-GFP to peroxisomes and 
mitochondria is independent of its expression level.  
 
 
 
 
 
 
 
Figure 4-4: Dual localisation of Msp1-GFP in WT cells under control of the HIS3 
promoter. WT cells were transformed with the Msp1-GFP expression plasmid under control 
of the HIS3 promoter alongside either a GAL1/10 regulatable Om45-mRFP plasmid (A) or 
HIS3 regulated HcRed-PTS1 plasmid (B). Cells were grown overnight in raffinose medium 
and transferred to galactose medium to induce GAL1/10 mediated expression (pulse) for 1 
hour. After the pulse, cells were transferred to glucose medium to shut down GAL1/10 
expression for 2 hours. For constitutive expression plasmids, cells were grown until 
logarithmic phase before epifluorescence imaging. Bar =5µm. 
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Figure 4-5: Dual localisation of Msp1-GFP in WT cells under control of the TPI1 
promoter. WT cells were transformed with a TPI1 promoter controlled Msp1-GFP expression 
plasmid and mitochondria and peroxisomes were visualised by expression of Om45-mRFP (A) 
or HcRed-PTS1, respectively (B). Cells were grown until logarithmic phase before 
epifluroscent imaging. Bar =5µm. 
 
 
 
 
However, 10-30% of the cells constitutively overexpressing Msp1-GFP from the TPI1 
promoter lacked peroxisomes as HcRed-PTS1 was mislocalised to the cytosol 
(Figure 4-6). The mitochondrial morphology was not studied in detail but a 
mitochondrial tubular network appeared to be present although some clumping was 
also observed. 
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Figure 4-6: Overexpression of Msp1-GFP under TPI1 promoter results in the absence of 
peroxisomes in 10-30% of WT cells. Some WT cells overexpressing Msp1-GFP from the 
TPI1 promoter showed a mislocalisation of HcRed-PTS1. Cells were grown until logarithmic 
phase before epifluorescence imaging. Bar =5µm. 
 
 
 
 
4-3 Functional analysis of Msp1 
  
A recent study implicated Msp1 in the quality control of mislocalised tail-anchored 
proteins to the MOM but a peroxisomal function remains to be uncovered. Thus, we 
investigated the potential peroxisomal function of Msp1. Gene function can be 
studied by analysing the consequences of either deleting the gene or overexpressing 
its product. This may result in a phenotype that points us into the direction of Msp1 
peroxisomal function. Therefore, we analysed msp1∆ for a peroxisomal phenotype 
compared to WT cells. Peroxisomes were visualised with GFP-PTS1 in WT and 
msp1∆ cells growing on glucose medium. GFP-PTS1 showed a clear punctate 
pattern indicative of peroxisomes (Figure 4-7). No cytosolic mislocalisation of this 
marker was observed. This indicates that peroxisomal membranes are formed and 
import of peroxisomal matrix proteins via the PTS1 pathway is unaffected. Under 
conditions of peroxisome proliferation by growth on oleate, no clear difference with 
WT cells was observed (Figure 4-7). Although no obvious phenotype was observed, 
it seemed that the number of peroxisomes per cells was increased in msp1 cells 
grown on glucose. To test this we performed a more detailed analysis. 
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Figure 4-7: Peroxisome formation is unaffected in msp1∆ cells grown under glucose or 
oleate growth conditions. WT and msp1∆ cells were transformed with HIS3 regulatable 
GFP-PTS1. Cells were grown until logarithmic phase on glucose or overnight on oleate 
medium before epifluorescence imaging. Bar= 5µm. 
 
 
 
In addition, the structure of the mitochondrial network was analysed in msp1Δ cells 
using a green MitoTracker. Mitochondrial morphology seems unaffected in msp1Δ 
cells (Figure 4-8). 
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Figure 4-8: Mitochondrial morphology in msp1Δ cells. Green MitoTracker was used to 
visualise the mitochondria. Cells were grown to logarithmic phase before adding the Mito 
Tracker. Bar= 5µm. 
 
 
 
4-3-1 Analysis of peroxisomes number in msp1∆ cells 
 
Several genes are involved in controlling peroxisome number and shape including 
VPS1, ATG36, PEX11, PEX25, PEX27, PEX28, PEX29, PEX30, PEX31, PEX32 and 
PEX34. Deletion of these genes leads to an increased number of smaller 
peroxisomes or a decreased number of enlarged peroxisomes. Peroxisomes number 
was determined in msp1∆ and WT expressing the peroxisomal marker GFP-PTS1. A 
statistically significant increase in the number of peroxisomes was observed in 
msp1∆ cells compared to in WT cells (when grown on glucose medium) (Figure 4-9). 
I conclude, deletion of Msp1 affects peroxisome abundance. 
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Figure 4-9: Increased peroxisome abundance in msp1∆ cells. Cells were grown on 
glucose in logarithmic phase and peroxisomes number was quantified in a bar chart. (At least 
100 cells were analysed per replica, n=3). A student T test was used to analyse the results. 
Error bars represent standard deviation, * show significance difference where P <0.05. 
 
 
4-3-2 Analysis of pexophagy in msp1∆ cells  
 
In Saccharomyces cerevisiae, β-oxidation of fatty acids occurs exclusively in 
peroxisomes. Cells contain few peroxisomes in glucose medium. However, by 
changing the carbon source to oleic acid, induces peroxisomes to proliferate 
(Veenhuis et al., 1987). When cells are returned to glucose medium, superfluous 
peroxisomes are degraded by an autophagic process (Veenhuis et al., 2000) 
depending on the peroxisome-specific autophagy receptor Atg36 (Motley et al., 2012). 
A block in pexophagy results in an increased number of peroxisomes (Motley et al., 
2012). Therefore, we tested if the increased number of peroxisomes in msp1∆ cells 
reflects a defect in pexophagy.  
We used the peroxisomal membrane marker Pex11-GFP to follow degradation of 
peroxisomes because it is most abundant peroxisomal membrane protein (PMP) and 
is induced in oleate growth conditions. A shift to nitrogen starvation glucose medium 
reduces the number of Pex11-GFP fluorescent puncta with time. A faint labelling of 
the vacuole can be observed from 3 hours onwards. After 22 hours, WT cells show 
vacuolar GFP labelling and strong reduction in peroxisome number (Motley et al., 
2012). Whereas Pex11-GFP breakdown can be semi-quantitatively followed by 
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western blot analysis, the transfer of Pex11-GFP into the vacuole lumen results in a 
decrease of GFP fluorescence intensity because of GFP’s acid sensitivity (pKa=6). 
Therefore, we used a more acid stable fluorophore for our imaging experiments 
below (mCherry =pKa <4.5) (Shaner et al., 2005). 
Cells expressing Pex11-mCherry were grown on oleate medium overnight to induce 
peroxisome proliferation. Subsequently, the cells were transferred to nitrogen 
starvation medium and imaged after 22 hours. Peroxisomes number started to 
decrease and vacuolar labelling became apparent after 6 hours, but was more 
pronounced after 22 hours on starvation medium in WT and msp1∆. No vacuolar 
labelling was observed in atg36∆ and peroxisome abundance remained high (Figure 
4-10). 
 
 
 
Figure 4-10: Peroxisome degradation was normal in msp1Δ cells. Cells expressing 
Pex11-mCherry were grown overnight on glucose and switched to oleate medium for 18 
hours to induce peroxisome proliferation. To induce starvation, cells were transferred and 
grown in glucose medium lacking nitrogen. 22 hours after starvation, cells were imaged. Bar 
=5µm. 
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The transfer of Pex11-GFP labelled peroxisomes to the vacuole corresponds to the 
accumulation of a GFP breakdown product that can be detected with western blot 
analysis. In msp1∆ cells, the accumulation of the GFP product followed the same 
kinetics as in WT cells. As expected, no breakdown product accumulates in atg36∆ 
cells (Figure 4-11). Thus, we concluded that Msp1 is not required for the degradation 
of peroxisomes. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-11:Msp1 is not required for pexophagy. Western blot analysis of Pex11-GFP. 
Cells were grown overnight on glucose and switched to oleate medium for 18 hours for 
peroxisome proliferation. For starvation, cells were transferred and grown in glucose medium 
lacking nitrogen for the time points indicated. GFP resembles a Pex11 degradation product, 
which is relatively protease-resistant and shows a vacuolar breakdown of Pex11. 
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4-3-3 Analysis of de novo peroxisomes formation in msp1∆ cells 
 
Peroxisomes can form de novo in cells temporarily devoid of peroxisomes with the 
source of membranes still debated but likely to be either the ER or preperoxisomal 
structures. The contributory factors in de novo peroxisome formation are still under 
investigation. Until now, two peroxins (Pex19, Pex3) in yeast and an additional one in 
mammals, Pex16, have a major role in peroxisome membrane biogenesis. Deletion 
of Pex3, Pex16 or Pex19 causes lack of any detectable peroxisomal structures 
(Hettema et al., 2000). However, reintroduction of the wild copy of these genes leads 
to de novo formation from the ER (Hoepfner et al., 2005; Kim et al., 2006; Toro et al., 
2009). To study de novo peroxisome formation, we constructed a conditional PEX19 
strain. PEX19 was placed under control of the GAL1/10 promoter. When grown on 
glucose, peroxisomes are absent but upon transfer to galactose medium, new 
peroxisomes can be detected after 3.5 to 4 hours (Motley et al., 2015). We tested if 
Msp1 is involved in the de novo peroxisome biogenesis pathway using the assay 
above. The PEX19 promoter was replaced by the GAL1/10 promoter in msp1 and 
WT cells by homologous recombination (Figure 4-12).  
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Figure 4-12: Construction of conditional PEX19 S. cerevisiae strains. PCR was used to 
amplify the GAL1/10 promoter using a forward primer, which contains 50 nucleotide of identity 
to the region upstream of the start codon of the PEX19 ORF. The 5' end of the reverse primer 
contains 50 nucleotides identical to the sequence downstream of the start codon of the 
PEX19 ORF. Insertion of the GAL1/10 promoter in front of PEX19 was performed by 
homologous recombination. Recombinants were selected on the basis of a co-amplified 
selectable marker. 
 
 
 
The conditional PEX19 msp1Δ and WT strains were transformed with a constitutively 
expressed peroxisomal matrix marker (GFP-PTS1 under control of the TPI1 
promoter). The GAL1/10 promoter is repressed by glucose. Therefore, in order to 
induce expression with galactose, the media and cells need to be depleted of 
glucose. For this reason, the strains were grown overnight in YM2 2% raffinose 
medium and switched to YM2 2% galactose to induce PEX19 expression for 2, 3, 4, 
5 and 6 hours. de novo formation is a slow process and it takes 3-4 hours to form 
new peroxisomes that are matrix protein import competent. de novo peroxisome 
formation does not appear to be affected as new peroxisomes are detected at the 
same time in WT and msp1Δ cells. However, we always observed a trend of a higher 
percentage of msp1Δ cells showing peroxisomes. This suggests that it may be faster 
but this difference was only significant after the 6 hours time point (Figure 4-13). We 
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conclude that Msp1 is not absolutely required for de novo peroxisome biogenesis but 
may regulate or influence the rate. 
 
 
 
 
Figure 4-13: Analysis of the influence of Msp1 on de novo peroxisome biogenesis. WT 
and msp1∆ strains containing a conditional PEX19 allele (under control of the GAL1/10 
promoter) were grown overnight on 2% raffinose medium. Pex19 expression was 
subsequently induced by transfer to 2% galactose medium. Cells were imaged after transfer 
at the indicated time points. This experiment was repeated three times and at least 100 cells 
were counted per time point per strain per replica. Analysis of the experimental data was 
performed using a student T test. Error bars showed the standard deviation, * repersents  
significance difference where P <0.05. 
 
 
 
4-3-4 Analysis of peroxisome segregation in msp1∆ cells 
 
During cell division, peroxisomes are duplicated and segregated between the bud 
and mother cells in S. cerevisiae, in which peroxisomes number is carefully 
maintained (Hoepfner et al., 2001). About half of the peroxisomes are transported to 
the bud. Transport to the bud depends on actin and the unconventional Myosin, 
Myo2. Myo2 is recruited to peroxisomes via the integral peroxisomal membrane 
protein Inp2, which acts as the myosin receptor that works together with Pex19 in 
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Myo2 recruitment to peroxisomes (Hoepfner et al., 2001; Fagarasanu et al., 2006). 
Furthermore, movement of peroxisomes to the bud is balanced by retention of the 
remaining peroxisomes within the mother cell. A peripheral peroxisomal membrane 
protein Inp1 is required for peroxisome retention (Fagarasanu et al., 2005). It was 
shown that deletion of Inp1 leads to transport of all peroxisomes to the bud and an 
inability to retain them in the mother cell (Fagarasanu et al., 2005). 
We investigated if Msp1 is involved in inheritance of peroxisomes. The msp1∆ cells 
expressing a peroxisomal maker showed segregation of peroxisomes between the 
bud and mother cells as observed in WT cells (Figure 4-14). Thus, we concluded that 
Msp1 is not required for peroxisome inheritance. 
 
 
 
 
Figure 4-14: Peroxisome distribution between bud and mother cells in msp1∆ cells. 
 WT and msp1∆ cells expressing GFP-PTS1 were grown on glucose medium and analysed 
with epifluorescence microscopy. Bar =5µm. 
 
 
4-4 A synthetic genetic screen to study Msp1  
 
We postulate that Msp1 performs a role in peroxisome biogenesis analogous to its 
Drosophila melanogaster homologue NMD. However, we did not find a role for Msp1 
either in de novo peroxisome biogenesis, segregation or pexophagy. However, we 
observed an increase in peroxisome number. The lack of clear phenotype in msp1∆ 
cells might be related to redundancy, i.e. that its function is buffered by another gene. 
Synthetic genetic interactions can be used to uncover redundant gene functions. 
These interactions are identified by second-site mutation that leads to suppression or 
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enhancement of the original mutant phenotype (Tong et al., 2001). A protocol has 
been developed by the Boone laboratory to systematically analyse genes for genetic 
interaction with a large number of non-essential gene deletion mutants called 
Synthetic Genetic Array technology (SGA) (Tong et al., 2001; see also Chapter 1). 
We decided to apply this technique to make double mutants with msp1∆ (Figure 4-
15), for detail see Chapter 2 section 2-7. 
 
 
 
 
 
Figure 4-15: Diagram explaining the SGA technique in steps. MATα cell carrying a single 
mutant (blue circle) was mated with MATa carrying a second mutation (red circle). Diploids 
are selected and sporulated to get haploids. In the final step, haploids containing both 
mutations are selected (For detail see Chapter 2 section 2-7).   
 
 
 
We applied this technique to perform a mini screen for msp1∆ with some pex 
mutants. We were looking to find any genetic interaction between MSP1 and any 
PEX genes. Most pex mutants do not contain peroxisomes and they mislocalise 
GFP-PTS1 to the cytosol such as pex1∆, pex5∆ and pex13∆. However, these 
mutants still contain ghosts (peroxisome remnants) except for pex3∆ and pex19∆, 
which are devoid of peroxisomes and peroxisomal remnants (Hettema et al., 2000). 
Some of the PEX genes are responsible for controlling peroxisome shape and 
number. Therefore, deletion of these genes will lead to cells that have a few large 
peroxisomes or increased numbers of small peroxisomes. A query strain was made 
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by replacing the MSP1 gene with the peroxisomal matrix marker expression cassette 
(GFP-PTS1 under control of TPI1 promoter linked to the cloNAT resistance marker). 
Peroxisomal membranes were visualised by a single copy plasmid encoding Pex11-
mCherry under control of its own promoter (Figure 4-16). The generated haploid 
strains are listed in Table 4-1.  
 
 
 
 
 
Figure 4-16: Peroxisome labelling in msp1∆ cells in the SGA query strain. The MSP1 
gene was deleted in a query strain by insertion of a selectable (cloNat) GFP-PTS1 expression 
cassette. This mutant was transformed with a plasmid expressing Pex11-mCherry under its 
own promoter and imaged. Bar =5um. 
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Table 4 -1: Haploid double mutants of msp1∆ with some selected mutants. 
 
 
The phenotype of the double mutants was compared to that of the single mutant 
strains using epifluorescence microscopy of logarithmically growing cells. Most 
double mutants showed a mislocalisation of GFP-PTS1 as observed in the 
corresponding single pex mutants. As expected, GFP-PTS1 was imported in dnm1∆ 
and pex7Δ cells and in the corresponding msp1Δ double mutants. Moreover, Pex11-
mCherry mislocalised to peroxisomes remnants (ghosts) and mitochondria in some 
pex mutants and it was completely mitochondrial in msp1∆/pex3∆ and 
msp1∆/pex19∆, in which there are no peroxisomes or peroxisomal ghosts (Figure 4-
17). 
 
Haploid double mutants 
  
Peroxisomal markers  
msp1∆/pex1∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex2∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex3∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex5∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex6∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex7∆ GFP-PTS1 and Pex11-mCherry   
msp1∆/pex8∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex10∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex12∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex13∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex14∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex15∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex17∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex19∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex22∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/pex25∆ GFP-PTS1 and Pex11-mCherry  
msp1∆/dnm1∆ GFP-PTS1 and Pex11-mCherry  
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Figure 4-17: Both peroxisomal membrane and matrix markers are mislocalised in 
msp1∆/ pex3∆ and msp1∆/pex19∆ cells. msp1∆/pex3∆ and msp1∆/pex19∆ cells showed 
mislocalisation of GFP-PTS1 to the cytosol and Pex11-mCherry to mitochondria. Cells were 
grown and imaged in logarithmic phase. Bar =5µm. 
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Peroxisome remnants were quantified in double mutants compared to single pex 
mutants. Peroxisomes remnants were increased slightly in most double mutants 
compared to the single pex mutants (Figure 4-18 and Table 4-2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4-2: Average of peroxisomal membrane structure number in double mutants with 
msp1Δ. 
 
Strains 
 
Average of peroxisomal 
membrane structures per cell 
 
msp1Δ /pex1Δ 
pex1Δ 
2.34 ±1.43 
2.34 ±1.30 
msp1Δ /pex2Δ 
pex2Δ 
1.93 ±1.17 
1.76 ±1.05 
msp1Δ /pex4Δ 
pex4Δ 
2.1 ±1.11 
1.75 ±0.96 
msp1Δ /pex5Δ 
pex5Δ 
3.80 ±1.50 
3.66 ±1.85 
msp1Δ /pex6Δ 
pex6Δ 
3.55 ±2.03 
3.15 ±1.75 
msp1Δ /pex7Δ 
pex7Δ 
4.7±2.03 
4.05±1.39 
msp1Δ /pex8Δ 
pex8Δ 
1.8 ±1.22 
1.9 ±1.15 
msp1Δ /pex10Δ 
pex10Δ 
2.20 ±1.19 
1.75 ±0.85 
msp1Δ /pex12Δ 
pex12Δ 
1.75 ±1.04 
1.49 ±0.69 
msp1Δ /pex13Δ 
pex13Δ 
3.52 ±1.78 
2.26±1.42 
msp1Δ /pex14Δ 
pex14Δ 
2.21 ±0.97 
2 ±0.94 
msp1Δ /pex15Δ 
pex15Δ 
2.28 ±1.39 
2.19 ±1.16 
msp1Δ /pex17Δ 
pex17Δ 
6.05 ±1.70 
5.45 ±1.53 
msp1Δ /pex22Δ 
pex22Δ 
5.35 ±2.62 
3.35 ±1.22 
msp1Δ /dnm1Δ 
dnm1Δ 
5.4 ±2.08 
4.14 ±1.85 
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Figure 4-18:Quantitative analysis of peroxisomal membrane structures in msp1Δ/pexΔ 
mutants. 
A-msp1∆/pex1∆ and pex1∆       B-msp1∆/pex2∆ and pex2∆         C- msp1∆/pex4 ∆and pex4∆ 
D-msp1∆/pex5∆ and pex5∆    E-msp1∆/pex6∆ and pex6∆     F-msp1∆/pex7∆ and pex7∆       
G-msp1∆/pex8∆ and pex8∆      H-msp1∆/pex10∆ and pex10∆     I-msp1∆/pex12∆ and pex12∆ 
J- msp1∆/pex13∆ and pex13∆ K- msp1∆/pex14∆ and pex14∆   L-msp1∆/pex15∆ and pex15∆ 
M- msp1∆/pex17∆ and pex17∆ N- msp1∆/pex22∆ and pex22∆ O-msp1∆/dmn1∆ and dnm1∆. 
Peroxisome number was determined and presented in a bar chart, Error bars represent 
standard deviation.  Bar =5µm.  
 
 
 
Interestingly, deletion of Msp1 in pex25∆ cells led to partial rescue of the severe 
phenotype observed in the pex25∆ single mutant (Figure 4-19). Pex25 is a PMP 
controlling peroxisome number and size, and deletion of Pex25 results in most cells 
containing less and enlarged peroxisomes (Rottensteiner et al., 2003). Many cells 
are lacking peroxisomes and GFP-PTS1 is mislocalised to the cytosol. Deletion of 
Msp1 in pex25∆ cells restores the import of matrix proteins.  
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Figure 4-19:  Deletion of Msp1 partially restores peroxisome abundance in pex25∆ cells. 
Deletion of Msp1 in pex25∆ cells leads to rescue of GFP-PTS1 import. WT, pex25∆ and 
pex25∆/msp1∆ cells expressing GFP-PTS1 were grown in selective media until logarithmic 
phase. Bar =5µm. A student T test was performed to analyse the data, error bars represent 
standard deviation. *  Shows significance difference where P <0.05. 
 
 
It might be that Msp1 negatively controls peroxisome number, while Pex25 positively 
controls peroxisome number. Thus, deletion of Msp1 led to an increase in 
peroxisome number. It was shown that Pex25 is required for de novo peroxisome 
formation and deletion of Pex25 leads to a delay in this process. However, deletion of 
Msp1 in pex25∆ did not rescue de novo formation of pex25∆ (Figure 4-20). 
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Figure 4-20: Analysis of de novo peroxisome biogenesis in msp1∆/pex25Δ, pex25Δ, 
msp1∆ and WT cells containing a conditional PEX19 allele. The  strains were grown 
overnight on 2% raffinose  medium then induced on 2% galactose medium  for  2, 3, 4, 5  and 
6 hours. The experiment was repeated three times. No sigificant difference was observed 
between strains. Error bars repersent the standard deviation. 
 
 
 
4-5 A genome-wide screen to identify Msp1 genetic interactors 
 
Many genetic screens have been performed to identify genes involved in 
peroxisomes biogenesis (Cregg et al., 1990; Liu et al., 1992; Nuttley et al., 1993; 
Elgersma et al., 1998). We hypothesise that the function of Msp1 in peroxisome 
biogenesis is redundant with that of another gene, which could be an essential or 
non-essential gene. In yeast, approximately 1500 genes are essential for growth on 
rich media. Of these, 1033 are conserved from yeast to human (Hughes, 2002). The 
primary role of most essential yeast genes is known, but the full breadth of function 
associated with essential genes is not characterised (Tong et al., 2001; Li et al., 
2011). A collection of approximately 4500 non-essential gene deletion mutants is 
available. Two collections of mutants in essential genes are available for SGA 
analysis, one contains temperature-conditional alleles and the other collection 
contains hypomorphic mutants (Schuldiner et al., 2005; Ben-Aroya et al., 2008). The 
latter collection was constructed by insertion of kanMX in the 3’UTR, which 
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destabilises the mRNA and results in dampening the expression (DAmP collection) 
(Schuldiner et al., 2005; Breslow et al., 2008). We decided to perform a genome wide 
screen to combine msp1∆ with non-essential gene mutants, temperature sensitive 
essential genes and the DAmP collection. The query strain was identical to the one 
used for the mini-SGA described above and was crossed with the different libraries in 
collaboration with David Lydall at Newcastle University. msp1∆ double mutants were 
distributed in a 384 well format over 12 plates for the non-essential gene collection, 3 
plates for the hypomorphic gene DAmP collection and 5 plates for the TS essential 
gene collection. In order to screen this library, we had to optimise growth conditions 
and the imaging of double mutants. Cells were grown using a synthetic medium in 96 
well glass bottom plates and resuspended in a non-fluorescent medium to reduce 
fluorescent background for imaging. We were able to screen and image two 96 well 
plates per day. The screen was imaged and analysed visually for any phenotype that 
leads to mislocalisation of GFP-PTS1 or that affects peroxisome number, peroxisome 
shape, peroxisome inheritance or peroxisome distribution. Most pex gene deletions 
lead to mislocalisation of GFP-PTS1 to the cytosol. Double mutants with msp1Δ 
showed the same phenotype (Figure 4-21) (as shown previously for some pex 
mutants in the mini SGA described above) indicating that the pex gene mutations 
have been introduced into the msp1Δ-GFP-PTS1 cells correctly.  
Two additional double mutants, msp1Δ/ygl152cΔ and msp1Δ /yjl211cΔ showed 
mislocalisation of GFP-PTS1 to cytosol (Figure 4-22). These genes are dubious 
open reading frames; YGL152C partially overlaps with PEX14 and YJL211C with 
PEX2. This overlap leads to a defect in PEX14 or PEX2 and mislocalisation of GFP-
PTS1, as was shown previously in a genome-wide screen (Saleem et al., 2010). 
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Figure 4-21: Most of the double pex mutants with msp1∆ showed a mislocalisation of GFP-PTS1 to cytosol. Cells were grown in synthetic 
medium in a 96 well glass bottom plate for 3 hours before epifluorescence imaging and cells were resuspended in non-fluorescent medium. Cells 
were imaged using a plan 40x /0.65 ph2 objective. Bar=5µm.
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Figure 4-22: The phenotype of msp1Δ/ygl152cΔ and msp1Δ/yjl11cΔ cells expressing 
GFP-PTS1. Cells were grown in synthetic medium in a 96 well glass bottom plate for 3 hours 
before epifluorescence imaging and cells were resuspended in non-fluorescent medium. Cells 
were imaged using a plan 40x /0.65 ph2 objective. Bar=5µm. 
 
 
 
In addition, inp1∆ and inp2∆ cells are known for affecting peroxisome distribution and 
display a defect in inheritance of peroxisomes. Deletion of Inp1 leads to a failure in 
retention of peroxisomes in the mother cell and this results in transport of all 
peroxisomes to the bud. In addition, deletion of Inp2 causes failure in the transit of 
peroxisomes to the bud. As predicted, msp1∆/inp1∆ and msp1∆/inp2∆ cells showed 
an inheritance defect. Thus, Msp1 does not have a genetic interaction with Inp1 or 
Inp2 and it is not involved with inheritance of peroxisomes (Figure 4-23). 
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Figure 4-23: The phenotype of msp1∆/inp1∆ and msp1∆/inp2∆ cells expressing GFP-
PTS1. The double mutants of msp1∆/inp1∆ and msp1∆/inp2∆ showed the same peroxisomal 
inheritance defect as inp1∆ and inp2∆ mutants. Cells were grown in synthetic medium in a 96 
well glass bottom plate for 3 hours before epifluorescence imaging and cells were 
resuspended in non-fluorescent medium. Cells were imaged using a plan 40x /0.65 ph2 
objective. Bar=5µm. 
 
 
 
Vps1 and Dnm1 play a role in controlling peroxisome abundance with Vps1 being 
more important for peroxisome fission than Dnm1 on glucose medium (Kuravi et al., 
2006). Both vps1∆ and msp1∆/vps1∆ cells contain a strongly reduced number of 
peroxisomes (Figure 4-24). Moreover, msp1∆/dnm1∆ showed normal numbers of 
peroxisomes.    
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Figure 4-24: The phenotype of msp1∆/vps1∆ and msp1∆/dnm1∆ double mutants. 
msp1∆/vps1∆ cells showed enlarged peroxisomes, which is similar to the phenotype of vps1∆ 
single mutant cells. No clear phenotype was observed with msp1∆/dnm1∆ cells. Cells were 
grown in synthetic medium in a 96 well glass bottom plate for 3 hours before epifluorescence 
imaging and cells were resuspended in non-fluorescent medium. Cells were imaged using a 
plan 40x /0.65 ph2 objective. Bar=5µm. 
 
 
[[  
Pex11, Pex25, Pex27 and Pex34 play a role in peroxisome proliferation and deleting 
these genes leads to cells containing a reduced number of enlarged peroxisomes. 
From our screen, pex11∆, pex27∆ and pex34∆ single mutant cells showed a 
peroxisome proliferation phenotype but Msp1 deletion did not have any effect in 
these mutants (Figure 4-25). However, as mentioned previously, deletion of Msp1 in 
pex25∆ cells rescued the severe phenotype of the pex25∆ single mutant (Figure 4-
25). Therefore, we conclude that there is a genetic interaction between Pex25 and 
Msp1, or that Msp1 might negatively control peroxisome number as its single deletion 
leads to an increase in peroxisome number (as shown in Figure 4-9). 
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Figure 4-25: The phenotype of msp1∆ double mutants with pex27∆, pex11∆, pex34∆ 
and pex25∆. No clear phenotype was observed with double mutants of msp1∆. Cells were 
grown in synthetic medium in a 96 well glass bottom plate for 3 hours before epifluorescence 
imaging and cells were resuspended in non-fluorescent medium. Cells were imaged using a 
plan 40x /0.65 ph2 objective. Bar=5µm. 
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Moreover, Pex28, Pex29, Pex30, Pex31 and Pex32 control peroxisome number and 
abundance. Double mutants with msp1Δ were indistinguishable from the single 
mutants (Figure 4-26). All peroxin genes identified in this screen were listed in Table 
4-3. 
 
 
 
 
Figure 4-26: The phenotype of msp1∆ double mutant with pex28∆, pex29∆, pex30∆, 
pex31∆ and pex32∆. No clear phenotype was observed with double mutants. Cells were 
grown in synthetic medium in a 96 well glass bottom plate for 3 hours before epifluorescence 
imaging and cells were resuspended in non-fluorescent medium. Cells were imaged using a 
plan 40x /0.65 ph2 objective. Bar=5µm. 
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Table 4-3: The double mutants of msp1∆ with all pex mutants generated by the SGA   
procedure displayed phenotypes as expected.  
 
Double mutant of msp1∆ with 
peroxisomal mutants 
 
Phenotype 
 
msp1∆/pex1∆ No peroxisomes and cytosolic mislocalisation of GFP-PTS1  
msp1∆/pex2∆  No peroxisomes and cytosolic mislocalisation of GFP-PTS1  
msp1 /pex3∆ No peroxisomes and cytosolic mislocalisation of GFP-PTS1 to 
cytosol 
msp1∆/pex4∆ No peroxisomes and  cytosolic mislocalisation of GFP-PTS1  
msp1∆/pex5∆  No peroxisomes and  cytosolic mislocalisation of GFP-PTS1  
msp1∆/pex6∆  No peroxisomes and  cytosolic mislocalisation of GFP-PTS1  
msp1∆/pex10∆  No peroxisomes and  cytosolic mislocalisation of GFP-PTS1  
msp1∆/pex12∆  No peroxisomes and  cytosolic mislocalisation of GFP-PTS1  
msp1∆/pex13∆  No peroxisomes and  cytosolic mislocalisation of GFP-PTS1  
msp1∆/pex14∆  No peroxisomes and  cytosolic mislocalisation of GFP-PTS1  
msp1∆/pex15∆  No peroxisomes and  cytosolic mislocalisation of GFP-PTS1  
msp1∆/pex17∆ No peroxisomes and  cytosolic mislocalisation of GFP-PTS1 
msp1∆/pex19∆ No peroxisomes and  cytosolic mislocalisation of GFP-PTS1  
msp1∆/pex22∆ No peroxisomes and  cytosolic mislocalisation of GFP-PTS1  
msp1∆/pex25∆ Rescue of GFP-PTS1 import  
msp1∆/pex27∆ Reduced peroxisomes as the pex27Δ single mutant  
msp1∆/pex28∆ Non indistinguishable phenotype from single mutant  
msp1∆/pex29∆ Non indistinguishable phenotype from single mutant  
msp1∆/pex30∆ Non indistinguishable phenotype from single mutant  
msp1∆/pex31∆ Non indistinguishable phenotype from single mutant  
msp1∆/pex32∆ Non indistinguishable phenotype from single mutant  
msp1∆/pex34∆ Reduced peroxisomes as the pex34Δ single mutant  
msp1∆/vps1∆ Reduced number and enlarged peroxisomes as vps1∆ 
msp1∆/dnm1∆ No clear phenotype  
msp1∆/inp1∆ Peroxisomes fail to retain in mother cells and move to the bud  
msp1Δ/inp2Δ Peroxisome retain in mother cells 
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The SGA for the msp1∆ screen did not identify genes that were redundant with 
respect to peroxisome biogenesis. We did not find any double mutants that had a 
more severe defect than the single mutants. Interestingly, msp1∆/ygr168c∆ double 
mutant cells showed somewhat bigger and less peroxisomes in comparison to the 
msp1∆ single mutant (Figure 4-27). YGR168C is a non-essential gene and a putative 
protein of unknown function. This gene is further characterised in chapter 5. It might 
be a novel PEX gene involved in controlling peroxisome number, abundance and 
size.  
 
 
 
 
 
 
[ 
Figure 4-27: msp1∆/ygr168c∆ cells contain less and bigger peroxisomes in comparison 
to msp1∆ cells. Cells were grown in YM2 medium in 96 well glass bottom plates for 3 hours 
before imaging. Cells were resuspended in non-fluorescent medium and imaged using a plan 
40x /0.65 ph2 objective. Bar =5µm. 
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Furthermore, the DAmP collection was analysed and screened for any phenotype 
related with peroxisomes. Unfortunately, we did not identify any hits from these 
mutants.  We did not screen the temperature sensitive essential genes, as each gene 
needs optimisation of screening. It will be interesting to analyse the phenotype of 
msp1∆ under conditional protein destabilisation of essential genes. Furthermore, 153 
double mutants could not survive during the SGA steps due to a synthetic lethality or 
inefficient selection for these mutants (Figure 4-28).  
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              * Negative genetic interaction. 
Figure 4-28: Double mutants with msp1Δ could not survive during SGA produce due to synthetic lethality or inefficient selection steps.  
msp1Δ/ybl094cΔ msp1Δ/lyp1Δ msp1Δ/ ecm37Δ msp1Δ /ydl041wΔ msp1Δ/zrt3Δ msp1Δ/ynl170wΔ msp1Δ/ygr025wΔ msp1Δ/ubi4Δ msp1Δ/wsc2Δ 
msp1Δ/mis1Δ msp1Δ/rad50Δ msp1Δ/mac1Δ msp1Δ /slc1Δ msp1Δ/msh4Δ  msp1Δ/ino4Δ  msp1Δ/ygr026wΔ msp1Δ/vps24Δ msp1Δ/pap2Δ 
msp1Δ/rps9bΔ msp1Δ/nut1Δ msp1Δ/ura5Δ msp1Δ /ste7Δ msp1Δ/lys1Δ msp1Δ/kgd1Δ msp1Δ/ste14Δ msp1Δ/ste5Δ msp1Δ/ygr031wΔ 
msp1Δ/lys2Δ msp1Δ/ygr011wΔ msp1Δ/ccs1Δ msp1Δ /gpr1Δ msp1Δ/opi3Δ msp1Δ/erg3Δ msp1Δ/ydl237wΔ msp1Δ/ssd1Δ msp1Δ/arc1Δ 
msp1Δ//ecm31Δ msp1Δ/rpl26bΔ msp1Δ/yml013c-aΔ msp1Δ /srb8Δ msp1Δ/arg2Δ msp1Δ/ylr065cΔ msp1Δ/rvs167Δ msp1Δ/gcs1Δ msp1Δ/rps25aΔ 
msp1Δ/fmt1Δ msp1Δ/get1 Δ mp1Δ/atp11Δ     msp1Δ /sro9Δ msp1Δ/msh4Δ msp1Δ/ylr218cΔ msp1Δ/sir4Δ  msp1Δ/arp8Δ msp1Δ/est2Δ 
msp1Δ/ ade1Δ msp1Δ/ leu1Δ msp1Δ/ Rps25aΔ msp1Δ /ybr266cΔ msp1Δ/ptk2Δ msp1Δ/ste11Δ msp1Δ/pmp3Δ msp1Δ/lys9Δ msp1Δ/hap5Δ 
msp1Δ/ybl054wΔ msp1Δ/gsc3Δ msp1Δ/mon2Δ msp1Δ/get2Δ* msp1Δ/arg3Δ msp1Δ/get3Δ* msp1Δ/htz1Δ msp1Δ/arg1Δ msp1Δ/lys12Δ 
msp1Δ /Rrn10Δ msp1Δ/vma21Δ msp1Δ/psd1Δ msp1Δ/his1Δ msp1Δ/grr1Δ msp1Δ/rpl20bΔ  msp1Δ/lip5Δ msp1Δ/ynr020cΔ msp1Δ/mre11Δ 
msp1Δ/ybl083cΔ msp1Δ/rmd11Δ msp1Δ/aep2Δ msp1Δ/ste2Δ msp1Δ/flx1Δ   msp1Δ/mnn2Δ  msp1Δ/exo1Δ msp1Δ/yol159cΔ msp1Δ/mfa1Δ 
msp1Δ /mrpl36Δ msp1Δ/thr1Δ msp1Δ/gas1Δ msp1Δ/arg5Δ msp1Δ/rad27Δ   msp1Δ/gsh1Δ  msp1Δ/coq2Δ msp1Δ/bul2Δ msp1Δ/gem1Δ 
msp1Δ/slm3Δ msp1Δ/mdm31Δ* msp1Δ/rim21Δ msp1Δ/npr2Δ msp1Δ/hsl1Δ msp1Δ/glo1Δ  msp1Δ/tgs1Δ msp1Δ/clb2Δ msp1Δ/orc2Δ 
msp1Δ /his7Δ msp1Δ/ste20Δ msp1Δ/sws2Δ msp1Δ/pda1Δ msp1Δ/sac1Δ msp1Δ/mdm12Δ msp1Δ/ste4Δ msp1Δ/vps4Δ  msp1Δ/ypl205cΔ 
msp1Δ/ dhh1Δ msp1Δ/tir3Δ msp1Δ/cox7Δ msp1Δ/kre28Δ msp1Δ/cbt1Δ msp1Δ/erg2Δ msp1Δ/pde2Δ msp1Δ/lys14Δ msp1Δ/mss18Δ 
msp1Δ /ram1Δ msp1Δ/apq12Δ msp1Δ/sin4Δ msp1Δ/ubp6Δ msp1Δ/eap1Δ msp1Δ/mne1Δ msp1Δ/yor300wΔ msp1Δ/lys2Δ msp1Δ/mrpl10Δ 
msp1Δ /rim1Δ msp1Δ/gpa1Δ msp1Δ/whi3Δ msp1Δ/ygl007wΔ msp1Δ/yll044wΔ msp1Δ/ura4Δ msp1Δ/mre11Δ msp1Δ/ygl218wΔ msp1Δ/mdm35Δ* 
msp1Δ/ his4Δ msp1Δ/phb2Δ msp1Δ/bni1Δ msp1Δ/ygr035cΔ msp1Δ/ura1Δ msp1Δ/rsc2Δ msp1Δ/rcy1Δ msp1Δ/ade4Δ msp1Δ/sir3Δ 
msp1Δ /ydl096cΔ 
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4-6 Analysis of Msp1 Walker A and Walker B mutants   
  
Next, we determined if mutations in the ATP binding domain (Walker A) or ATP 
hydrolysis domain (Walker B) affect Msp1 activity on peroxisomes. We tested if the 
Msp1 Walker B mutant generates a dominant-negative phenotype and whether 
ATPase activity is required for Msp1 function. Msp1 with Walker A mutation (K139T) 
and Walker B mutation (E193Q) were constructed and expressed as untagged 
proteins under control of their endogenous promoter. The mutants Walker A and B 
were transformed into WT cells alongside HcRed-PTS1. Expression of these mutants 
did not affect peroxisome size, number and segregation compared with WT cells 
(Figure 4-29A). Peroxisome number was increased in the Walker A and B mutants in 
comparison to WT cells (Figure 4-29B). 
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Figure 4-29: Peroxisome number is increased in WT cells expressing Walker A and B 
mutants of Msp1. A- Peroxisomal phenotype of WT cells expressing Msp1 Walker A and B 
mutants. Bar=5μM.  B- Bar chart represents peroxisome number in WT cells expressing 
Walker A and B mutants. Cells were grown until logarithmic phase before imaging. 
Peroxisome number was quantified and analysed in a bar chart. At least 100 cells were 
counted and the data analysed using a student T test, error bars represent the standard 
deviation. *  shows significance difference where P <0.05. 
 
 
 
In addition, the mitochondrial phenotype was analysed in the Walker A and B mutant 
cells. MitoTracker Green staining was visualised in logarithmic cells co-expressing 
Walker A and B mutants alongside the peroxisomal marker HcRed-PTS1. Walker A 
and B mutants showed a normal distribution of peroxisomes and mitochondria 
(Figure 4-30). 
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Figure 4-30: Peroxisomal and mitochondrial morphology in cells expressing Msp1 
Walker A and B mutants. Cells were grown until logarithmic phase and a green MitoTracker 
was used to visualise mitochondria. The culture was left at 30°C for 20min before 
epifluorescence imaging. Bar =5µm. 
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4-6 Discussion 
 
Msp1 is an intramitochondrial sorting protein, which localises to the mitochondrial 
outer membrane. It was demonstrated that the Msp1 is not required for growth on 
fermentable or nonfermentable carbon sources and  cells lack  a clear phenotype for 
Msp1 because it might be a redundant protein (Nakai et al., 1993). Msp1 is a 
conserved AAA+ ATPase and its homologues in human (ATAD1) and Drosophila 
(NMD) share a localisation on mitochondria and peroxisomes.  
Recent studies showed that Msp1 and ATAD1 are involved in mitochondrial quality 
control by clearing the MOM of mistargeted tail-anchored proteins (Chen et al., 2014; 
Okreglak and Walter, 2014). However, their peroxisomal function has not been 
shown yet. NMD acts as a peroxin involved in peroxisome membrane biogenesis and 
knockdown of NMD leads to a cytosolic mislocalisation of GFP-PTS1 (Joanne Lacey, 
Hettema lab). However, no clear peroxisomal phenotype was observed for msp1∆ 
yeast cells or in human cells deleted for ATAD1 (Alison Motley, Hettema lab). 
Msp1 was expressed under control of different promoters (GAL1/10, HIS3 and TPI1) 
in WT cells. Msp1 was localised in tubular mitochondria and puncta that localised to 
peroxisomes. However, peroxisomes appear to be absent in 10-30% of WT cells 
expressing Msp1 under control of the TPI1 promoter. This suggests that 
overexpression of Msp1 leads to a disturbance in peroxisome abundance. In addition, 
Msp1 has no role in peroxisome de novo formation, peroxisome segregation or 
pexophagy. Peroxisome number is slightly increased in msp1∆ cells in comparison to 
WT cells. So far, the Msp1 peroxisomal function remains to be uncovered and lack of 
a clear phenotype of msp1∆ might be related to redundancy. Genetic interactions 
were studied between MSP1 and some PEX genes. No genetic interaction was 
found between MSP1 and PEX genes, except with PEX25. Deletion of Msp1 leads to 
restoration of matrix protein import in pex25∆ cells. Pex25 is a peroxisomal 
membrane protein involved in controlling peroxisome number and size and as a 
factor in de novo peroxisome formation. However, we could not find a role of Msp1 in 
de novo formation. Nonetheless, the suppression of the pex25Δ phenotype suggests 
a role for Msp1 in peroxisome biogenesis. 
The SGA technique presents a good tool to identify genetic interactions that would 
result in an absence of peroxisomes, as is observed for the single NMD mutant in 
Drosophila melanogaster. However, no such genetic interactions were identified in 
yeast and the screen did not allow for a quantitative analysis of peroxisome number 
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compared to the isogenic single mutants. Visual analysis did however; identify one 
new gene (YGR168C) that in combination with msp1Δ normalised peroxisome 
numbers.  
Msp1 Walker A and B mutants expressed in WT cells resulted in an increase in 
peroxisome number, just like the msp1Δ gene deletion mutant. This implies that the 
mutants act in a dominant-negative manner. Furthermore, the mitochondrial 
phenotype was normal during expression of these mutants.  
In conclusion, Msp1 appears to play a role in peroxisome biogenesis but what this 
role is has remained obscure. Genetic interactions were found with two genes. Their 
role in peroxisome biogenesis is also unknown and our studies have not unravelled 
this any further yet.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
138 
Chapter 5 
 
 5  Preliminary functional analysis of a novel PMP that genetically 
interacts  with Msp1 
 
5-1 Introduction 
 
To date, 34 PEX genes have been identified in different organisms and they are 
involved in import of peroxisomal matrix proteins, membrane biogenesis and control 
of peroxisome number, size and abundance (Tower et al., 2011). Deletion of 
peroxins involved in peroxisomal matrix protein import leads to mislocalisation of 
matrix proteins to cytosol. However, membrane proteins are not affected and are 
inserted into membrane structures known as peroxisomal remnants (Hettema et al., 
2000; Koek et al., 2007). The most severe phenotype is observed with deletion of 
either Pex3 or Pex19 in yeast, as both membrane biogenesis and matrix protein 
import is affected. The least studied group of PEX genes is those that affect 
peroxisome number and size. Deletion of these genes does not affect peroxisome 
function (Yuan et al., 2016). Initial genetic screens were based on the isolation of 
yeast mutants that could not grow on carbon sources (oleate, methanol) that require 
peroxisomal function for their metabolism (Erdmann et al., 1989; Cregg et al., 1990; 
Gould et al., 1992; Liu et al., 1992). Later on, additional PEX genes were identified 
by proteomics and systems biology approaches (Tower et al., 2011; Kohlwein et al., 
2013). So far, understanding of the peroxisome biogenesis process is still unresolved. 
This may be associated with redundant gene functions. 
The aim of this chapter is to determine the function of a novel PMP. Ygr168c 
was identified in a genome wide SGA screen as a suppressor of Msp1 gene deletion. 
A BLASTP search of Ygr168c showed limited conservation to related yeast species 
but no orthologues were identified in more distant fungi (Figure 5-1).  
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Figure 5-1: Multiple sequence alignment of Ygr168c with its homologues in related 
yeast species. Ygr168c in S. cerevisiae; PORF 8872 in S. mikatae; PORF 8981 in S. 
paradoxus; PORF Sbay_Contig600.22 S. bayanus; PORF Scas_Contig620.4 in S. castellii 
and PORF Sklu_Contig2222.7 in S. kluyveri. In yellow identical residues are indicated. In pink 
and green, strong and weak similarity are indicated, respectively. 
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TMHMM (http://www.cbs.dtu.dk/services/TMHMM/) and Phobius analysis (http:// 
phobius.sbc.su.se/) predicts Ygr168c to be an integral membrane protein that 
contains five transmembrane segments (Figure 5-2). 
 
 
 
 
 
Figure 5-2: Predicted membrane topology of Ygr168c. TMHMM analysis was performed 
for Ygr168c topology prediction. The red labelling represents hydrophobic amino acid 
sequences and transmembrane domains (TMDs). With ‘inside’ indicating inside the cytosol 
and ‘outside’ indicating the luminal side of the membrane. 
 
 
 
Currently, no data is available regarding Ygr168c localisation, expression and 
function. Yeast two-hybrid data accessed from the Yeast Resource Center (YRC) 
indicates that Ygr168c interacts physically with Pex15, which is a peroxisomal 
membrane protein. Pex15 interacts with other peroxisomal proteins in this screen 
(Figure 5-3). 
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Figure 5-3:Unpublished data from yeast resource center showed Ygr168c interaction 
with a peroxisomal membrane protein Pex15 in a yeast two-hybrid screen. 
http://www.yeastrc.org/pdr/viewProtein.do?id=530769. 
 
 
 
5-2 Analysis of Ygr168c localisation in WT cells  
 
In order to determine the subcellular location of Ygr168c, Ygr168c was tagged with 
GFP and expressed under control of the GAL1/10 promoter. Expression was induced 
in WT cells expressing the peroxisomal matrix marker HcRed-PTS1. Ygr168c-GFP 
was distributed in a punctate pattern that overlapped with HcRed-PTS1.This 
confirmed that Ygr168c localises to peroxisomes (Figures 5-4). Furthermore, extra 
GFP puncta were observed that did not colocalise with the peroxisomal marker. They 
might represent an overexpression artefact or a preperoxisomal structure, or it may 
be a peroxisome arising from asymmetric peroxisome division that has very little 
luminal contents. The same is observed with induced overexpression of a variety of 
PMPs. 
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Figure 5-4: Localisation of Ygr168c-GFP in WT cells after induction from the GAL1/10 
promoter. WT cells were transformed with a GAL1/10 controlled Ygr168c-GFP expression 
plasmid and HIS3 regulated HcRed-PTS1 plasmid. Cells were grown overnight on 2% 
raffinose medium, transferred to 2% galactose medium to induce GAL1/10 mediated 
expression (pulse) for 1 hour. After the pulse, cells were transferred to glucose medium to 
shut down GAL1/10 expression for 2 hours before epifluorescence imaging. Bar =5µm. 
 
 
 
 
The pex3Δ and pex19Δ mutants lack any peroxisomal structures and mislocalise the 
peroxisomal matrix proteins to cytosol. Induction of Ygr168c-GFP expression in 
these mutants led to a very faint diffuse signal in the cytosol (Figure 5-5). It appears 
that Pex3 and Pex19 are required for stability of Ygr168c. This has previously been 
reported for a large variety of PMPs (Hettema et al., 2000). Therefore, it is likely that 
Ygr168c encodes a novel PMP. In addition, Ygr168c-GFP localisation was studied in 
a variety of peroxisome biogenesis mutants, as well as a fission mutant. Ygr168c 
clearly localises to membrane structures (peroxisomal ghosts) in mutants blocked in 
matrix protein import. These are the hallmarks of a peroxisomal membrane protein 
(Figure 5-6). 
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Figure 5-5: Ygr168c-GFP localisation in pex3Δ and pex19Δ after induction from the 
GAL1/10 promoter. Cells were transformed with a GAL1/10 controlled Ygr168c-GFP 
expression plasmid and HIS3 regulated HcRed-PTS1 plasmid. Cells were grown overnight in 
raffinose medium and transferred to galactose medium to induce GAL1/10 mediated 
expression (pulse) for 1 hour. After the pulse, cells were transferred to glucose medium to 
shut down GAL1/10 expression for 2 hours before epifluorescence imaging. Bar =5µm. 
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Figure 5-6: Localisation of Ygr168c-GFP under control of GAL1/10 in pex5Δ, pex7Δ, 
vps1Δ and pex13Δ cells. Cells were transformed with a GAL1/10 controlled Ygr168c-GFP 
expression plasmid and HIS3 regulated HcRed-PTS1 plasmid. Cells were grown overnight in 
raffinose medium and transferred to galactose medium to induce GAL1/10 mediated 
expression (pulse) for 1 hour. After the pulse, cells were transferred to glucose medium to 
shut down GAL1/10 expression for 2 hours before epifluorescence imaging. Bar =5µm. 
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Furthermore, long-term overexpression (overnight on galactose medium) of Ygr168c-
GFP in WT cells showed a decrease in peroxisome abundance (Figure 5-7). This, 
together with the observation that deletion of Ygr168c normalises peroxisome 
number in msp1Δ cells, suggests that Ygr168c might be involved in control of 
peroxisome abundance. Overnight overexpression of Ygr168c-GFP was distributed 
non-uniformily in the cytoplasm in pex3Δ and pex19Δ cells (Figure 5-7). Whether it 
localises to a specific structure is unclear.  
 
 
 
 
Figure 5-7: Overexpression of Ygr168c-GFP under control of the GAL1/10 promoter in 
WT, pex3Δ, and pex19Δ cells. WT cells showed a decrease in peroxisome abundance. 
Overnight overexpression of Ygr168c-GFP did not label specific structures in either pex3Δ or 
pex19Δ cells. Cells were grown overnight on galactose medium before epifluorescence 
imaging. Bar=5μm. 
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Subsequently, Ygr168c-GFP localisation was studied when expression was under 
control of its endogenous promoter. The GAL1/10 promoter was replaced with the 
YGR168C promoter in the GFP expression plasmid. However, we could not detect 
any Ygr168c-GFP signal in WT cells (Figure 5-8A). This suggested that Ygr168c-
GFP is very lowly expressed and/or that it is induced under specific growth 
conditions. Only in cells reaching stationary phase, some expression was detected 
(Figure 5-8B). 
 
 
 
Figure 5-8:  Localisation of Ygr168c-GFP under control of its endogenous promoter in 
WT cells. A-No clear GFP pattern distinct from untransformed cells was observed in WT cells 
expressing Ygr168c-GFP in a plasmid under control of its own promoter. Cells were grown to 
logarithmic phase in glucose medium before epifluorescence imaging. B-GFP puncta of 
Ygr168c were observed in some cells in a stationary culture. Bar= 5μm. 
  
 
147 
Furthermore, Ygr168c was genomically tagged with GFP at its C-terminus in WT 
cells and the integration was checked by PCR. No GFP signal of Ygr168c was 
observed under glucose or peroxisome proliferation conditions (oleate) (Figure 5-9).  
 
 
 
Figure 5-9: Localisation of Ygr168c genomically tagged with GFP at the C-terminus in 
WT cells. No expression was observed for Ygr168c genomically tagged with GFP at the C-
terminus in glucose or oleate grown cells. Cells were grown on A- glucose (logarithmic phase) 
B- oleate (overnight). Bar=5μm. 
 
 
 
This suggested that the expression of Ygr168c is very low. The promoter and the 
ORF sequence were analysed in the SNAP GENE viewer programme. An upstream 
open reading frame (uORF) of 6 codons followed by a stop codon was found starting 
at 26 bp upstream of the main ORF (Figure 5-10A). uORFs are defined as 
sequences with both an initiation and termination codon located upstream of the 
main ATG start codon. Most genes containing uORFs are expressed only during 
stress conditions. Scanning ribosomes that encounter a uORF start to translate it but 
then either dissociate when reaching the stop codon, or stall on the uORF and inhibit 
further association of additional ribosomes, thereby blocking translation. Furthermore, 
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the early dissociation of ribosomes from the mRNA may induce mRNA decay via the 
nonsense mediated decay (NMD) pathway (Barbosa et al., 2013).  
Site direct mutagenesis (SDM) was performed to mutate the ATG codon of this 
uORF in the Ygr168c-GFP fusion construct under control of its own promoter (500bp 
region upstream of the main ORF). The plasmid was transformed into WT cells 
alongside the peroxisomal marker HcRed-PTS1. No Ygr168c-GFP expression was 
detected in these cells under glucose or oleate growth conditions (Figure 5-10B). It 
remains obscure how Ygr168c expression is repressed under normal growth 
conditions (unstressed conditions). Moreover, the expression of Ygr168c-GFP under 
control of its endogenous promoter, either with or without the point mutation in the 
uORF, was tested under different stress conditions. Ygr168c-GFP expressing cells 
were analysed under various stress conditions, during exposure to; 1M NaCl 
overnight, 2mM DTT for 3 hours, 1mM H2O2 for 3 hours and heat shock for 20 min at 
37°C. No GFP expression was observed under any of the tested conditions (data not 
shown). In addition, Ygr168c-GFP under control of its endogenous promoter was 
transformed into upf1Δ, upf2Δ and upf3Δ cells. UPF1, UPF2 and UPF3 are the main 
components to trigger the NMD pathway and deletion of these genes leads to 
stabilisation of aberrant mRNA (Wang et al., 2001). No Ygr168c-GFP puncta were 
observed in these mutants (data not shown). 
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Figure 5-10: A point mutation in the start codon of the Ygr168c uORF. A-The sequence 
of the micro open reading frame (uORF) of Ygr168c  B-GFP puncta were not detected in WT 
cells expressing Ygr168c-GFP with point mutation in the ATG of the uORF under glucose or 
oleate growth condition. Bar= 5μm. 
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5-3 Analysis of Ygr168c targeting to peroxisomes  
 
Peroxisomal membrane proteins are targeted to peroxisomes via two routes: a direct 
route from the cytosol to the peroxisomal membrane or via the ER to peroxisomes 
(van Ael and Fransen, 2006). Most PMPs are sorted posttranslationally from the 
cytosol to peroxisomes and they contain a membrane peroxisomal targeting signal. 
This targeting signal known as the mPTS consists of either a cluster of basic amino 
acids or a mixture of positively charged and hydrophobic residues flanked alongside 
one or two transmembrane segments (Rottensteiner et al., 2004). Based on the 
hydrophobicity profile and the instability of GAL1/10 induced Ygr168c-GFP in pex3Δ 
and pex19Δ cells (Figure 5-4), we hypothesised that Ygr168c is a peroxisomal 
membrane protein. Thus, we set out to characterise the targeting and sorting signals 
of Ygr168c by construction of several GFP tagged truncations (Figure 5-11A). As 
shown in Figure 5-3, full-length Ygr168c fused to GFP under control of the GAL1/10 
promoter colocalised with the peroxisomal marker HcRed-PTS1. Ygr168c truncations 
were constructed under control of the GAL1/10 promoter to investigate the 
peroxisomal targeting signal. The Ygr168c truncations were chosen around 
predictive TMDs and positive clusters at the N-terminus (Figure 5-11B). 
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Figure 5-11:Construction of Ygr168c-GFP truncations under the control of the 
inducible GAL1/10 promoter. A-Schematic diagram of each Ygr168c truncation B-Protein 
sequence of Ygr168c showing the transmembrane domains (highlighted boxes) and a 
positive cluster of amino acids (labelled red).  
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The localisation of each truncation was analysed after induction on galactose 
medium (pulse) and chase on glucose medium. The C-terminal truncations (Ygr168c 
219-376aa, Ygr168c 141-376aa and Ygr168c 74-376aa) were unstable after 
shutdown of the GAL1/10 promoter. In addition, the N-terminal truncation 1-74aa was 
broken down during the chase. However, the 1-141aa truncation localised to the ER 
and some puncta that was closely associated with the ER, while the 1-219aa 
Ygr168c truncation showed an ER localisation (Figure 5-12A) as confirmed by 
colocalisation with the ER marker Sec66-HcRed (Figure 5-12B). Furthermore, the 
puncta observed with 1-141aa-GFP colocalised with Pex13-mCherry, which is a 
known marker for the peroxisomal membrane in WT cells (Figure 5-12C). The dual 
localisation at the ER and ER associated puncta suggests that Ygr168c might travel 
via the ER to peroxisomes, and that the peroxisomal and ER targeting signals are 
situated around 1-141aa. Further experiments are required to confirm this hypothesis 
and to characterise the signals in more detail. 
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Figure 5-12: Localisation of Ygr168c-GFP truncations (1-141aa and 1-219aa) in WT cells. 
A-The truncation 1-141aa localised to puncta and the ER, while 1-219aa localised to the ER 
only   B-The ER localisation of both truncations was confirmed by colocalisation with the ER 
marker Sec66-HcRed  C-1-141aa Ygr168c truncation labelled puncta showed colocalisation 
with Pex13-mCherry. Cells were grown overnight in raffinose medium and transferred to 
galactose medium to induce GAL1/10 mediated expression (pulse) for 1 hour. After the pulse, 
cells were transferred to glucose medium to shutdown GAL1/10 expression for 2 hours before 
epifluorescence imaging. Bar =5µm. 
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5-4 Analysis of the ygr168cΔ phenotype 
 
So far, we were unable to detect endogenous expression of Ygr168c-GFP. Only 
when expressed under control of the GAL1/10 promoter could we clearly detect the 
GFP signal in WT cells and observe peroxisomal labelling. Ygr168c was identified as 
a potential PEX gene by its genetic interaction with Msp1. The ygr168cΔ cells import 
GFP-PTS1 into peroxisomes, indicating that peroxisomal membrane biogenesis and 
matrix protein import are not severely affected in these cells. The ygr168cΔ 
phenotype was further investigated using a variety of assays: analysis of peroxisome 
abundance, de novo formation of peroxisomes, peroxisome inheritance and 
peroxisome degradation. 
 
 
5-4-1 Analysis of peroxisome number in ygr168cΔ cells 
 
Several peroxins controlling peroxisome abundance were identified after quantitative 
analysis of gene deletion mutants. These mutants showed a normal peroxisomal 
localisation of PMPs and matrix proteins (Yuan et al., 2016). We hypothesise that 
Ygr168c is a peroxin involved in controlling peroxisome number. Thus, we deleted 
the Ygr168c in msp1Δ and WT cells. Peroxisome number was determined in WT, 
ygr168cΔ, ygr168cΔ/msp1Δ and msp1Δ cells expressing the peroxisomal marker 
GFP-PTS1. As shown in the previous chapter, msp1Δ cells showed an increase in 
peroxisome number in comparison to WT cells. Deletion of Ygr168c in the msp1Δ 
background led to a restoration of peroxisome number to a wild type level (Figure 5-
13).  
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Figure 5-13: Restoration of peroxisome number in msp1Δ cells to a WT level after 
Ygr168c deletion. Cells were grown on glucose to logarithmic phase and peroxisome 
number was quantified. At least 100 cells were counted for each strain and the experiment 
repeated three times. Data analysis was performed using a student T test. Error bar show the 
standard deviation, *  represents significance difference where P <0.05. 
  
 
5-4-2 Analysis of de novo peroxisome formation in ygr168cΔ cells 
 
Cells with ygr168cΔ were analysed for the ability to form peroxisomes de novo. A 
conditional PEX19 strain was used to follow this process. This strain behaves as a 
pex mutant when grown under repressive conditions (glucose media) and lacks any 
peroxisomal structures. Under galactose induction conditions, PEX19 expression is 
induced and cells are forced to form peroxisomes de novo. This is an easy assay to 
follow this process. Ygr168cΔ was constructed in the conditional PEX19 background. 
The conditional PEX19 ygr168cΔ and WT cells were also constitutively expressing 
GFP-PTS1 (under control of the TPI1 promoter) to visualise the presence of 
peroxisomes. De novo formation in these strains was followed after PEX19 induction 
in galactose medium for 0, 2, 3, 4, 5, 6 and 7 hours. In both strains, cells containing 
peroxisomes were detected after 3 hours of induction and the percentage of 
peroxisome containing cells increased with time in both. However, there was a trend 
of a higher percentage of cells forming peroxisomes in the ygr168cΔ background at 
later time points (Figure 5-14).   
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Figure 5-14: The de novo formation of peroxisomes occurs with similar kinetics in the 
conditional PEX19 ygr168cΔ and WT cells. Cells expressing GFP-PTS1 were grown 
overnight in raffinose medium. PEX19 expression was induced by transferring cells to  2% 
galactose medium and peroxisomes were visualised using epifluorescence microscopy at the 
time points indicated. About 400 cells were counted for each time point and analysed in a bar 
chart. The experiment was repeated three times and no significant difference was observed 
between the strains. Error bar represents the standard deviation. 
 
 
 
5-4-3 Analysis of peroxisome inheritance in ygr168cΔ cells 
 
Whether Ygr168c plays a role in peroxisome inheritance was tested by analysis of 
peroxisome distribution in ygr168cΔ cells. WT and ygr168cΔ cells were transformed 
with the peroxisomal marker GFP-PTS1.Ygr168cΔ cells showed a normal distribution 
of peroxisomes between the mother and bud, as observed in WT cells (Figure 5-15). 
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Figure 5-15: Peroxisome distribution in ygr168cΔ cells. WT and ygr168c∆ cells 
expressing GFP-PTS1 were grown logarithmically on glucose medium before imaging. Bar= 
5μm. 
 
 
 
5-4-4 Analysis of peroxisomes degradation in ygr168cΔ cells 
 
Ygr168c was analysed for any involvement in peroxisome degradation and 
pexophagy was followed by a combination of microscopy and biochemical assay, as 
described previously in chapter 4 for msp1Δ cells. For the fluorescence microscopy-
based analysis, ygr168cΔ cells were transformed with Pex11-mCherry, which was 
used as a peroxisome degradation marker. In addition, WT and atg36Δ cells were 
transformed with Pex11-mCherry and used as controls. WT cells show normal 
peroxisome degradation in contrast to atg36Δ cells, where this process is blocked. 
Cells expressing Pex11-mCherry were grown on oleate medium overnight to induce 
peroxisome proliferation. Subsequently, the cells were transferred to nitrogen 
starvation medium and imaged after 22 hours. Peroxisome number was decreased 
and vacuolar labelling was apparent after 22 hours on starvation medium in WT and 
ygr168c∆ cells. No vacuolar labelling was observed in atg36∆ cells and peroxisome 
abundance remained high (Figure 5-16). 
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Figure 5-16:Peroxisome degradation is normal in ygr168cΔ cells. Cells expressing 
Pex11-mCherry were grown in glucose medium overnight. Cells were switched to oleate 
medium for 18 hours to induce peroxisomes proliferation. The cells were harvested, 
transferred into nitrogen starvation media and imaged at the time point indicated. Bar= 5μm. 
 
 
In addition, this process was followed by a biochemical assay using western blot 
analysis to follow peroxisome breakdown. Pex11-GFP was used as a breakdown 
marker. WT, ygr168cΔ and atg36Δ cells expressing Pex11-GFP were grown on 
oleate medium before switching to starvation medium. The breakdown was analysed 
after 0, 6 and 22 hours on starvation medium. In agreement with the fluorescence 
microscopy analysis, the western blot showed that degradation of peroxisomes is 
normal in ygr168cΔ cells (Figure 5-17). 
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Figure 5-17:Ygr168c is not required for pexophagy. Cells were grown overnight in glucose 
and switched to oleate medium for 18 hours for peroxisomes proliferation. For starvation 
condition, cells were transferred and grown in a glucose medium lacking nitrogen for the time 
points indicated. GFP resembles a Pex11 degradation product, which is relatively protease-
resistant and shows vacuolar breakdown of Pex11. 
 
 
5-5 Discussion  
 
Ygr168c is predicted to be an integral membrane protein with unknown function. 
Bioinformatics analysis showed it is not conserved between eukaryotes but recently 
a name for it was reserved on Saccharomyces Genome Database (SGD). 
Interestingly, this name is PEX35. We identified Ygr168c by a genetic interaction with 
Msp1 in the genome wide SGA screen. The peroxisomal function of Msp1 is still 
unknown but our data demonstrates an increase in peroxisome number in msp1Δ 
cells compared to WT cells. Deletion of Ygr168c in an msp1Δ background reduces 
peroxisome abundance to WT levels. Further research is required to understand this 
phenomenon and to establish whether this represents a functional link between the 
two proteins. In addition, overexpression of Ygr168c-GFP under control of the 
GAL1/10 promoter in WT cells showed a decrease in peroxisome abundance. 
However, we do not exclude the possibility that the tag would interfere with 
overexpression. Therefore, this experiment needs to be repeated with an untagged 
version of the protein.  
Our studies followed the expression of Ygr168c-GFP in WT cells. However, this gene 
was only detected under control of an inducible GAL1/10 promoter but did display 
peroxisomal localisation in these conditions. It behaves as a peroxisomal membrane 
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protein in many peroxisomal mutants studied. Ygr168c-GFP was not detected under 
control of its endogenous promoter, either plasmid based or at the chromosomal 
locus. Expression was neither detected when grown on glucose nor on oleate. Some 
low level expression of Ygr168c-GFP was found only in a subset of cells growing in 
starvation conditions (stationary phase culture 2 days old). This suggested the 
YGR168C promoter might be suppressed under most conditions. It was previously 
shown that uORFs are involved in posttranscriptional control of gene expression. 
These uORFs are located upstream of the main ORF and may affect translation of 
the main ORF by premature termination. In addition this may affect mRNA stability 
(Barbosa et al., 2013). Analysis of the YGR168C promoter sequence showed a 
uORF located before the main ATG. However, a point mutation in the initiation codon 
of this uORF did not have any effect on Ygr168c expression under normal or stress 
growth conditions. Searches in expression databases did not uncover any potential 
conditions that would induce Ygr168c expression.  
The peroxisomal targeting signal was located at the N terminus of this protein as is 
the case for several other PMPs (van Ael and Fransen, 2006). Analysis of the 
ygr168cΔ phenotype did not show any defect in peroxisomal matrix import and 
deletion of Ygr168c in msp1Δ cells restores the WT phenotype. This suggested that 
these genes may be functionally linked but the mechanism remains unknown. The 
ygr168cΔ phenotype did not display any defect in peroxisome inheritance, de novo 
formation or pexophagy. Since the phenotype of peroxisome abundance in ygr168cΔ 
cells is weak and since we cannot reliably detect expression of the Ygr168c, it 
remains unclear what its function is. 
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Chapter 6 
6 General discussion 
 
6-1 introduction 
 
The main aim of this study was to characterise Pnc1 import into peroxisomes and 
understand the mechanism and factors required for this. Peroxisomal matrix proteins 
are post-translationally imported into peroxisomes. Import of these proteins is 
dependent on two targeting signals, PTS1 and PTS2, which are recognised by the 
cytosolic receptors Pex5 and Pex7, respectively (Islinger and Schrader, 2011). Most 
peroxisomal matrix proteins harbour a PTS1 targeting signal, whereas few contain a 
PTS2.  However, alternative routes of import exist as not all matrix proteins contain a 
PTS1 or PTS2. Since peroxisomes are able to import folded and oligomeric proteins 
some proteins can hitchhike on PTS-containing proteins by binding to them a 
process known as “piggy-back import” (Glover et al., 1994; McNew and Goodman, 
1994). The mechanisms of this type of import remained a mystery (reviewed by 
Smith and Aitchison, 2013, Kim and Hettema, 2015). Pnc1 is targeted to 
peroxisomes, dependent on the PTS2 pathway but lacks a clear targeting signal 
(Anderson et al., 2003).  
A further aim of this study was to analyse the role of the AAA+ATPase Msp1 in 
peroxisome biogenesis. Yeast Msp1/Human ATAD1 is the third AAA+ATPase to be 
identified on peroxisomes, alongside Pex1 and Pex6 (Wiese et al., 2007; Grimm et 
al., 2016). Msp1/ATAD1 both localise to peroxisomes and mitochondria, and have a 
shared function in mitochondrial quality control. However, the peroxisomal role of 
each remains unknown (Wiese et al., 2007; Chen et al., 2014; Okreglak and Walter, 
2014; Grimm et al., 2016).   
 
6-2 Pnc1 import by piggy-back mechanism   
[[  
The first evidence of a piggy-back mechanism was observed when a subunit lacking 
a PTS was still imported into peroxisomes by interacting with another subunit 
carrying a PTS. Only few examples of a natural piggy-back mechanism have been 
reported (Islinger et al., 2009; Thoms, 2015).  
Pnc1 lacks a peroxisomal targeting signal but its import requires a functional PTS2 
pathway. We hypothesised that Pnc1 can be imported into peroxisomes by 
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interacting with another protein containing a PTS2. Only two PTS2 proteins are 
known in Saccharomyces cerevisiae and a third one was suggested to follow this 
pathway (Glover et al., 1994b; Cartwright et al., 2000; Jung et al., 2010). This 
suggested that one of these proteins could be a candidate factor involved in Pnc1 co-
import. Indeed, the localisation of Pnc1-GFP was followed in these mutants and we 
observed cytosolic mislocalisation in gpd1Δ cells. This observation gave the first 
evidence linking Gpd1 with Pnc1 import. This was confirmed by rescue of Pnc1-GFP 
peroxisomal import after expression of Gpd1 in gpd1Δ cells. In addition, both Gpd1 
and Pnc1 showed a strong correlation in expression under high osmolality (1M NaCl 
and 1M sorbitol) and these proteins shared a tripartite localisation to the peroxisome, 
nucleus and cytosol thereby suggesting a functional connection (Jung et al., 2010).  
We found that Pnc1 physically interacts with Gpd1 and Gpd1 import requires Pex7, 
alongside the cofactor Pex21, but not with Pex18. The same requirements were 
found for Pnc1 import as observed with two independent studies (Effelsberg et al., 
2015; Kumar et al., 2015). Previously, it was observed that Pex21 and Pex18 share a 
redundant function in the PTS2 pathway for thiolase import (Purdue et al., 1998). It 
was shown that Pex21 is required for PTS2 protein import in the absence of oleate or 
salt stress conditions when Pex18 is not significantly induced (Effelsberg et al., 2015). 
Thus, Pnc1 import is the first natural PTS2 piggy-backing mechanism to be identified 
in S. cerevisiae, which is dependent on Pex7, Pex21 and Gpd1. 
Many studies have demonstrated that PTS-less proteins can be imported by piggy-
back import via interacting with subunits carrying a PTS. In addition, this mechanism 
is described for both PTS1 and PTS2 pathways (Glover et al., 1994a; McNew and 
Goodman,1994; Elgersma et al.,1996; Lee et al., 1997; Thomas et al.,2008; Jung et 
al.,2010; Schueren et al.,2014). The piggy-backing import of Pnc1 with Gpd1 raised 
the question as to whether Gpd1 import via the PTS1 pathway could also co-import 
Pnc1. However, Pnc1-GFP could not be imported in mutant cells blocked in the 
PTS2 pathway (pex7Δ, pex21Δ), whereas Gpd1-mCherry-PTS1 was correctly 
imported via the PTS1 pathway. This observation is unusual as oligomeric import is 
reported for both PTS pathways. Piggy-back oligomeric import is reported even for 
the bacterial reporter protein chloramphenicol acetyltransferase (CAT) carrying a 
PTS1. CAT is a homo-trimer and CAT lacking a PTS1 can be imported when 
expressed with a wild copy of CAT-PTS1 (McNew and Goodman, 1994). 
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6-3 Pnc1 import depends on Gpd1 dimerisation   
 
Gpd1 has been reported to form a homo-dimer (Ou et al., 2006; Alarcon et al., 2012). 
We analysed the crystal structure of Gpd1 (in cooperation with Dr Patrick Baker) 
using the human and S. cerevisiae structures, and identified R270 and E195 as 
important residues at the dimer interface (Figure 6-1). As expected, the R270E 
mutation disrupts Gpd1 dimer formation and Pnc1 co-import. Microscopic and 
biochemical experiments showed that the Gpd1 R270E mutant failed to form a dimer 
with WT Gpd1 and was imported as a monomer. Even though Gpd1 R270E can be 
imported into peroxisomes, it failed to support Pnc1 co-import and confirmed that 
Gpd1 dimerisation is necessary for Pnc1 import.  
 
 
 
 
 
 
 
 
 
Figure 6-1: Homo dimerisation of Gpd1. A diagram of the crystal structure as generated by 
the Jmol programme, PDB=4FGW. Red = Glu195, Green=Arg270, Blue=alpha helix and Gray 
=beta sheet structure. 
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Furthermore, the finding that Gpd1-PTS1 cannot co-import ΔPTS2-Gpd1 via the 
PTS1 pathway, gives an explanation for the lack of Pnc1 co-import. A possible 
explanation for this observation is that Pex5 binding to the PTS1 prevents Gpd1 
dimerisation. Recently, in vitro studies revealed that Pex5 binds monomeric catalase, 
acyl-CoA oxidase and urate oxidase, and prevents their homo-oligomerisation. 
Import of monomers was shown to be more efficient than oligomeric import. These 
observations suggest that the peroxisomal import machinery prefers import of 
monomeric proteins. This could be favourable if the PTS1 is located close to the 
oligomerisation interface and Pex5 binding thereby prevents oligomerisation (Freitas 
et al., 2011; Freitas et al., 2015; Thoms, 2015). Whether this is the case for Gpd1 is 
unclear and further experiments are needed to solve this conundrum. The second 
explanation is that fast import of Gpd1-PTS1 could affect dimer formation due to 
depletion of the cytosolic pool of Gpd1. Mating experiments showed that this is not 
the case. However, Gpd1-PTS1 has the ability to co-import the ΔPTS2-Gpd1 dimer 
via its PTS2. Together these observations support a model where Pnc1 co-import 
requires Gpd1 to contain a PTS2 and to follow the PTS2 pathway.  
 In this study, it was shown that a double mutant of Gpd1 could artificially restore 
Gpd1 homo-dimerisation. Combination of the R270E mutation with E195R is able to 
restore dimer formation and Pnc1 import. From our data, we postulate a model for 
Pnc1 import that is dependent on Gpd1 homo-dimerisation, as well as Pex7 and 
Pex21 (Figure 6-2). Initially, the newly synthesised Gpd1 dimerises in the cytosol and 
then forms a complex with Pex7, Pex21 and Pnc1, which is imported into 
peroxisomes.  
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Figure 6-2: Our model of Pnc1 piggy-back mechanism. Newly synthesised Gpd1 
monomer dimerises in the cytosol. Subsequently, Pex7, Pex21 and Pnc1 form a pre-import 
complex with Gpd1 dimer followed by import into peroxisomes. 
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6-4 Msp1 peroxisomal function has not revealed yet  
 
Initially, Msp1 was identified as an AAA+ATPase family member involved in intra 
mitochondrial protein sorting (Nakai et al., 1993). The study described it as an 
integral membrane protein located on the outer mitochondrial membrane. However, 
the first evidence for its peroxisomal localisation came from proteomic studies on 
mouse kidney peroxisomes. In fractionation studies combined with mass 
spectrometry, the mouse homologue ATAD1 was identified as a novel component of 
the peroxisomal membrane (Wiese et al., 2007). ATAD1 shares 50% identity and 
70% similarity to Msp1. Two independent studies demonstrated that Msp1 and 
ATAD1 are dually localised to mitochondria and peroxisomes and that they are 
involved in mitochondrial quality control by clearing the MOM of mistargeted tail-
anchored proteins (Chen et al., 2014; Okreglak and Walter, 2014). However, their 
peroxisomal function remains undiscovered.  
We performed a detailed analysis to understand the peroxisomal role of Msp1. 
Deletion of NMD (fly homologue of Msp1) in S2 cells results in mislocalisation of 
peroxisomal matrix and membrane proteins (our lab data), so we wanted to 
determine if deletion of Msp1 displays the same phenotype. No matrix protein import 
defect was observed in S. cerevisiae cells deleted for Msp1, indicating that Msp1 
performs a different function to fly NMD. However, an increase in peroxisome 
number was observed in msp1Δ cells. Additionally, 10-30% of cells lost peroxisomes 
after overexpression of an Msp1 fusion protein. Together, these results suggest a 
role for Msp1 in regulating peroxisome abundance. Controlling the peroxisome 
number and size is a complicated process and may be associated with other 
processes such as; segregation, degradation of peroxisomes and de novo formation 
(reviewed by Smith and Atichison, 2013). Analysis of Msp1 involvement in these 
processes has not uncovered its exact peroxisomal function. This raises the 
possibility that Msp1 performs a redundant function with other peroxins or 
peroxisomal proteins.  
Genetic interaction studies of Msp1 alongside candidate peroxisomal genes was able 
to identify Pex25 as a factor associated with Msp1 function. Previous studies indicate 
that Pex25 is a peroxisomal membrane protein involved in controlling peroxisome 
number and de novo formation (Smith et al., 2002; Huber et al., 2012). Deletion of 
Pex25 showed a reduction in peroxisomal matrix import and peroxisome numbers, 
whereas deletion of Msp1 in pex25Δ cells was able to restore peroxisomal matrix 
import to WT levels. This observation suggests that Msp1 and Pex25 might work in a 
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pathway to regulate peroxisome number, whereby Msp1 suppresses peroxisome 
proliferation and Pex25 enhances this process (Figure 6-3). However, it is difficult to 
interpret the data because the complete peroxisomal function of Pex25 itself is still 
unknown. The suppression of the pex25Δ phenotype supports a role of Msp1 in 
peroxisome abundance, but factors in this pathway still need to be identified.  
 
 
Figure 6-3:  A model showing that Msp1 negatively controls peroxisome number, while 
Pex25 enhances peroxisome proliferation. 
 
We performed a SGA genome-wide screen using msp1Δ cells combined with all non-
essential gene mutants and did not uncover any Msp1 redundant factors. Our study 
has not resolved the peroxisomal role of Msp1. However, a genetic interaction was 
observed with a hypothetical gene called YGR168C. Deletion of this gene in msp1Δ 
cells led to restoration of peroxisome number to WT level. Further analysis was 
performed to try to understand the function of this gene. Unfortunately, Ygr168c 
expression was undetectable under its native promoter, but displayed peroxisomal 
localisation when expressed under an inducible promoter. This suggested that the 
YGR168C promoter might be suppressed under most conditions. Searches in 
expression databases did not uncover any potential conditions that would induce 
Ygr168c expression. Thus, interpretation of the peroxisomal role of Ygr168c needs 
more detailed bioinformatics and molecular studies, which this study has not covered. 
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6-5 Future directions 
 
Gpd1 cannot support co-import of ΔPTS2 Gpd1 or Pnc1 via PTS1 pathway. 
Therefore, in vitro transcription/ translation and size-exclusion chromatography are 
needed to test if Pex5 prevent oligomerisation. 
We observed an increase in peroxisome number in msp1Δ cells. The genome-wide 
SGA screening did not identify any mutants displaying a severe matrix protein import 
defect in combination with msp1Δ, but peroxisome numbers were not statistically 
analysed. Therefore, statistical analysis for peroxisome number in double mutants 
could be used to assist in identification of Msp1 interactors. Although, a genetic 
interaction with Pex25 and Ygr168c was observed, the exact function of these genes 
remains and their connection to Msp1 gene remains unknown. Therefore, proteomic 
studies could be used to find interactions between Msp1 and other peroxins or other 
peroxisomal membrane proteins, which could group Msp1 function to particular 
protein complexes or cellular pathways. In addition, 10-30% of cells expressing Msp1 
(under TPI1 promoter) lack peroxisomes, which can provide a tool to screen for 
mutants showing less or more severe peroxisomal phenotype. 
Ygr168c expression level is low under our conditions. It would interest to find 
conditions where Ygr168c expression is induced, as this may hint to the role of this 
protein in the peroxisomal membrane. Furthermore, double mutants of ygr168cΔ with 
pex mutants or overexpression may provide understanding of its role in controlling 
peroxisome abundance. Moreover, a genome wide screen combining ygr168cΔ with 
non-essential gene mutants can assist revealing its function. 
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